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This progress report from the Biomedical Computer Laboratory (BCL) I 
summarizes activities during the period from July 1, 1979 through June 
30, 1980. The Biomedical Computer Laboratory collaborates with research 
investigators throughout the Washington University School of Medicine I
and its affiliated hospitals in the application of advanced computer techniques 
to problems in biology and medicine. This often requires work in areas 
stretching from basic physiology through mathematical models to equipment Idesign. Our orientation is interdisciplinary with the recognition that 
effective communication for workers with differing backgrounds comes only 
through extended collaboration and mutual respect. I 
The vigorous development and evolution of specialized computer 
systems for use in the solution of research and clinical problems has 
continued to be the central focus of BCL activities. Several systems I 
now in clinical use have seen a progression from exploratory pilot studies, 
to major developmental project, to local clinical trial, to clinical trials 
in multiple locations, to public availability through commercial manufacture. 
Perserverance in this sometimes tedious chain of development has found I 
reward in the effective fielding of specialized computer systems to the 
medical community. I 
One class of computer applications requires strong coupling of 
the computer to its environment for digital signal processing. These 
applications typically involve the use of commercially available minicomputers Iand microprocessors in conjunction with specialized hardware designed and 
built locally. We have pursued many such applications by bringing signals 
from hospital wards and research laboratories to BCL by means of either 
analog or digital tape recordings or telephone lines and, more frequently, I 
by taking the computers to the investigator's laboratory or the patient's 
bedside. I 
For those classes of applications dominated by information processing 
requirements, provisions have matured from telephone lines linking our 
minicomputers to the IBM System/360-370 at the Washington University Computing IFacilities, through development and support of a minicomputer based MUMPS 
system, to the establishment of independent groups such as the Medical 
Computing Facility and the Medical Computing Service Group which serve 
the local medical complex. Diverse needs continue to be met by these various I 
options while collaborative work continues on more advanced information­
processing developments. I 
Still another class of applications requires extensive use of large­
scale computational services. Many investigators are assisted in their 
research through the use of generalized numerical, non-numerical, and sta­ Itistical routines. This work is carried out in part by staff members of 
BCL, but primarily by members of the Division of Biostatistics under the 
direction of Dr. Dabeeru C. Rao, and the University Computing Facilities 
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I	 The BCL enjoys collaboration with over 15 departmental divisions 
within the medical school but also finds support and enrichment through 
close ties with other facilities throughout the University. These arrange­
ments are of benefit both to the BCL and to graduate students who find 
projects and employment among the activities in the laboratory. The Department 
of Computer Science is under the direction of Dr. Jerome R. Cox, Jr., past 
Director of the BCL. Close collaboration with the department currently 
emphasizes the area of information systems. Strong ties with the Department 
of Electrical Engineering are sustained through the Engineering School's 
Biomedical Engineering Program and common interests in digital signal processing 
techniques. The Department of Electrical Engineering is chaired by Dr. 
Donald L. Snyder, past Associate Director of BCL. 
The Washington University Computer Laboratories is a federation 
of two research laboratories and two working groups which brings together 
the interests and resources of major segments of the University. The Bio­
medical Computer Laboratory is a component of the Medical School. The 
Computer Systems Laboratory is organizationally directly under the Chancellor. 
Both BCL and CSL share staff members with the Medical School and the School 
of Engineering and Applied Science. The Information Systems Group is housed 
within the Department of Computer Science and the Systems Design Aids Group 
is housed within the Department of Electrical Engineering. 
The Coordinating Committee for the Washington University Computer 
Laboratories is charged with the task of monitoring long-term interactions 
between programs. The present composition of the Coordinating Committee is: 
J.	 R. Cox, Jr., (Chairman) Principal Investigator for the Resource 
and Chairman, Computer Science 
R.	 J. Benson, Director, University Computing Facilities and Assistant 
Vice Chancellor 
S. B. Guze, Vice Chancellor for Medical Affairs 
E. L. MacCordy, Associate Vice Chancellor of Research 
J. M. McKelvey, Dean, School of Engineering and Applied Science 
C. E. Molnar, Director, Computer Systems Laboratory 
D. L. Snyder, Chairman, Electrical Engineering 
L. J. Thomas, Jr., Director, Biomedical Computer Laboratory 
D. F. Wann, Group Leader, System Design Aids 
To aid in long-range planning of the health-related activities of 
the Washington University Computer Laboratories, a National Advisory Panel 
meets periodically with the Coordinating Committee. Particular attention 
is given to the confluence of important needs in biology and medicine with 
the technical advances capable of meeting these needs. Successful developments 
by WUCL may suggest implementation on a larger, perhaps national scale. 




P. H. Abbrecht, Professor of Physiology and Internal Medicine, I




H. L. Bleich, Associate Professor of Medicine, Harvard University 
W. A. Clark, Consultant and former Director of CSL, Cambridge, I
 
Massachusetts 
J. N. Gray, IBM Research Laboratories, San Jose, California 
F. E. Heart, Bolt, Beranek & Newman, Cambridge, Massachusetts I
D.	 M. Kipnis, Professor and Chairman, Department of Internal Medicine, 
Washington University 
B.	 W. Matthews, Professor of Physics and Director of the Institute 
of Molecular Biology, University of Oregon I
 
J. M. Smith, Computer Corporation of America, Cambridge, Massachusetts 
E. A. Stead, Jr., Professor of Medicine, Duke University 
C. Vallbona, Professor and Chairman, Department of Community I
 































II. SOURCES OF SUPPORT 
I 
I During the period covered by this report the primary source of 
support for the Biomedical Computer Laboratory was a grant from the National 
Institutes of Health, Division of Research Resources. 
RR 00396 A Resource for Biomedical Computing. 
I A research grant to study the relationship of arrhythmias and sudden death sponsored by the National Heart, Lung and Blood Institute has continued, 
in collaboration with the Department of Medicine and the Jewish Hospital.
I HL 18808 Prediction and Prevention of Sudden 
Cardiac Death. 
I A subcontract was continued by the American Heart Association under 
I
 






Another subcontract was continued by the University of Rochester
 
under NHLBI grant HL 22982 to support establishment of a Multicenter Post­

coronary Risk Stratification Program.
 
I 
NHLBI contract N01 HV 72941 continues to fund a Holter Monitoring 
Core Laboratory to support a Multicenter Investigation of Limitation of 
Infarct Size. 
Collaborative research continues with St. Louis University, underI NHLBI Contract N01 HV 62960, to establish a data management system and with the Jewish Hospital of St. Louis for research sponsored by their 
contract with Sandoz-Wander, Inc. 
I 
I NCHSR grant HS 03792 was awarded to develop a medical information 
systems design methodology in the Computer Science Department and this 
laboratory. 
Collaboration with other investigators often involved work already 
supported by other grants.I 
I CA 04483 
EY 00256 
I EY 00336 





Public Health Services grants.
 
Effects of X-rays on Normal and Malignant Cells,
 
Factors Affecting Intraocular Pressure,
 
Glaucoma Clinical Research Center,
 
Automated Digital Processing of the Human Visual Field,
 
Clinical Correlations to Vitamin D Status in Infants,
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HL 07081 Multi Disciplinary Heart and Vascular Di~eases, 
HL 13851 Cyclotron Produced Isotopes in Biology and Medicine, 
HL 17646 Study of Ischemic Heart Disease, 
HL 18144 Preprocessor System for Cardiograms, 
HL 24394 Clinical Trial of Nifedipine During Cardiac Surgery, 
MH 31054 Mental Health in the Aged: Biomedical Factors, 
NS 03856 Auditory Communication and Its Disorders, 
NS 06833 An Interdisciplinary Stroke Program, 
NS 06947 Bioelectric Studies of Cerebral Cortex, 
NS 14834 Mechanisms of Seizures and Anticonvulsant Drugs, 




Personnel employed by the Biomedical Computer Laboratory during the 
period covered by this report were: 
Director 
Lewis J. Thomas, Jr., M.D., and Associate Professor of Anesthesiology, 
Physiology and Biophysics, Biomedical Engineering, and Electrical 
Engineering 
Associate Director 
G.	 James Blaine III, D.Sc., and Affiliate Associate Professor 
of Electrical Engineering and Computer Science * 
Assistant Director 
V. W. Gerth, Jr., M.S. * 
Senior Research Associate 
Jerome R. Cox, Jr., Sc.D., and Chairman, Computer Science, Professor 
of Computer Science, Electrical Engineering, and Biomedical 
Engineering in Physiology and Biophysics, Senior Research Associate, 
Computer Systems Laboratory 
Business Manager 
Virginia M. Bixon, B.S. 
Research Associates 
Robert J. Arnzen, Ph.D., and Computer Systems Laboratory 
R. Martin Arthur, Ph.D., and Associate Professor of Electrical 
Engineering 
Kenneth W. Clark, M.S. 
James G. Dunham, Ph.D., and Assistant Professor of Electrical 
Engineering 
A. Maynard Engebretson, D.Sc., and Central Institute for the Deaf 
Ronald W. Hagen, M.S., and Surgery (Cardiothoracic Surgery) 
Richard E. Hitchens, B.S., and Lecturer in Computer Science 
William F. Holmes, Ph.D., and Associate Professor of Biological 
Chemistry
 
Kenneth B. Larson, Ph.D.
 
*In March of 1980 V. W. Gerth, Jr. left the Laboratory and G. James Blaine III, 







James G. Miller, Ph.D., and Professor of Physics, and 
Associate Director for Biomedical Physics, Laboratory for Ultra­





Harold W. Shipton. C.Eng .• and Electrical Engineering I 
Research Assistants 
H. Dieter Ambos, and Medicine (Cardiology) IDavid E. Beecher, M.S.
 
Gary H. Brandenburger, M.S.
 
Michael W. Browder, M.S.
 




Nian C. Cheng, M.S.
 
Stanley A. Garfield, B.S.
 
Alexander J. Gray, B.S.
 
Robert H. Greenfield, D.Sc.,
 
Ophthalmology 
Ross K. Hartz, M.S. 
Russell E. Hermes, B.S. 
Janet A. Johnson, M.S. 
Margaret C. Jost, M.S. 
John R. Klepper. Ph.D. 
Ricardo G. Kortas, M.D. 
Joanne Markham, M.S. 











M. Michael Maurer, Jr., M.D., and Assistant Professor of Pediatrics 
Charles N. Mead, M.D. IJ. Philip Miller, A.B., and Assistant Professor of Biostatistics in 
Preventive Medicine
 




Jack G. Mottley, M.S.
 
Nizar A. Mu11ani, B.S., and Research Associate in Radiology
 
Michael A. Province, M.A •• and in Biostatistics
 IHeino R. Pull, B.S.
 
Wayne R. Roloff, B.S.
 
Kenneth B. Schechtman, Ph.D.




Engineering Assistants I 
Stanley R. Phillips
 






















Ellen M. Friedman, M.S.,
 

















Donald W. Stein, Jr.
 
Cami1e A. Stelzer, B.S. 
R.N. 
and in Biostatistics 
I 




J. Randall Thompson 
James S. vlallis 











Monica W. Shieh, M.L.S.I Secretaries 
I Rebecca J. Bozesky Jill D. Buchholz 
Elizabeth A. Dennis 
I Shirley A. Gonzalez-Rubio Celeste J. O'Rourke Polly E. Raith 
I The following members from other departments and divisions have joint appointments with the Biomedical Computer Laboratory to facilitate 
collaboration and enhance interdisciplinary research: 
I G. Charles Oliver, M.D., Associate in the Biomedical Computer 
Laboratory, Professor of Medicine and Chief, Cardiology Division, 
Jewish HospitalI Rexford L. Hill, III, M.S., Research Associate in the Bio~edica1 Computer Laboratory and Assistant Professor of Computer Applications 
in Radiology
I 




Carol S. Higgins, A.B., Research Assistant in the Biomedical Computer 
Laboratory and Research Associate in Radiology 
In addition, the following people worked at the laboratory for brief I 
periods: 





John R. Hamm, Ph.D.
 IThomas L. Hammonds 
G. Howard Hays, Jr., B.A.
 










RESEARCH COLLABORATORS IDuring the period covered by this report the following investigators 
from other laboratories, departments, or institutions, collaborated with 
BCL staff members on problems of joint interest. I 
J. Achtenberg, A.B., Medicine 
R. L. Allen, M.S., Electrical Engineering 
W. E. Ball, D.Sc., Computer Science IC. D. Barry, Ph.D., Computer Systems Laboratory 
D. Bauwens, M.D., Medicine 
B. Becker, M.D., Ophthalmology IW. L. Becker, Ophthalmology 
R. J. Benson, J.D., Computing Facilities 
L. D. Berenbom, M.D., Medicine 
S. R. Bergmann, Ph.D., Medicine I 
G. E. Bickmore, Radiology 
D. R. Biello, M.D., Radiology 
S. B. Boxerman, D.Sc., Health Care Administration and Planning Program IM. M. Buckley, Pediatrics 
K. R. Cash, Medicine 
B. K. Clark, B.S., Cardiothoracic Surgery IR. E. Clark, M.D., Cardiothoracic Surgery 
L. A. Coben, M.D., Neurology 
R. D. Cohen, M.D., Medicine 
P. B. Corr, Ph.D., Medicine and Pharmacology I 
W. A. Crafford, M.D., Medicine 
R. M. Doroghazi, M.D., Medicine 
A. A. Ehsani, M.D., Medicine IJ. O. Eichling, Ph.D., Radiology 
D. L. Elliott, Ph.D., Systems Science and Mathematics 




R. G. Evens, M.D., Radiology 




 D. C. Ficke, B.S., Radiology 
O. Fukuyama, M.D., Medicine 
I
 M. H. Gado, M.D., Radiology
 E. Gaelig, R.N., Medicine 
G. G. Garcia, Barnes Hospital
I,
 w. D. Gillette, Ph.D., Computer Science
 E. M. Geltman, M.D., Medicine 
S. A. Golden, B.S., Neurological Surgery 
D. w. Goldfarb, Computer ScienceI S. Goldring, M.D., Neurological Surgery w. J. Grodzki, Jr., D.D.S., Ophthalmology 
R. L. Grubb, Jr., M.D., Neurological Surgery
I
 K. v. Gurumurthy, M.S., Electrical Engineering
 S. N. Hack, M.S., Medicine
 
E. B. Hagelstein, B.S., Electrical Engineering 
I
 w. M. Hart, Jr., M.D., Ph.D., Ophthalmology
 A. Hernandez, M.D., Pediatrics 
R. R. Heye, M.S., Radiology 
L. S. Hillman, M.D., PediatricsI J. T. Hood, B.S., Radiology J. T. Hood, Jr., Radiology 
S. Igielnik, Ph.D., Medical Computing Facilities 
I
 A. S. Jaffe, M.D., Medicine
 G. C. Johns, B.S., Computer Systems Laboratory 
E. G. Jones, M.D., Ph.D., Anatomy 
I
 R. G. Jost, M.D., Radiology
 M. A. Kass, M.D., Ophthalmology 
B. Kumar, M.D., Radiology 
S. Lang, Ph.D., Physiology and BiophysicsI B. E. Laux, B.S., Radiology J. Y. Lee, Ph.D., Biostatistics 
R. A. Lerch, M.D., Medicine 
I
 P. A. Ludbrook, M.D., Medicine
 A. T. Marmor, M.D., Medicine 
R. E. Marshall, M.D. Pediatrics 
I
 L. A. Martin, C.P.N.P., Pediatrics
 C. J. Mathias, B.A., Radiology M. M. Maurer, Jr., M.D., Pediatrics 
T. R. Miller, M.D., RadiologyI J. W. Mimbs, M.D., Medicine C. E. Molnar, Sc.D., Computer Systems Laboratory 
T. H. Morrison, B.S., Electrical Engineering 
I
 R. A. Moses, M.D., Ophthalmology
 D. W. Murch, B.A., Pathology
 
M. O'Donnell, Ph.D., Physics
 
I
 R. E. Olson, A.A.S., Computer Systems Laboratory
 M. V. Olson, M.D., Genetics
 D. S. Payne, Medicine 












S. C. Prasad, Ph.D., Radiology 
J. L. Price, Ph.D., Anatomy 
J. A. Purdy, Ph.D., Radiology IM. E. Raich1e, M.D., Radiology and Neurology 
J. L. Roberts, M.D., Pediatrics 
R. Roberts, M.D., Medicine IA. Roos, M.D., Physiology and Biophysics 
F. U. Rosenberger, D.Sc., Computer Systems Laboratory 
J. E. Saffitz, M.D., Pathology and Medicine 
S. J. Salmons, P.N.P., Pediatrics I 
M. J. Schlessinger, Microbiology and Immunology 
S. M. Scott, M.D., Pediatrics 
D. P. Schreiter, B.S., Medical Computing Facilities IB. A. Siegel, M.D., Radiology 
D. H. Snyder, M.D., Medicine 
B. E. Sobel, M.D., Medicine IS. P. Sutera, Ph.D., Mechanical Engineering 
M. M. Ter-Pogossian, Ph.D., Radiology 
T. J. Tewson, Ph.D., Radiology 
A. J. Tiefenbrunn, M.D., Medicine I 
R. G. Tilton, Ph.D., Pathology 
L. J. Tolmach, Ph.D., Anatomy and Radiology 
J. R. Udell, B.S., Pathology IJ. L. Vacek, M.D., Medicine 
D. F. Wann, D.Sc., Electrical Engineering 
I. R. Weinstein, M.D., Medicine IM. J. Welch, Ph.D., Radiology 
C. S. Weldon, M.D., Cardiothoracic Surgery 
R. Wette, D.Sc., Biostatistics 
P. M. Wheelock, Medicine I 
J. R. Williamson, M.D., Pathology 
F. x. Witkowski, M.D., Medicine 
K. F. Wong, M.S., Computer Science IT. A. Woolsey, M.D., Anatomy 
Baptist Memorial Hospital, Memphis, Tennessee I 
R. S. Gordon, B.A. 
Central Institute for the Deaf, St. Louis, Missouri I 
D. H. Eldredge, M.D. 
G. Friedman, M.S. IR. G1aesner 
M. T. Hakkinen 
I. J. Hirsh, Ph.D. 
R. G. Karzon, M.A. I 
J. L. Lauter, Ph.D. 
J. D. Miller, Ph.D. 
R. B. Monsen, Ph.D. ID. A. Ronken, Ph.D. 
I 




 M. Skinner, Ph.D. 
J. P. Tadlock 
I
 N. R. Vemula, D.Sc.
 
Columbia University, New York, New York 
I J. T. Bigger, Jr., M.D. 
Creighton University, Omaha, NebraskaI F. M. Nolle, D.Sc. 
A. Zencka, M.D. 




Duke University Medical Center, Durham, North Carolina 
I D. B. Hackel, M.D.
 
Erasmus University, Rotterdam, The Netherlands
 
I K. L. Ripley, M.S. 
I
 Indiana University School of Medicine, Indianapolis, Indiana
 
C. Fisch, M.D. 
S. B. Knoebel, M.D.I Jewish Hospital, St. Louis, Missouri 
I
 L. L. Brandenburger, R.N.
 B. R. Hieb, M.D. 
J. R. Humphrey, R.N. 
I R. R. 
R. 
I S. P. 
E. Kleiger, M.D. 




Massachusetts General Hospital, Boston, Massachusetts 
I H. K. Gold, M.D. 
H. W. Strauss, M.D. 
I Mennen-Medical, Clarence, New York 








Mitchell Humphrey and Co., St. Louis, Missouri 
R. K. Stimac, B.S. I 
The MITRE Corporation, Bedford, Massachusetts 
R. E. Zapolin, M.S. I 
Pennsylvania State University, University Park, Pennsylvania ID. B. Geselowitz, Ph.D. 
Peter Bent Brigham Hospital, Boston, Massachusetts I 
E. Braunwald, M.D. 
Research Triangle Institute, Research Triangle Park, North Carolina I 
w. K. Poole, M.D. IRoosevelt Hospital, New York, New York 
H. M. Greenberg, M.D. I 
St. Louis University, St. Louis, Missouri 
S. M. Ayres, M.D. I 
M. Bland, R.N. 
A. E. Dyer, R.N. 
R. G. Evans, B.A. IS. A. Kaiser, R.N. 
H. S. Mueller, M.D. 
St. Luke's Hospital East, St. Louis, Missouri I 
R. Paine, M.D. I 
University of Illinois at Chicago Circle, Chicago, Illinois 
R. Langendorf, M.D. I 
University of Iowa, Iowa City, Iowa 
R. C. Arzbaecher, Ph.D. I 
University of Kentucky College of Medicine, Lexington, Kentucky I 
B. Surawicz, M.D. 
I 
I 
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1 University of Louisville School of Medicine, Louisville, Kentucky 
1
 N. C. Flowers, M.D.
 
University of Rochester School of Medicine, Rochester, New York 
I, A. J. Moss, M.D.
 




1 J. T. Willerson, M.D.
 
University of Vermont College of Medicine, Burlington, Vermont
 
D. S. Raabe, M.D.
 
1 Previous years have seen occasional collaborative efforts with various
 
computer firms and equipment manufacturers. This year projects of joint 
interest have involved:1 Mennen Medical, Clarence, New York and Hewlett-Packard, Waltham, 
Massachusetts - An arrhythmia monitoring system. 






IV. PHYSICAL RESOURCES 
The Biomedical Computer Laboratory was formed on April 15, 1964 and I 
the original staff moved into laboratory space at 700 South Euclid Avenue 
in Saint Louis next to the Washington University School of Medicine's main 
building complex. While the laboratory has remained at this location, the I 
floor space has increased from an original 5,515 square feet (gross) to 
the present 18,000 square feet (gross). Collaborative activities have frequently 
produced situations in which BCL staff members and systems occupy other Iareas within the Washington University Medical Center at or near the site 
of project applications. Facilities for computational applications, laboratories, 
staff offices and a reference room are located within BCL. Other physical 
resources include a well-stocked electronics shop, a large inventory of I 
electronic and computer test equipment, a variety of digital system modules 
and both digital and analog recording instruments. IThe Laboratory has steadily increased its computing capabilities 
since the time when a single LINC (Laboratory Instrument Computer) provided 
the original staff with an opportunity to apply a digital computer to 
interesting problems in medicine and biology. The small stored-program I 
LINC computer had been designed specifically for use in biological and 
medical laboratories where there was a requirement for strong coupling 
between the computer, the investigator and the experiment. That first I 
LINC is still used for a few service functions at BCL. During the past 
sixteen years BCL has addressed diverse medical and biological problems 
for which digital computing techniques seemed promising and appropriate, I
and today BCL has interest and involvement in over one hundred minicomputer 
systems (representing twenty different makes and models) within the Washington 
University Medical Center. In addition to these systems, BCL has direct 
responsibility for several systems which include a complement of computing I 
hardware and software from a variety of minicomputer system manufacturers. 
These resources include: I 
- PDP-II's from Digital Equipment Corporation
 
- TI-980's from Texas Instruments Incorporated
 
- PC-12's from Artronix, Inc.
 I
- l35's from California Data Processors
 
- System 7 from International Business Machines Corporation
 
- MMS-X's from Computer Systems Laboratory
 I 
Access to an IBM 360/370 system at the Washington University Computing Facility 
and to a MUMPS system at the Medical Computing Facility is available through 
several data terminals. Microcomputers of the personal class have been Iincorporated into the design of research instrumentation systems and several 
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I V. RESEARCH PROJECTS 
I Introductory Summary 
I The goal of the Biomedical Computer Laboratory (BCL) is the application of digital computing techniques to problems in medicine and biology. This 
often requires work in areas stretching from basic physiology through 
mathematical models and frequently to the design of specialized equipment.
I The Laboratory's capability to respond to a broad range of research needs is the direct result of long-standing BRP support. BCL's research program 
is organized into several major project areas with the staff grouped into 
I teams whose interests are focused correspondingly. This year, 80 individual projects can be categorized in nine areas. 
In the area of ischemic heart disease and ECG analysis, algorithmI developments for high-speed ECG processing have continued progress toward a major revision of Argus with emphasis on frequency-domain analysis. 
A new QRS detector and delineator has passed an extensive evaluation with 
I flying colors; and a recently developed strategy for supraventricular analysis has been shown to outperform commercially available state-of-the­
art processing. Novel work in ST-segment analysis from long-term ECG 
I
 recordings is still preliminary but it looks promising. Two ECG processing
 systems have full Argus/2H capability and are in heavy use for local,
 
national, and international collaborative studies ranging from fundamental
 
electrophysiology to large-scale clinical trials. A third system based




past year, Argus/2H software has been exported to Mennen-Medical, Inc.,
 
Dalhousie University in Nova Scotia, and Erasmus University in the Netherlands.
 




The American Heart Association database for the evaluation of dysrhythmia
 
detectors is now nearly complete and it provides an impetus for core research
 
to develop a model for detector-performance evaluation.
 
Collaborative work with the Department of Physics and the Division
 
of Cardiology continues to address tissue characterization via ultrasound
I through quantitative studies of both reflection (backscatter) and transmission
 (attenuation and time of flight), with tomographic reconstructions providing
 
assessment of the latter. A ray-tracing model of geometric acoustics
 
I




to simulate wave propagation in tissue. The effects of reflection, refraction,
 
and diffraction are included. Backscatter measurements have been correlated
 
with collagen content in infarcted hearts in vitro and with drug-induced
 
cardiomyopathy. Transmission scans of dog hearts have successfully imaged
 
post-infarction scarring in remarkable detail, using both time-of-flight
 
and attenuation parameters. The minimization of phase-cancellation effects
I through use of a locally developed acoustoelectric transducer, the inclusion
 of compensation for beam-width frequency dependence, and the application
 










Positron-emission transaxial tomography (PETT) systems continue 
to advance in both experimental applications and technological developments. 
PETT IV is now in routine use in the Barnes Hospital coronary care unit, 
where clinical studies have shown that scintigraphically delineated wall­ I 
motion abnormalities correlate with irreversible metabolic dysfunction 
(regional failure of IIC-palmitate uptake). During the past year, PETT 
IV has also been applied successfully to liver scanning, using a new radio­ I 
pharmaceutical, 68Ga-iron hydroxide colloid. Meanwhile, isolated-perfused­
heart studies which anticipate the capability for quantifying dynamic 
tracer uptake and clearance, have used PETT V to test the feasibility Iof estimating regional myocardial blood flow. Recent results are encouraging. 
PETT VI, the newest generation scanner just now being completed, will 
provide high-resolution and rapid (one-second) scans for small-animal 
studies such as those mentioned above, but its primary application will I 
be to extend current studies of regional blood flow and metabolism in 
the human brain. The rapid scanning capability of PETT VI is accomplished 
through the use of cesium fluoride rather than sodium iodide crystals Iin the scintillation detectors. As PETT VI nears completion, work is 
nOw beginning on the next generation scanner, "Super PETT," which will 
also employ CsF crystals plus a high-speed acquisition and preprocessing Isystem to achieve sub-nanosecond coincidence-timing resolution. The primary 
significance is that it should be possible to achieve sufficient information 
on differential time-of-flight estimates for coincidences to achieve an 
order of magnitude improvement in sensitivity over conventional PETT scanners. I 
Feasibility experiments have shown substantial improvements in image quality. 
Also, work is in progress to develop a non-deterministic model and to 
use the maximum-likelihood method of statistics for incorporating the I
time-of-flight data in image reconstructions. 
Over the past year radiation treatment planning activities have Imoved on from establishing the physical validity of our "delta volume ll 
method for computing three-dimensional absorbed-dose distributions in 
inhomogeneous media using differential scatter-air ratios. Work now focuses 
on the application of advanced digital systems with appropriate algorithmic I 
modifications to render the method practical in the clinical setting. 
By distributing tasks between a TI 980B computer and restructured macromodules 
which capitalize on opportunities for parallelism, it appears that the I
entire dose distribution in a 4096 cm3 volume can be calculated in about 
six minutes. As the system is being integrated, experiments are in progress 
for exploring ways to utilize the MMS-X display system for presentation 
of the dose distributions. I 
In the general area of systems for pathophysiologic studies, work 
on a clinical physiologic research system continues to be motivated by I 
a need for a systematic and flexible approach to the application of micro­
computers to acquisition and digital processing of physiologic signals. 
To this end, the IEEE-488 communication standard has been adopted to Iaccomodate both locally designed and commercially available hardware 
components and software modules have been written to serve as a useful 
library to support applications needs. The past year has seen new applications 


















extracellular cardiac potentials. The inventories of software modules 
and hardware designs continue to grow. Other projects include an M6800 
data-acquisition perimetry system which is now in active use for patient 
studies and a constant-area tomography system for tracking dynamic intraocular 
pressure changes, both in the Department of Ophthalmology. 
In addition to participation in Information Systems Group (ISG) 
activities to develop fundamentally novel approaches to system design, 
BCL maintains active participation in the development of several databases 
for disease management and research. The neonatology database is of 
central importance because it serves as a challenging test bed for the 
ISG work by virtue of its need to represent complex medical information 
relations and because it accomodates data sharing among several investigators. 
Other BCL databases support management functions for collaborative clinical 
research in ischemic heart disease at both the local and national levels 
(multicenter clinical trials and epidemiological studies). In general, 
as the data management tasks are completed, the verified data are transferred 
to other systems for extensive statistical analyses. Within the Medical 
School Community at Washington University, BCL supports only those databases 
directly relevant to our research activities. Most others are implemented 
and maintained by the Medical Computing Facility (MCF) , an administratively 
distinct service organization which was spawned by BCL in 1975. During 
the past year, BCL staff worked with the University's Computing Facilities, 
the Division of Biostatistics, and MCF to establish a new service facility, 
the Medical Computing Service Group (MCSG). The charge of MCSG is to 
augment and extend the functions of MCF by providing comprehensive support 
to biomedical investigators for the development, usage, management, and 
analysis of research databases. 
Speech and hearing research continues a longstanding collaboration 
with the Central Institute for the Deaf. Recent emphasis has been on 
the development of digital instrumentation for studies to explore electro­
cutaneous stimulation as an alternative sensory modality for speech perception, 
for the measurement of glottal source characteristics of normal and deaf 
talkers, for the development of visual displays for lip-reading studies, 
and for psychoacoustic studies of speech perception. The latter studies 
are directed toward an understanding of the acoustic and neural transformations 
which occur at the cochlear level and that are important in speech perception. 
To that end, the spectral characteristics of natural vowel sounds have 
been studied with a psychophysical hearing model and a comprehensive study 
of the relative merits of methods of vowel normalization has been undertaken. 
It appears that vowels can be best discriminated by the log transform 
of their spectral "shapes." This provocative finding has suggested new 
directions to be taken in theories of vowel perception. 
Several projects focus on various aspects of central nervous sytem 
diseases and electroencephalogram analysis in addition to those noted 
above which utilize PETT studies. A system for the collection and processing 
of averaged visual evoked potentials was completed during the year and 
is now in routine use for studies of senile dementia. The Laboratory 





Surgery to develop an automated system for monitoring EEGs of epileptic 
patients via indwelling electrodes. A prototype of a new system for 
analyzing neuroanatomical autoradiomicrographs is near completion. Studies 
of image-processing algorithms for counting individual silver grains in I
 
the radiographs have been initiated and detector-performance evaluations
 
are planned for the near future.
 I
 
Supporting activities span exploratory biomedical applications, 
system development aids, and digital hardware and software designs of 
general utility to other laboratory activities. An especially promising I

exploration is a new collaboration with the Department of Genetics to 
develop an automated electrophoretic gel reader in support of a global 
approach to physical mapping of eukaryotic DNA. The design of a cross 
assembler for the M6800 based on our previously developed FORTRAN cross­ I
 
assembler (FOCRAS), the characterization of solid-state video imaging
 
devices, and the extension of our generalized "universal storage device"
 
to satisfy data acquisition needs on multiple projects are all examples
 I
 



























I Individual Projects 
I A. Ischemic Heart Disease and ECG Analysis 
I 
Many of the projects reported in this section represent long-standing 
work in signal analysis of the electrocardiogram (ECG) including algorithm 
development toward improving analysis of the ECG signal as well as applications 
of existing signal-analysis technology to the processing of tape-recorded 
ECGs acquired for local and multicenter studies. Algorithm developmentI focuses on time- and frequency-domain measures which are likely to improve QRS-detection and QRS-c1assification performances. Higher-level algorithm 
development focuses upon more recent strategies for the detection of 
I supraventricular arrhythmias and ST-segment-deviation changes. Current algorithms are used in two "Argus/2H" computer systems for rapid analysis 
of 24-hour, tape-recorded ECGs from a local clinical trial of nifedipine 
I in cardioplegia, a multicenter investigation of limitation of infarct size, a multicenter post-infarction risk program, and a variety of smaller 
studies. One system is also used for the creation of the American Heart 
Association database of ventricular arrhythmias, work which has stimulated 
I the formulation of a performance evaluation model which, in turn, might be used when automated analysis systems are evaluated with the database. 
The systems have been used since 1977-1978 when they succeeded a prototype 
I Argus/H system which analyzed several thousand long-term ECGs for a natural history study of sudden death. Rigorous biostatistica1 analysis of that 
I 
study is underway, and major findings to date are reported here. Interest 
in Argus/2H, here and abroad, has resulted in both partial and full export 
of its software. 
I 
BCL personnel are involved in many other local investigations of 
ischemic heart disease. Digital techniques applied to clinical echocardiog­
raphy are reported in this section, whereas other ultrasonic work applied 
to tissue characterization is considered in section B. In other investi­
I gations, BCL involvement is less direct and of a more collaborative nature. These projects include enzyme-release kinetics, myocardial perfusion and 












A-I. Argus Algorithm Development 
Personnel: K. W. Clark, BCL 
R. G. Kortas, BCL 
P. W. McLear, BCL 
C. N. Mead, BCL 
S. M. Moore, BCL 
S. J. Potter, BCL 
L. J. Thomas, Jr., 
E. Thompson, BCL 







Long-range plans call for a complete revision of the Argus algorithms. 
The first step, development and evaluation of a new QRS detector/delineator, 
to replace the current Primitive, has been completed and reported. l Imple­ I 
mentation of .the new detector awaits completion of a revision of the Cycle 
algorithm for QRS classification. The present Cycle algorithm is limited 
to classifying beats as normal, PVC, abnormal (but not PVC), and borderline. IThe revised Cycle will assign only shapes, not labels, and will include 
a feedback loop to the new detector to supply Q-Q and S-S intervals of 
normal-shaped beats. A new algorithm, called "Sequence," will make final 
beat classi:ication and incorporate logic from the current Cycle algorithm I 
for PVC labeling, global logic using total tape cluster information adapted 
from machine-edit strategies for confirming Cycle-flagged PVCs as true-
PVCs, and logic excerpts from recent work in the area of supraventricular I 
dysrhythmic event detection. In addition to QRS detection and classification, 
algorithms to detect ST-segment changes are under investigation. The 
QRS detector, recent work in supraventricular dysrhythmia analysis, and Iearly work in ST-segment analysis are reported here. 
gRS detector/delineator. An evaluation data set consisted of more 
than 300,000 QRS complexes from 145 different waveform segments of 15 I 
to 30 minutes duration. Each waveform segment was analyzed by the detector 
and the results reviewed on a beat-by-beat basis by one of four technicians 
using a special version of the Argus/2H edit program. In reviewing each I 
detected complex, the technician indicated whether or not the candidate 
complex was a real event, P wave, T wave, or noise. For real events, 
the technician approved or disapproved of the detector's determination Iof both onset and termination. Real events missed by the detector were 
"inserted" by the technician. Individual beat information as well as 
all technician decisions were retained in machine-readable form so that 
machine-generated summaries were easily produced. The evaluation criteria I 
were (1) false-positive rate, (2) false-negative rate, and (3) percentage 
of total beats measured correctly. The false-positive rate was computed 
as the number of P waves, T waves, and noise events detected as QRS complexes. I 
~- The false-negative rate was computed from the number of technician-inserted 
beats. The complex was considered to be measured correctly if (a) either 
onset or termination was correct; (b) no "major" vectors of the complex Iwere missing, and (c) no "major" vectors from surrounding P wave, T wave, 
I 














or noise were included in the complex. The term "major" was defined as 
greater than 30% of the largest vector of the complex. Of 301,292 QRS 
complexes from 131 recordings of one-half hour each, the detector's false­
positive rate was 0.7%, false-negative rate was 0.1%, and correctly-measured 
rate was 99% (both onset and termination were correctly measured in 95% 
of the complexes). In a subset of 14 recordings which included 33,130 
QRS complexes and which were chosen because the standard Argus detector 
found in them a significant percentage artifact, the new detector proved 
mildly superior to Argus in correct delineation and false-negative rate 
but especially superior in false-positive rate (2% vs. 9%). In a set 
of 14 recordings of 15 minutes each, supplied by Hewlett-Packard, which 
consisted of very-low-amplitude PVCs, the new detector also proved superior 
to the Argus detector. The lower false-positive rate should be of considerable 
interest to providers of false-alarm-ridden real-time monitoring systems; 
the lower false-negative rate would be especially important in the analysis 
of recorded long-term electrocardiograms. 
Supraventricular dysrhythmia analysis. Early work in the detection 
of supraventricular dysrhythmic events (PR 15, A-l) has progressed and 
been reported. 2 At this point, the system routinely indicates the presence 
or absence of such events; an evaluation of frequency of individual beats 
and episodes has not yet been conducted. The procedural steps can be 
categorized as being either active or passive, from the computer's point 
of view, depending upon whether algorithmic computations on the Cycle 
stream data are required (active) or whether a simple search on a specified 
parameter suffices (passive). 
Passive approaches include interactive review of suspiciously short 
and long intervals, shortest and longest Normal-Normal intervals, and 
fastest and slowest 5-beat heart rates. These methods are likely to uncover 
missed low-amplitude QRS complexes, bradycardias and tachycardias, 2nd 
and 3rd degree AV blocks, SPCs and SPC salvos, PST, escape beats, QRS-like 
noise spikes, signal dropouts, excessive baseline wander, and evidence 
of battery failure. 
Active approaches focus on the forward coupling interval (FCI) 
and backward coupling interval (BCI) ratios (r = FCI/BCI) of Normal and 
Borderline beats. Dispersion of individual fifteen-minute frequency dis­
tributions of all {1/2 < r < 3/2} is used to qualify the period as pre­
dominantly "normal-sinus rhythm," "sinus arrhythmia," or "atrial fibrillation." 
Periods of normal-sinus rhythm are more closely scrutinized to identify 
SPCs which then may be reviewed as true or false with an interactive SPC-
edit program. 
We regard our approach to background rhythms as still experimental 
and threshold values are mostly empirical. Meanwhile we are collecting 
a database sufficient for rigorous evaluation. Although the method appears 
to work where sinus arrhythmia or atrial fibrillation is the dominant 
rhythm, we have too few examples to test the response to paroxysms of 
either. These algorithms do nothing more than identify those waveforms 





the scrutiny of the electrocardiographer, who may then differentiate between 
events such as atrial and junctional premature complexes. Supraventricular 
arrhythmias not specifically addressed by this strategy are: regular junctional 
rhythm, first degree heart block, atrial flutter, shifting atrial mechanism, I 
atrial parasystole, and atrial fusion beats. 
Because we have neither a large database of supraventricular arrhythmias I
annotated beat-by-beat nor the economic means to generate one, it has 
not been possible to perform a thorough evaluation of this strategy. We 
have compared our results, however, with those of the leading nationwide Icommercial scanning service in St. Louis. Sixty-four tapes were selected 
from those already processed by Argus/2H and sent to the scanning service 
for full processing, including cardiologic review. The method of tape 
selection was specifically designed to increase the probability that Argus/2H I 
had missed a supraventricular event of interest. We had observed from 
the results of an earlier post-infarction study, that the best predictor 
of the arrhythmic content of an ambulatory recording is another recording Ifrom the same patient, even though separated by several months. Accordingly, 
we chose only those for which both 3-month and 6-month recordings were 
available and for which Argus/2H had identified a supraventricular arrhythmia 
on one but not the other and for which the arrhythmia in question could I 
not be detected on the basis of heart rate alone. No instances of atrial 
fibrillation were represented in this subset. I 
Neither the scanning service nor their cardiologist has any connection 
with our institution and the purpose of the processing was not revealed 
until after all tapes and results were returned. Argus/2H outperformed Ithe commercial scans: 92% versus 74% for the presence of SPCs and 94% 
versus 44% for the presence of SPC couplets and runs. Neither processing 
uncovered any episodes of paroxysmal supraventricular tachycardia, atrial 
fibrillation, or sinus arrhythmia and we have no independent evidence I 
that any were present. Most of the recordings included significant ventricular 
ectopic activity; 47 showed multiform PVCs and 27 contained PVC couplets. I 
ST-segment changes. Automated ST-segment analysis in long-term 
ECG recordings has received little attention primarily because of lack 
of control over the calibration of the ECG during recording and playback. ICalibration is of course crucial to the reporting of diagnostic statements 
of absolute millivolts of ST elevation or depression with which the physician 
is familiar. Nonetheless, significant ST-segment changes within a long-
term ECG recording may warrant at least the attention of the physician. I 
On that hypothesis, we began to formulate algorithms for detection of 
ST-segment changes within long-term ECG recordings. I 
Utilizing an edited Cycle data stream of beat labels and occurrence 
times, the first ST routine searches every 2 minutes of real-time-equivalent 
Cycle for 8 consecutive normal beats with stable interbeat intervals. IThe heart rate is computed and digital waveform samples for the octet 
are signal-averaged. The Aztec and Primitive data-reduction algorithms 
are run on the averaged waveform to specify QRS onset, termination, duration 








 milliseconds in the front of the QRS. The ST segment is defined as the 
'I
 curve of best fit through "x" points beginning "y" points beyond the QRS.
 Computed ST parameters are absolute elevation/depression, elevation/depression 
as a percent of QRS height CPQH) , slope, and area. The metric PQH to 
some degree compensates for amplitude variations arising from signal-gain 
1 adjustments permitted the playback-device operator attempting to optimize performance of the arrhythmia detector. 
A second ST routine displays a time-PQH histogram designed to reveal1 sustained or transient elevation/depression or gradual or abrupt changes. 
1 
From the gross display, an operator may view the episode of maximum PQH 
or any other episode by setting a time-axis cursor. The secondary display 
includes the episode, an expanded view of the averaged complex with delineator 
tics for baseline and ST segment, and numerical measurements. Plots and 
printouts preserve display content. 
1 A rigorous evaluation of the ST algorithms has been stymied by 
an inadequate database of interesting, bizarre, and challenging examples 
of ST-segment deviations. Extramural investigators have been solicited1 for such examples so that we can expand the database to test ST algorithms and future refinements to them. 
1 
1 1. C. N. Mead, K. W. Clark, S. J. Potter, S. M. Moore and L. J. Thomas, 
Jr., "Development and Evaluation of a New QRS-Detector/Delineator," 
Proceedings of the IEEE Conference on Computers in Cardiology, IEEE 
Catalog No. 79CH1462-lC, Geneva, Switzerland, pp. 251-254, September 
26-28, 1979. 
1 2. L. J. Thomas, Jr., K. W. Clark, C. N. Mead and J. W. Mimbs, "Supra­ventricular Arrhythmias: Strategies for Detection," in Ambulatory 
ECG Recording, Year Book Medical Publishers, in press. 
1 
1 A-2. High-Speed ECG Processing: Hardware 
Personnel: R. E. Hitchens, BCL1 S. M. Moore, BCL T. L. Weadon, BCL 
1 Support: RR 00396 
1 Work has continued on the upgrade of IBM System/7 hardware CPR 15, A-2) in order to add peripheral support necessary to process and edit 24-hour 
2-channel Holter recordings. A 160 megabyte disk system CPR 15, G-17) 
has been tested and diagnostic programs have been written. The cycle-steal1 800/1600 bit-per-inch tape system has been designed, built and tested. 
1
 




The design of an LSI-II based high-speed oscilloscope display is under 
way. This system will be DMA refreshed from the LSI-II memory, thus in­
creasing the System/7 memory space available for programs. In addition, 




A-3. High-Speed ECG Processing: Software 
I
Personnel: K. W. Clark, BCL
 
S. M. Moore, BCL 
S. J. Potter, BCL 












Operational software for the two Argus/2H systems has temporarily 
reached a stable state. No significant additions were made last year. 
In the near future, we expect to implement promising algorithms which I
 
are beyond the early stages of development and include a new QRS detector/ 
delineator, supraventricular arrhythmia analysis, and ST-segment analysis 
(A-I). I
 
The Argus/H system is being revamped into an Argus/2H-like system.
 
A new operating system and file-handling software have been written (PR 15,
 
A-3). A dual-density tape drive and two high-density disk drives were
 I
 
recently added; software utilities for use with those new devices have
 
been written. Although the high-speed scan algorithms (Aztec, Primitive,
 
Cycle) for processing long-term ECGs were originally written on the Argus/H
 I
 
system, they have been rewritten for more efficient processing. Near-future 
plans call for the writing of post-scan programs necessary for 

















I A-4. Holter Tape Processing 
1 Personnel: K. W. Clark, BCL H. D. Ambos, BCL 
T. L. Hammonds, BCL 
I.	 W. R. Hosman, BCL K. A. Madden, BCL 
M. A. Marlo, BCL 











·'I While the Argus/H system undergoes hardware and software reorganization;
'I (A-2, A-3), only the two Argus/2H systems are used for processing long-f',:- term (Holter) ECG recordings. These two systems are used primarily for the Multicenter Investigation of Limitation of Infarct Size (MILlS) (A-2l) 
and the Multicenter Post-Infarction Program (MPIP) (A-19). The tape pro­
'''';< 
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cessing protocols for these studies were described last year (PR 15, A-4). 
The total number of tapes analyzed for these ongoing studies is 772 (MILlS) 
and 367 (MPIP). Data management support for these projects is described 
elsewhere (D-8). The systems have also been used for an efficacy study 
of LB-46 (Prindolol) (PR 14, A-6) and a clinical trial of nifedipine in 
cardioplegia (A-22). Systems tlme not used to process recordings is dedi­




A-5. Argus Exportation 
Personnel: K. W. Clark, BCL IR. E. Hitchens, BCL 
C. N. Mead, BCL 
S. M. Moore, BCL 
K. L. Ripley, M.S., Erasmus University I 
J. A. Ritter, M.S., Mennen-Medical 
J. Sherwood, Dalhousie University 
L. J. Thomas, Jr., BCL I 
Support: RR 00396 
I 
The Argus/2H computer system for analysis of Holter-recorded ECGs 
was designed and assembled in a fashion we perceived as amenable to exportation 
to the commercial sector or at least to other research institutions. IFor one reason or another, system duplication never came to pass except 
for a local replication (PR 15, A-2) when we were charged with processing 
Holter recordings for a Multicenter Investigation of Limitation of Infarct ISize (A-2l). Nonetheless, we have been quite active in the dissemination 
of some of the Argus/2H algorithms and/or software. 
Mennen-Medical has adapted the essence of the QRS detector/delineator I 
(A-l) for use with their real-time monitoring system. Erasmus University 
has applied portions of the software to Holter-tape analysis for use in 
an international multicenter drug study. Dalhousie University is incorporating Iportions of the Argus/2H software into a Holter-tape analysis system whose 
hardware configuration is quite similar to that of Argus/2H. Several 















 A-6. Extended Analysis of Argus/H and Argus/2H Quantified VEA 
I Personnel: J. P. Miller, BCL K. W. Clark, BCL 
E. M. Friedman, BCL 
I R. E. Kleiger, M.D., Jewish Hospital S. M. Moore, BCL 
G. C. Oliver, M.D., Medicine 











Following the processing and editing of Holter tapes by Argus/H 
or Argus/2H (A-4) the beat-by-beat annotation of the 10- or 24-hour recordingsI (Cycle streams) were accumulated on industry-compatible tape and transported to the IBM System/360-370 for bulk processing in order to extract salient 
features of the ventricular ectopic activity (VEA). 
I 
I SUMMARY (PR 12, A-2), the PL/I program which runs on the System/360-370 
and is designed to reduce the Cycle streams to variables of interest, 
was altered so that both Argus/H and Argus/2H created Cycle streams could 
be utilized to produce the expanded output for each PVC on the record 
(PR 15, A-6). The revised S~~RY will then be utilized to reprocess 
the tapes acquired in the Sudden Death Study (A-7) to more fully understandI the relationships among the various features of the ambulatory ECG and the type of VEA observed on the tapes. 
I A more extensive analysis of ventricular runs (3 or more consecutive 
I 
PVCs) was completed. Of 1822 recordings obtained on 289 patients two 
weeks to twelve months post MI, 1464 had at least one PVC, and 136 (7.5%) 
had at least one run. Eighty-five of the tapes with runs (62.5%) had 
at least one episode of VTACH (runs with average rates over l20/minute), 
while 70 of them (51.5%) had at least one episode of AIVR (runs with rates 
under l20/minute). Since 20 of the 70 tapes with AIVR also had VTACH,I it was questioned whether the conventional wisdom of AIVR being a benign 
I 
arrhythmia was prudent. When the tapes were stratified by PVC rate, tapes 
with couplets, bigeminy, multiform PVCs or late PVCs (coupling intervals 
greater than 600 ms) carried an additional risk of runs, thus supporting 
the concept that complex VEA are associated among themselves, relatively 
I 
independent of PVC rate (PR 15, A-6). R-on-T did not appear to carry 
this same independent risk, although PVCs with coupling intervals either 
less than 400 ms or more than 600 ms were more likely to initiate couplets 
or runs than PVCs of 400-600 ms. 
I Day-to-day variation estimates of some 65 of the Summary-program (PR 12, A-2) variables were also obtained, using 24-hour Holter recordings 
I 





made on eighteen patients enrolled in a double-blind, cross-over study 
on antiarrhythmic agent (VIB). For each patient, four recordings were 
utilized, two made within one-day intervals during the control phase, Iand two made within one-day intervals during the placebo phase. Thus, 
for each variable, a 36 degree-of-freedom estimate of the day-to-day variation 
within patients was obtained. These estimates can now be used in assessing 
the significance of the variations found in these variables across recordings I 
made from the same patient (or different patients) throughout the year 
following their MI. The average PVC rate/hour (in log 10 scale) was found 
to have a within-patient standard deviation of .20. Similarly, the average I
couplet rate/hour and the average run rate/hour had standard deviations 
of (in log 10 scale) 0.24 and 0.29, respectively. The within-patient 
standard deviation for average heart rate (in beats/min) was 3.8, while Ithe average non-PVC to PVC and average PVC to PVC coupling intervals 
in ms had within-patient standard deviations of 18 and 55, respectively. 
The intrapatient variances for PVC rate appears to be due largely to the 
Argus reprocessing error (PR 14, A-6) while heart rate is more reflective I 
of changing	 day-to-day activity levels. 
I 
A-7. Natural History Study of Sudden Death I 
Personnel:	 G. C. Oliver, M.D., Medicine 
L. L. Brandenburger, R.N., Jewish Hospital 
K. W. Clark, BCL I 
J. R. Humphrey, R.N., Jewish Hospital 
R. E. Kleiger, M.D., Jewish Hospital 
R. J. Krone, M.D., Jewish Hospital IJ. P. Miller, BCL 
P. T. Wallace, Jewish Hospital 
P. Moore, BCL IM. A. Province, BCL 
S. Thanavaro, M.D., Jewish Hospital 
L. J. Thomas, Jr., BCL 
E. Thornton, BCL I 
Support:	 RR 00396 





We have completed the clinical and demographic data collection 
on 2175 patients recovering from myocardial infarction. During the past 
year, we have thoroughly scrutinized the database, and believe we have I 









I Several important studies have examined the relationship between 
clinical features which characterize patients during their coronary care 
unit stay and their subsequent prognosis. The first focused on in-hospital 
mortality. We found that the type of infarction (transmural vs. non-transmural) 
was of only minor importance, if any, in predicting survival whereas the 
I,
 levels of serum enzymes (which reflect the amount of myocardium damaged)
 was of considerable importance. As a group, patients with non-transmural 
I
 
infarction had a lower in-hospital mortality (3% vs 11%, p < 0.01) but
 
this difference was no longer significant if the analysis corrected for
 
the higher SGOT levels present in patients with transmural infarction.
 
I 
More recently we have investigated the long-term prognosis of the 
same patient population, again comparing patients with first transmural 
to those with first non-transmural infarct. We found that risk factors 
for death in the first year (measures of the amount of left ventricular 
damage) were not successful in predicting mortality 2-3 years after infarction.I In contrast, at this late stage of recovery, patients with non-transmural infarcts, particularly those aged 65-75 years, had an extremely high death 
rate. 
I 
I Other studies have identified clinical features which best predict 
the occurrence of runs of ventricular tachycardia during the year following 
an infarction. Using only data routinely available on patients during 
their coronary care unit stay we were able to divide patients into quartiles 
of risk. Those in the highest risk quartile had a ten-fold higher incidence 
of runs over those in the lowest quartile.I Finally, we evaluated the relationship between length of Holter 
recordings and the likelihood of detecting ventricular arrhythmias. We 
found that one hour of recording was insensitive for detecting complex 
arrhythmias except in patients with peak PVC rates of 30 or more per hour. 
Twelve hours of recording detected 92% of patients with complex PVC's 
(multiforms, couplets or runs), or high PVC rates, but only 76% of those 
with runs. Thus, the choice of an appropriate recording duration is 





A-8.	 Development of the American Heart Association Database for Arrhythmia 
Detector Evaluation 
IPersonnel: R. E. Hermes, BCL 
R. M. Arthur, BCL 
D. B. Geselowitz, Ph.D., Pennsylvania State University 
M. P. McInnis, BCL I 
G. C. Oliver, M.D., Medicine 
L. J. Thomas, Jr., BCL 
E. Thornton, BCL I 
Support:	 RR 00396 
HV 72989 I 
This project has had as its goal the development of a database 
for the evaluation of automated ventricular arrhythmia detectors. The I 
database consists of 160 digital tapes, each containing a digitized 3-hour 
segment of a two-channel ambulatory ECG recording. Each recording has 
been sampled at 250 samples per second, 12 bits per sample. Each QRS Icomplex in the final half hour of each record is annotated on a beat-by­
beat basis. 
IThe database is divided into eight distinct arrhythmia classes. 
Each class, which contains 20 tapes, is further subdivided into two parts, 
a test set and a developmental set. This format allows evaluation of 
VAD performance on all or any select types of ventricular arrhythmias. I 
The eight classes are No PVCs, Isolated Uniform PVCs, Isolated Multiform 
PVCs, Bigeminy, Couplets, R-on-T, Ventricular Rhythms, and Ventricular 
Fibrillation. I 
Assimilation of data for use in the database was handled by an 
organization of independent committees of well respected members of the 
cardiology community. Integral parts of the organization were the Tape I 
Selection Committee, the Committee of Expert Electrocardiographers, and 
the Contributing Institutions. The Biomedical Computer Laboratory (BCL) 
has served as the center for the development of this database under the I
supervision	 of the American Heart Association Committee of Electrocardiography. 
The Tape Selection Committee consists of four leading authorities Ion arrhythmias and arrhythmia detection: Dr. Robert C. Arzbaecher, University 
of Iowa; Dr. Nancy Flowers, University of Louisville; Dr. J. Thomas Bigger, 
Jr., Columbia University; and Dr. Suzanne Knoebel, Indiana University. 
Individual committee members, on regular visits to the BCL, chose candidate I 
tapes for entry into the database. Then at periodic meetings of the entire 
committee, tapes were accepted to become part of the final database. IThe expert electrocardiographers have annotated, individually, 
each tape selected for database inclusion. Members of this committee 
are: Dr. Charles Fisch, Indiana University; Dr. Borys Surawicz, University 
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I has this group annotated each beat of each record, but they have noted 
the noise contents and background rhythms contained in the tapes as well. 
I 
I Two-channel ambulatory tapes were solicited from interested institutions. 
Seventeen major contributing institutions as well as several individual 
contributors have submitted a total of over four hundred tapes. The 
institutions are: 
Contributing Institutions 
I Alleghany General Hospital Pittsburgh, PA 
William Beaumont Hospital Royal Oak, MI 
I Cleveland Metro. General Hospital Cleveland, OH University Hospital Copenhagen, Denmark 
Cornell University New York, NY 
I Creighton University Omaha, NB Danbury Hospital Danbury, CT 
I 
Duke University Durham, NC 
Kyusha University Fukuoka, Japan 
Louisville Jewish Hospital Louisville, KY 
I 
Institute of Cardiology Montreal, Canada 
Lariboisiere Hospital Paris, France 
Thoraxcentrum Rotterdam, The Netherlands 
University of California Los Angeles, CA 
University of California - V.A. Hosp. San Diego, CA
 
Washington University St. Louis, MO
I Yale University New Haven, CT
 
I Rigorous protocols were established for the selection of the database 
I 
tapes. First, contributors sent tapes to the BCL for preliminary processing 
by the Argus/2H system. A four-hour portion of each tape considered to 
be of sufficient quality and content was reviewed by a member of the Selection 
Committee. Of the more than 400 tapes submitted, 299 were reviewed by 
the Selection Committee. Those not reviewed were considered technically 
inadequate or contained insufficient arrhythmias for database inclusion. 
I 
I The four-hour segments reviewed by individual members of the Selection 
Committee were either accepted, rejected, or held for later review. If 
a tape was accepted, a three-hour portion (from the four-hour record) 
was proposed as a candidate for the final database. 
I Tapes accepted during individual review were then reviewed by the full committee and were again either accepted, rejected, or held. Only 
those tapes accepted were sent to the Expert Electrocardiographers for 
annotation. 
I 
I The last half hour of each tape accepted was written out on paper 
strips with each QRS complex indicated by a time of occurrence marker. 
These strips were sent independently to each of the three electrocardiographers 
who annotated each beat. Complete agreement among all electrocardiographers 
I 




was necessary before a beat annotation was accepted as final. Disagreements 
were resubmitted to the experts for re-examination and ultimate resolution. 
Currently, the database has 145 of the needed 160 tapes. With the use 
of the MECCA system (A-9) installed in the Jewish Hospital Medical Intensive I 
Care Unit as well as various other resources, the rare tapes needed to 
complete the Ventricular Fibrillation and R-on-T classes should become 
available. Meanwhile final processing, documentation, and microfilming I 
of all other tapes is continuing. 
Efforts are being made to find a database distribution center which Iwill act as a service organization for providing users of the database 
with copies of the database tapes and technical assistance. In addition, 
methods of distribution of the developmental tapes and associated documentation 
are being formulated. l Protocols for system evaluation using the test I 
set of tapes are also under consideration. These plans for distribution 
and evaluation are expected to be complete before the final database is 
ready for release. Until then, a database tape format description and I 
an example tape are being distributed to potential database users so that 
they may familiarize themselves with the database. The projected date 
for completion is December 31, 1980. I 
1.	 R. E. Hermes and G. C. Oliver, "Use of the American Heart Association 
Database," in Ambulatory ECG Recording, Year Book Medical Publishers, I 
in press. 
I 
A-9. MECCA System I 
Personnel: R. E. Hermes, BCL 
R. M. Arthur, BCL 
B. R. Hieb, M.D., Jewish Hospital I 
S. R. Phillips, BCL 
Support: RR 00396 IHV 72989 
IA continuing effort has been made to make the MECCA system functional 
(PR 15, A-9). Many problems have had to be overcome because of the environment 
in which the system must function. The system is designed to collect 
3 to 4 hours of ECG data on any 4 patients within the Jewish Hospital I 
Medical Intensive Care Unit (MICU). Original plans called for four mobile 
ECG amplifier carts to be moved to the bedside of each patient to be 
monitored. This plan required MICU staff to move the carts from bedside Ito bedside as well as to apply an extra set of five electrodes to the 
patient and to connect a cable which transmitted the analog ECG signal 
to the computer. Each bedside is equipped with an alarm button to be 


















had or was occurring. The alarm button was to be pressed by MICU personnel. 
This signal-acquisition scheme was tried for a short time, but had to 
be abandoned due to reluctance of MICU staff to connect and move the 
ECG carts and press the alarm button. 
The system then remained idle for several months due to computer 
room construction. Meanwhile, a new method of connecting patients to 
the system was planned. We found that we could use the hospital's new 
analog ECG monitoring system to buffer and transmit the analog ECG signal 
back to the computer. This required neither the use of the ECG carts 
nor the application of extra electrodes to each patient. The bedside 
alarm buttons were replaced with a separate panel of alarm buttons on 
the monitoring console at the main nursing station. In the event that 
a monitor technician spotted an arrhythmia on the console ECG monitors, 
a simple press of a button within arm's length of the technician would 
signal the computer. 
The new approach is more functional and independent of the MICU 
staff, with the exception of the monitor technician whose job is normally 
watching the main-station ECG monitor. We hope to have the system running 
routinely soon. 
A-lO.	 Assessment of Vascular Integrity of the Myocardium Following 
Ischemic Injury 
Personnel:	 R. G. Tilton, Ph.D., Pathology 
K. B. Larson, BCL 
D. W. Murch, B.A., Pathology 
A. J. Perejda, Ph.D., Pathology 
J. R. Udell, B.S., Pathology 
J. R. Williamson, M.D., Pathology 
Support:	 RR 00396 
HL 07081 
HL 17646 
The Kilo Diabetes and Vascular Research Foundation 
We have continued our previously reported studies (PR 15, A-lO) 
of the pathophysiology of ischemic injury to the heart. Our objectives 
are to characterize time-dependent effects of ischemic injury on membrane­
permeability characteristics of the cardiac vasculature and musculature 
and to evaluate effects of drug interventions on the preservation of the 
coronary vasculature and musculature. The approach chosen for this investigation 
has been to use appropriate vascular- and extracellular-space markers 
labeled with gamma-emitting isotopes that can be monitored by external 
detection. Experiments are performed under constant-flow conditions using 





I-percent dialyzed bovine-serum albumin (BSA) and O.S-percent dialyzed 
300,000-MW polyvinyl pyrrolidone. Radioactive count-rate data are analyzed 
using mathematical models based on established principles of tracer kinetics. I 
Effects of reperfusion for 60 min following global ischemic injury 
of 15, 30, 45 and 60 min duration have been characterized using light 
and electron microscopy. Additional studies for comparing the effects I 
of low-flow versus no-flow ischemic injury have also been initiated.
 
A 30-min ischemic interval was chosen for evaluating drug interventions.
 
Studies are now in progress to evaluate the protective effects of nifidipine,
 Idiltiazem and verapamil on the coronary vasculature and musculature. The 
choice of 30 min for the ischemic time interval was based on the following 
observations: 1) significant increases in the residual fraction of BSA 
remaining in the detector field (suggesting compromised vascular function), I 
and 2) slight increases in left-ventricular end-diastolic pressure with 
recovery of left-ventricular developed pressure to 85 percent of the initial 
value (suggestiny intact sarcolemmal membranes). A S-min infusion to I
steady state 9f 2S I - BSA, l4C-sucrose and 3HOH terminates the reperfusion 
period and provides an independent assessment of the vascular-, extracellular-, 





A-II. Physiologic Signal Processing IPersonnel: C. N. Mead, BCL 
J. S. Cheng, BCL 
L. J. Thomas, Jr., BCL I 
Support: RR 00396 
I 
During the past two years, we have been exploring the feasibility 
of utilizing frequency domain (FD) analysis in ECG classification algorithms, 
particularly with respect to the long-term Holter-ECG recordings which IBCL currently analyzes entirely in the time domain (TD) using the Argus/2H 
system. Our motivations for examining the ECG in the FD were several: 
1) a desire to examine pattern recognition parameters in a domain distinctly 
devoid of preconceived notions of what parameters seem "most reasonable" I 
as shape descriptors; 2) an expectation that information could be obtained 
in the FD which would be useful in classifying a variety of "problem" 
waveforms in the TD, e.g. fusion PVCs and noise-contaminated Normal waveforms; I 
and 3) a long-range goal of extending our knowledge of ECG analysis in 
the FD into the more general context of physiologic signal processing. IWe began by computing variable-length Fourier Transforms (FT) on 
a large variety of waveforms previously analyzed by Argus. From our initial 
data we learned that: 1) filtering of the ECG was necessary to eliminate 









the ECG power spectrum; 2) the most useful information in terms of ECG 
waveform classification lay at a frequency band from 2-30 Hz; and 3) theI center of gravity (First Spectral Moment (FSM» of a waveform's power spectrum (normalized so as to eliminate differences in spectral shape 
for wavefo~ms of similar shape but different amplitude, a common occurrence 
in Holter recordings) was a fairly stable and accurate QRS shape descriptor,I useful as a first-order screen of QRS complexes of truly different shapes. 1 
I As our experience with FD analysis of the ECG increased, we made several additional observations including the increased effectiveness 
of the discriminatory power of FSM if the FT was computed on a 512 msec 
rather than a 200 msec window (the latter had originally been chosen soI as to isolate the QRS complex; the increased window length allowed for the inclusion of the entire PQRST complex). Additional parameters were 
I 
explored including several "subspectra1 moments" and a measure of the 
concentration of a given spectrum's power. Finally, phase information 
was examined and found to be sufficiently unstable to warrant its exclusion 
from current analysis strategies. 2 
I During the past year we have continued to refine our parameter 
selections. At present, we are evaluating a correlation-based parameter 
I 
easily obtained from the FT data utilizing the fact that integration (i.e. 
correlation) in the TD is equivalent to multiplication in the FD. Initial 
results suggest that this correlation coefficient is at least as accurate 
as any TD coefficient currently in use; addiona11y, it offers the advantage 
I of being easily computable from data already available for use in FD-based feature extraction techniques, thus giving rise to the possibility of 
a "hybrid" (i.e. feature extraction and correlation) classification algorithm. 
In particular, TD systems have routinely had to restrict classificationI approaches to either feature extraction or correlation techniques because 
I 
the computations associated with each strategy tend to manipulate relatively 
dissimilar data (e.g. compressed versus raw sample). In the FD however, 
both features (e.g. FSM) and a correlation measure can be computed from 
I 
the same data, i.e. the set of coefficients obtained from processing the 
original signal via the FT. At present we are evaluating the effectiveness 
of the correlation coefficient as an isolated classification parameter 




1. C. N. Mead, S. M. Moore, B. F. Spenner, R. E. Hitchens, K. W. Clark, 
and L. J. Thomas, Jr., "Detection of Multiform PVCs Using a Combination 
of Time-Domain and Frequency-Domain Information," Proceedings of 
the IEEE Conference on Computers in Cardiology, IEEE Catalog No. 
78CH1391-2C, Stanford, California, pp. 343-346, September 12-14, 1978. 
I 2. C. N. Mead, J-S. Cheng, R. E. Hitchens, B. F. Spenner, and L. J.
 
Thomas, Jr., "Recent Progress in Frequency-Domain Analysis of the
 
ECG," Proceedings of the IEEE Conference on Computers in Cardiology,
I IEEE Catalog No. 79CH1462-1C, Geneva, Switzerland, pp. 43-47, September
 26-28, 1979. Also Biomedical Computer Laboratory Monograph No. 375.
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A-12. Performance Evaluation of Ventricular Arrhythmia Detectors 
Personnel: R. E. Hermes, BCL IJ. R. Cox, Jr., BCL 
K. L. Ripley, M.S., Erasmus University 
Support: RR 00396 I 
For nearly a decade, providers and users of ventricular arrhythmia I 
detectors have sought a consistent performance evaluation methodology. 
Now with the advent of the American Heart Association (AHA) Database (A-8) , 
the need is even more pressing. Early work toward establishing such a Imethodology (PR 11, A-20) was not completed. In recent months, a new 
emphasis has been placed on the problem and work restarted. 
Needed is a performance evaluation methodology which can evaluate I 
systems efficiently, easily, and effectively, as well as providing performance 
parameters which are consistent and informative. To this end, we have 
developed a stochastic detector modell to which we have applied estimation I
theory techniques to derive performance parameters. The following block 
diagram represents the model. 
IThe large block represents the detector and detection process. 
The detector is presented at Node A with the process NA(t), which is a 
string of annotated beats with an arrival rate of AR. We realize that 
a system may do one of three things with an input event; it may detect I 
it with probability PT' miss it with probability I-PT' or detect it more 
than once with the conditional probability PElT' In addition to these 
three possibilities, the detector may also randomly insert a false detection I
at a rate AF' Arriving at node D are the three constituent counting pro­
cesses, NT(t), NF(t), and NE(t), resulting from correct, false, and extra 
detections respectively. These processes sum to form the output process 
ND(t), which represents all detections. Using these related processes I 
and probabilities, and assuming some probability distributions for correct, 
false, and extra detections, we have been able to derive, using maximum­
likelihood estimation, three parameters to represent system performance. I 
The parameters for correct, false, and extra detections are a, 8, and y. 
Preliminary tests using this model have proven successful in providing I
results with more sensitivity and specificity than present statistical 
methods. Continuing efforts focus on an even more rigorous mathematical 
basis for the model as well as proving any assumptions. The model and 
the resulting model parameters must then be validated. I 
Concurrent with the model development is work toward a performance 
methodology. This effort is being coordinated along with plans for distribution I 
and use of the AHA Database (A_8).1,2 Our hope is that this new evaluation 



































L	 J. R. Cox, Jr., R. E. Hermes, and K. L. Ripley, "Performance Evaluation 
of Ventricular Arrhythmia Detectors," in Ambulatory ECG Recording, 
Year Book Medical Publishers, in press. I 
2.	 R. E. Hermes and G. C. Oliver, "Use of the American Heart Association 





A-13. Modification of Infarct Size 
Personnel:	 R. Roberts, M.D., Medicine I 
H. D. Ambos, BCL 
L. D. Berenbom, M.D., Medicine 
W. A. Crafford, M.D., Medicine IR. M. Doroghazi, M.D., Medicine 
O. Fukuyama, M.D., Medicine 
E. M. Geltman, M.D., Medicine IA. S. Jaffe, M.D., Medicine 
J. Markham,	 BCL 
A. T. Marmor, M.D., Medicine 
B. E. Sobel, M.D., Medicine I 
J. L. Vacek, M.D., Medicine 
I. R. Weinstein, M.D., Medicine ISupport:	 RR 00396 
HL 17646 
I 
Studies were performed in the Cardiac Care Unit at Barnes Hospital 
to assess the effect of selected pharmacological agents on infarct size, 
ventricular dysrhythmia, and hemodynamics in patients with myocardial I 
infarction. Infarct size was estimated from serial plasma creatine kinase 
(CK)	 changes during a 72 hour interval and results in controls were compared 
to those observed in the treated group. All Holter tapes were digitized I
and processed by the Argus/H computer system. Hemodynamics including 
cardiac output were determined by Swan-Ganz thermodilution technique and 
the effect of the drug assessed by comparing hemodynamics before and after 
administration. In selected cases left ventricular functio~ ~as assessed I 
by radionuclide ventriculograms before and after therapy.l, , 
A randomized trial initiated in 1978 to assess the effect of intravenous I 
nitroglycerin on chest pain, ventricular arrhythmias, and infarct size 
in patients	 with acute myocardial infarction is progressing well. The 
intravenous	 infusion of nitroglycerin is titrated so that the systolic Iblood pressure does not fall below 100 mm Hg and the heart rate does not 
increase by more than 10 beats per minute. The drug is initiated immediately 
after the patient is admitted to the Coronary Care Unit and observed infarct 









randomized controls. Thus far, 134 patients have been entered into the 
study. Patients have tolerated the drug well without any significantI side effects and in patients with cardiac failure or pulmonary edema, marked improvement in hemodynamics has been observed without any significant 
increase in heart rate. 
I 
I Nitroglycerin has been shown to be beneficial in animals with experi­
mental myocardial infarction. To determine its effects in man, 134 patients 
(Class I-II) were randomized to control (C) (n = 62) or treated (T) (n = 72). 
Nitroglycerin was started at 10 ~g/min and increased until a 10% decline 
in blood pressure, a 10 beats/min increase in heart rate or 200 ~g/min 
was attained. ECGs were recorded continuously and analyzed by the Argus/2H 
computer system. Frequency of PVCs in the first 12 hours was similar inI treated patients and controls (156 ± 41 (SE) vs 134 ± 31, NS) as were 
the incidences of ventricular tachycardia and couplets (4.7 + 1.5 vs 
I
 2.8 + 1.0/12 hours). Infarct size index was similar (11.3 (T) vs 14.6
 
I 
(C) CK-g-eq, NS). Severity of pain, reflected by the amount of morphine 
given was similar (13.2 (T) vs 14.6 (C) mg/24 hours). Slightly more lido­
caine was required in the treated group averaging (1522 vs 1410 mg/24 
hours, NS). Radionuclide ventriculograms showed slight improvement in 
ejection fraction in the treated group (n = 22) (46 vs 49%, p<0.05) versus 
controls (n = 15, 34 vs 34%) and there was slight reduction of wall-motionI abnormalities. Thus, nitroglycerin did not reduce analgesic requirements or ventricular ectopy despite absence of hypotension or tachycardia. 
I The role of digoxin in the treatment of cardiac failure associated 
I 
with acute myocardial infarction is controversial. Accordingly, we compared 
the hemodynamic effects of digoxin to those of dobutamine, an agent with 
positive inotropic effects and rapid onset of action and clearance (t~ = 2.5 min)
2in 6 patients (Killip Class II-III) who were catheterized within 36 hours 
of acute myocardial infarction. Dobutamine (5 to 10 ~g/kg/min) was given 
intravenously for 30 minutes and then discontinued until hemodynamicsI returned to baseline. Digoxin (0.0125 mg/kg) was then given intravenously and hemodynamics were recorded for 90 minutes. Dobutamine markedly decreased 
ventricular filling pressure (23.8 to 8.5 mm H3, p<0.05) and systemic vascular resistance (1624 to 1202 dyne.sec.cm- , p<0.05) and increased 
I 
I cardiac index (2.4 to 3.2 L/min/M2 , p<O.OOl) and stroke work index (23.7 
to 35.6 g.m/M2 , p<0.02) without eliciting a change in heart rate or arterial 
pressure. In contrast, digoxin had no effect on filling pressure (19.0 
to 18.8), systemic vascular resistance, or stroke work index (21 to 24, 
p<0.05). Neither drug affected the incidence of ventricular arrhythmia. 
Thus, dobutamine increased cardiac output, decreased filling pressureI and afterload as opposed to digoxin which did not affect filling pressure or afterload. 
I
 We have previously shown that patients with anterior infarction
 and inferior infarction have similar infarct size but that the mortality 
in patients with anterior infarction is 23% compared to only 11% in those 
I
 with inferior infarction. The patients with inferior infarction exhibited
 more impairment of right ventricular function compared to patients with 








inferior myocardial infarction is more frequently associated with right 
ventricular damage than generally appreciated and that the functional 
impact of the same overall infarct size is shared by both ventricles. 
In contrast, in patients with anterior infarction the impact is felt by I 
only one ventricle, namely the left. This hypothesis may in part explain 
why patients with inferior infarction have a better long-term prognosis. 
To further test the hypothesis, studies have been initiated with radio­ I 
ventriculography to assess regional ventricular wall motion in right and 
left ventricles of patients with anterior and inferior infarction. Studies 
were initiated in 1979. All ~atients included are admitted to the clinical Iinvestigation unit and have 9 mTc-red blood cell ventriculograms performed. 
Global and inferior and lateral regional right ventricular and left ventricular 
ejection fractions are measured. Studies have been progressing well and 
to date 87 patients have been entered into the study. In controls, right I 
ventricular ejection fraction averaged 43 ± 9 (SD) with variability in 
repeat studies of 4%. Regional ejection fractions averaged 53 and 79% 
in inferior and lateral zones. Right ventricular ejection fraction was I 
depressed only early after anterior myocardial infarction (30 ± 10) but 
normalized within 10 days (40 ± 4, p<O.Ol). Inferior and lateral regional 
right ventricular ejection fraction exhibited comparable sequential changes 
(Inferior - 26 ± 7 and 51 ± 15; Lateral - 17 ± 16 and 38 ± 21). In contrast, I 
after inferior myocardial, right ventricular ejection fraction depression, 
evident at 48 hours (25 ± 9), persisted (23 ± 9 and 28 ± 9 at 10 and 
90 days) and correlated with enzymatically estimated infarct size (r = 0.84). I 
Regional inferior and lateral values were comparably and persistently 
depressed. Thus, global and regional right ventricular ejection fractions 
are depressed only transiently after anterior infarction but are depressed I 
persistently after inferior myocardial infarction suggesting concomitant 
right ventricular injury.4,5,6,7 ITreatment designed to protect ischemic myocardium is more effective 
if administered, as has been shown experimentally, prior to the development 
of an ischemic episode. This is generally not possible clinically except 
in those patients who develop recurrent infarction. However, determination I 
of the frequency of recurrent infarction has been difficult as has been 
prospective identification of subsets of patients at particularly high 
risk who may benefit most from prophylactic measures designed to protect Iischemic myocardium. Based on ST-T changes on the ECG, an apparent incidence 
of recurrent infarction as high as 86% has been reported. Enzymatic criteria 
based on total plasma creatine kinase activity, provide an apparent incidence Iranging from 35 to 65%, potentially falsely high due to creatine kinase 
release from non-cardiac sources. Utilization of MB CK isoenzyme analyses 
may provide increased diagnostic sensitivity and specificity in detection 
of the initial and subsequent recurrent episode. Thus, a prospective I 
study was initiated in September 1979 involving all patients admitted 
to the Coronary Care Unit with documented myocardial infarction. The 
study is designed to determine and characterize the incidence and nature I
of early recurrent myocardial infarction (extension) based not only on 
clinical and electrocardiographic criteria but also on analysis of plasma 
MB CK, plasma myoglobin and serial radioventriculograms and to identify Ifeatures of patients at particularly high risk. Following transfer from 
I 




 the Coronary Care Unit, patients are continuously monitored by telemetry 
for a total of at least 14 days. Clinical and electrocardiographic status 
I
 are monitored and recorded at least daily throughout the hospitalization.
 
I 
Serial plasma samples are obtained for assay of total CK, MB CK and myoglobin 
every 4 hours for the first 72 hours and every 12 hours subsequently for 
14 days" Re-elevation of MB CK activity to > 15 IU/l after decline of 
values to baseline or < 8 IU/l are considered evidence of recurrent necrosis. 
Serial radionuclide ventriculograms are performed initially within 2 days 
and repeated within 12 days after the onset of initial symptoms. To date,I 200 patients have been enrolled. The following is a brief summary of the results: among the 200 patients studied (128 males, 62 females) mean 
age averaged 68 ± 17 years. Initial infarction was transmural in 62%, 
I subendocardial in 29% and of undetermined locus in 9%. The overall hospital mortality was 14%. It was 15% among patients with transmural and 12% 
I 
among patients with subendocardial myocardial infarction. The 165 patients 
(83%) without early recurrence had an overall hospital mortality of 13.4%. 
Mortality was 18% for patients with transmural but only 7% for patients 
with subendocardial infarction. Overall hospital mortality among the 
35 patients (17%) who experienced early recurrent infarction was 20%.I In the patients with recurrent infarction following an initial transmural 
I 
infarction overall hospital mortality was 25% compared to 16% in patients 
with initial subendocardial infarction. Thus, the patients with initial 
subendocardial and recurrent infarction had an increase in mortality of 
128% over that of patients with subendocardial infarction and no recurrence. 
Among the 58 patients with subendocardial myocardial infarction, 25 (43%) 
I exhibited early recurrent infarction compared to only 8% of those with initial transmural myocardial infarction. Thus, 71% of all recurrences 
occurred in patients with an initial subendocardial infarction. 8 
I Among the 58 patients with subendocardial infarction, 25 (43%) exhibited early recurrent infarction. Identification of such a high risk 
population has clinical and investigative implications. Patients in this 
I category merit particularly intense and prolonged monitoring for detection of electrocardiographic changes as well as changes in clinical status. 
Furthermore, they represent a subset of patients in whom the efficacy 
I of therapy can be assessed rapidly and without the necessity for enrolling a prohibitively large number of patients in an extensive trial. 
I 1. R. Roberts and B. E. Sobel, "The Distribution, Inactivation and Clearance of Enzymes," in Enzymes in Cardiology: Diagnosis and Research, 
D. J. Hearse and J. De Leiris, eds., John Wiley and Sons Limited, 
I Chichester, pp. 97-114, 1979. 
2. B. E. Sobel, J. K. Kjekshus, and R. Roberts, "Enzymatic Estimation 
I of Infarct Size," in Enzymes in Cardiology: Diagnosis and Research, D. J. Hearse and J. De Leiris, eds., John Wiley and Sons Limited, Chichester, pp. 257-289, 1979. 
I 
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Maintenance and operation of the PETT IV tomographic system for 
cardiac imaging (B-6) continues to be a major activity in this project. 
During the past year, the programs and operational procedures for processing I 
of the PETT IV scan data were streamlined to make it practical to perform 
4 studies a week. The natural history of evolution of jeopardized to 
infarcted myocardium protrayed by serial PETT IV images is currently under I
study in order to provide the baseline needed for evaluation of selected 














An interactive tracing system using a joy stick interfaced to the 
Ramtek display system was designed and bUilt, and will soon be evaluated 
and tested. A comprehensive software package which will allow non-computer 
personnel to use the joy stick to outline regions of interest on the Ramtek 
display will be written during the next year. This system will substantially 
reduce the time required for procedures such as calculation of infarct 
size based on analysis of PETT IV images. 
Several new programs were written and some of the PETT IV programs 
were modified so that PETT V data could be processed from animal studies 
in which the washout of 11C-pa1mitate from the heart is being investigated. 
A program was written to compute the average number of counts in selected 
regions of a set of PETT images. After correction for isotope decay, these 
data were used to compute decay constants describing the rate of washout 
of isotope and hence characterize regional myocardial metabolism. 
Additional activities of the SCOR Computer System continue to involve 
analysis of demographic, clinical, laboratory, physiological, and hemodynamic 
data characterizing patients with acute myocardial infarction, development 
of an improved, interactive database, characterization of myocardial physical 
properties based on attenuation and backscatter of ultrasound, and support 
of clinical and laboratory investigative activities in which enzymatic 
estimation of infarct size plays a central role. 
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During the past year, studies have continued regarding the correlation 
of electrophysiological derangements and biochemical and adrenergic neural I 
factors underlying malignant dysrhythmia due to ischemia. The overall 
concept of the research is that potential arrhythmogenic metabolites accumu­
late in ischemic tissue and exert deleterious effects on membranes and I
that their effects may be exacerbated by the concomitant influences of 
the adrenergic nervous system. Thus, the research involves the interaction 
between potential arrhythmogenic metabolites within ischemic tissue and 
the influence of adrenergic neural influences on the generation of these I 
metabolites and their overall impact on the profound electrophysiological 
sequalae apparent in ischemic tissue in vivo. During the last several 
years we have demonstrated that disparate electrophysiological alterations I 
underlie those dysrhythmias induced by ischemia alone compared to those 
dysrhythmias induced by reperfusion of the coronary artery.l Since both 
types of dysrhythmias may be collectively important in sudden death in I 
man, each may require different therapeutic interventions. In addition, 
studies have recently been completed demonstrating a major electrophysio­
logical role of a-adrenergic stimulation during both coronary occlusion 
and reperfusion. Z In these studies, a- compared to S-adrenergic input I 
on dysrhythmias induced by left anterior descending (LAD) coronary occlusion 
and by reperfusion were assessed in chloralose anesthetized cats, a model 
which has been extensively characterized in our laboratory. As discussed I 
in PR 15, A-15, a-adrenergic blockade with either phentolamine (a and al	 Zblocker) or prazosin (a blocker) significantly reduces the number of pre­
mature ventricular complexes during coronary reperfusion, abolishes early Iventricular fibrillation and prevents the increase in idioventricular rate 
otherwise seen with coronary reperfusion. Beta-receptor blockade with pro­
pranolol is without effect. Ventricular dysrhythmias induced by coronary 
occlusion alone without reperfusion are also attenuated markedly by a-receptor I 
blockade under conditions in which perfusion (measured with radiolabeled 
microspheres) within ischemic zones is not affected. In addition pretreat­
ment with 6-hydroxydopamine (to deplete myocardial norepinephrine and render I 
the heart unresponsive to tyramine) attenuates dysrhythmia induced by both 
coronary occlusion and reperfusion in a fashion identical to that seen with 
a-receptor blockade. Enhanced a-adrenergic responsiveness is seen during Ithe period of coronary reperfusion as assessed by either efferent left stellate 
I 







nerve stimulation or regional infusion of the ischemic zone with methoxamine,
 
a response blocked by a- but not S-b1ockade. Thus, it appears that during
 
both coronary occlusion alone as well as during subsequent reperfusion,
 
enhanced e1ectrophysio1ogica1 responsivity occurs to a-adrenergic input 
I
 




More recently, we have completed experiments to assess whether the 
enhanced a-responsivity characteristic of ischemic tissue was associated 
with a corres1onding increase in a-adrenergic as opposed to S-adrenergicI receptors. 3 H-prazosin, a specific a 1 receptor ligand, was used to measure (total receptor number) and KD (receptor affinity) in membrane prepara­BmaxI tions from ischemic and normal regions prior to and at 5 and 30 minutes after coronary occlusion and at 2 and 15 minutes after reperfusion. 3H­
prazosin binding was rapid, reversible, saturable and stereospecific. Within 
30 minutes after occlusion, Bm~x increased to 178% of control values (toI 27 ± 4 fmo1/mg protein, p<.OOl). This increase persisted during early 
reperfusion but values returned to control 15 minutes after reperfusion 
(13 ± 1.6). KD (2.4 ± .2) was not significantly altered at any time. Beta­I receptor number (3H-DHA binding) and Na+-K+ ATPase activity in control and ischemic myocardium 30 minutes after occlusion and 2 minutes after repre­
fusion were not altered. Thus, the enhanced a-adrenergic responsiveness 
I and marked antiarrhythmic effectiveness of a-adrenergic blockade during 
I 
ischemia appears to be mediated through a reversible increase in available 
a-adrenergic receptors. The specificity of the response is indicated also 
by the apparent lack of alteration of membrane bound enzymes (Na+-K+ APTase) 
and S-receptor number. The time course of altered a-adrenergic receptors 
I 
correlates well with enhanced e1ectrophysio1ogica1 responsivity and suggests 
that one promising approach to the treatment of malignant ventricular dys­
rhythmias during myocardial ischemia may be blockade of a-adrenergic mediated 
I 
influences. Additional studies now in progress include verification of 
a-receptor increases in ischemic tissue with a more purified membrane prepara­
tion as well as delineation of the role of amphiphi1ic metabolites in the 
receptor alterations. 
As reported in PR 15 we have detected the accumulation of 1ysophospho­
glycerides in ischemic myocardium early after myocardial occlusion as well 
I 
I 
as in effluents from isolated perfused hearts under hypoxic conditions. 4 
Studies in vitro in isolated Purkinje fibers and ventricular muscle have 
indicated that 1ysophosphatidy1 choline (LPC) induces marked e1ectrophysio­
logical alterations closely analogous to those changes characteristic of 
ischemic tissue in vivo, implicating this amphiphi1ic metabolite as one 
potential biochemical mediator of malignant dysrhythmia associated withI ischemia. 5 The concept that arrhythmogenesis during early myocardial ischemia 
is related to the accumulation of metabolites in the hyperfused myocardium 
is supported by the following observations: 5 1) the e1ectrophysio1ogica1I alterations occurring during the first 20 minutes of myocardial ischemia in vivo are reversed when the tissue is superfused in vitro; 2) perfusion 
I 
of ischemic regions in vivo with saline bubbled in nitrogen results in 
immediate reversion of the derangements observed in subepicardial action 
potentials, despite the persistence of hypoxia; 3) arrhythmogenic effects 
I 
I




in vitro have been elicited with venous blood draining ischemic regions 
in vivo, effects apparently independent of lactate, potassium, pH ~ se 
and p02; and 4) ischemia in vivo is a more arrhythmogenic phenomenon than 
hypoxia with concomitant, maintained perfusion. More recently, we have I 
demonstrated that LPC increases two-fold in effluents from ischemic feline 
myocardium in vivo within 10 minutes of coronary occlusion. 6 To determine 
whether this increase was sufficient to account for arrhythmogenicity of I 
venous effluents, LPC was added to normal feline plasma to yield a comparable 
increase (0.74 mM), and used to superfuse normoxic endocardium characterized 
with standard microelectrode procedures. 6 Superfusion with LPC at pH 7.4 Iinduced little change in resting membrane potential (RMP) (-96 + 1 to -89 
± 3 mV), or amplitude (102 ± 3 to 92 ± 5 mV), although dV/dt of-phase 0 (V )max Iwas depressed (178 + 24 to 62 + 14 V/sec). In contrast, when pH was reduced to 6.7, marked changes in acti;n potentials occurred with LPC including 
a decrease in RMP (to 35 ± 7 mV), amplitude (to 36 + 8 mV), Vmax (to 26 
± 11 V/sec) and conduction velocity with fractionation of the action potential. 
Acidosis alone induced only a significant decrease in Vmax • Thus, the two­ Ifold increase in LPC in effluents coupled with acidosis typical of that 
seen in ischemic regions in vivo (pH = 6.7) is sufficient to induce marked 
electrophysiological derangements and may explain the arrhythmogenic properties 
of venous effluents from ischemic zones. Additional studies have demonstrated I 
that the arrhythmogenic effects of LPC increase 3-fold in the presence of 
concomitant acidosis (pH = 6.7).7 Thus, the concomitant effects of acidosis 
and accumulation of arrhythmogenic metabolites such as lysophosphoglycerides I 
may have profound influences on ventricular dysrhythmia during early ischemia. 
Long-chain acyl carnitine accumulates also in ischemic tissue in I
vivo particularly in the presence of elevated free fatty acid (FFA) and 
shows striking structural similarities to LPC. 7 In a recently completed 
series of experiments,7 we have demonstrated that long-chain acyl carnitine 
(L-palmitoyl carnitine) induces electrophysiological alterations in canine I 
Purkinje fibers analogous to those seen with LPC. In addition, as with 
LPC the effects of palmitoyl carnitine were exacerbated by acidosis; the 
effects of palmitoyl carnitine were additive to those of LPC. Thus, acyl I 
carnitine accumulating during ischemia, coupled with concomitant acidosis 
and the presence of arrhythmogenic effects of LPC together contribute to 
the amphiphilic burden of the heart and may be a major precipitant of malignant Iventricular dysrhythmia. 
More recently, studies have been performed to determine whether alter­
ations in transmembrane potentials induced by LPC depend on actual incorpor­ I 
ation of LPC into the membrane. In these studies, canine Purkinje fibers 
studied with standard microelectrode procedures were incubated with l4C_ 
palmitoyl LPC (200 ~mol). After 3 to 6 minutes fibers were rapidly removed Ifrom the bath, washed, and extracted for lipid analysis with chloroform: 
methanol. Lipids were separated by HPLC and individual phospholipids quanti­
fied by scintillation spectrometry. Changes in maximum diastolic potential, Iamplitude and Vmax occurred only when LPC incorporation was greater than 
or equal to 0.62 nmol/mg protein. Average incorporation was 1.1 + .13 nmol/mg 
representing 2.2 + 0.2% of membrane phospholipids totaling 50 nmol/mg protein. 
Thus, marked electrophysiological alterations occur when as little as 2.2% I 
of membrane lipid is supplanted by incorporated LPC. 
I 
- 53 - I 
1 
1 
1	 To determine whether the electrophysiological alterations induced 
by LPC in vitro resulted in action potentials dependent exclusively on the 
slow inward current (lsi)' LPC effects were examined in superfused canine 
purki~e fibers with inhibitors of fast (tetrodotoxin) and slow (verapamil 
I,
 
or Mn ) channels. As reported in PR 15, LPC induced action potentials
 
dependent exclusively on lsi as assessed by their responsivity to blockade
 
by verapamil or Mn++ and unresponsiveness to tetrodotoxin. 8 However, ex­

periments by others suggest that lsi is exquisitely sensitive to acidosis. 
Thus under conditions of ischemia with concomitant LPC and acidosis, action 
potentials dependent exclusively on lSi may not be initiated. In an extensive 
series of experiments we demonstrated that slow response action potentials 
were propagated despite the presence of concomitant acidosis (pH = 6.7) 
in both canine Purkinje fibers and ventricular muscle. In addition, slow 
response action potentials induced by increasing extracellular potassium 
to 22 mM and addition of isoproterenol were not blocked by concomitant 
acidosis in either ventricular muscle or Purkinje fibers. Thus, LPC can 
induce action potentials dependent exclusively on I . in both ventricularSl
muscle and Purkinje fibers independent of concomitant acidosis, suggesting 
that in the milieu of ischemia action potentials dependent exclusively 
on lsi may propagate reentrant circuits and result in malignant ventricular 
dysrhythmia. 
Since hypothermia may protect the ischemic heart, a preliminary series 
of experiments has been completed to determine whether hypothermia attenuated 
the membrane alterations induced by lysophosphoglycerides. At 37° LPC (150 ~M) 
induced marked alterations in the transmembrane action potential including 
decreased maximum diastolic potential (MDP) (-96 + 3 to -67 + 4 mV), amplitude 
(142 ± 3 to 71 ± 4 mV), dV/dt of phase 0 (V ) (558 ± 22 to-168 ± 4 V/sec),maxdecreased conduction velocity, and fractionation of the action potential.
 
Cooling to either 35° or 33° failed to blunt these deleterious effects.
 
In contrast, cooling to 31° precluded any effects induced by LPC on MDP
 
(96 + 2 to 98 + 2 mV), amplitude (140 + 5 to 134 + 3 mV) or action potential
 
conflguration.- V was changed modestly (396 + 12 to 252 + 17 V/sec).

max	 -­LPC effects were not blunted by hypothermia at 29°. Thus, optimal resistance 
of membranes in ischemic hearts to LPC-induced effects requires hypothermia 
within a highly specific and narrow range. These results may also indicate 
the mechanism for the observed protective effect of hypothermia in the ischemic 
heart and may be related to alterations in phase transition induced by lower 
temperatures (31°C) possibly preventing the incorporation of LPC and hence 
its electrophysiological effects on membranes. 
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The goal of	 this project is the implementation of a system for ultra­ I

sonic reconstruction based on measurements of regional attenuation and 
backscatter of normal and ischemic myocardium and of normal and atherosclerotic 
vascular tissue. Although initial experiments have been performed in trans­









 use of reflected ultrasound. The current research program involves experiments 
designed for investigation of tissue properties utilizing three approaches:
I I} characterization of ultrasonic and biochemical properties of tissue in vitro, 2) development of a method for the measurement of quantitative back­
scatter by reflected ultrasound in vivo, and 3) refinement of a data acqui­
I,
 sition system designed by Digisonics to make it applicable to tissue
 characterization. During the past year a study was completed demonstrating 
that one of the major determinants of ultrasonic backscatter is intact 
collagen within regions of infarction, and that the correlation between1 collagen content and ultrasonic backscatter is close among 110 regions 
I 
analyzed among 18 dogs studied two, four, and six weeks after coronary occlusion 
and among hearts from 21 rabbits studied five to seven weeks after coronary 
occlusion. Demonstration that tissue characterization could be achieved 
with backscatter analyses provides encouragement regarding the possibility 
that tissue characterization in vivo will be possible with the use of ultra­
I
 sound in studies employing reflection as opposed to simply transmission.
 Additional studies were completed with isolated perfused rabbit hearts
 
in which it was found that marked alterations in ultrasonic backscatter




in which the tissue was exposed to selected combinations of media containing
 
buffer, albumin, and hyaluronidase. These changes were independent of those
 
found to be attributable to formed elements in the blood which independently
 
contributed to the magnitude and nature of ultrasonic backscatter. Alterations 
in ultrasonic properties of rabbit myocardium in animals subjected to adminis­
I
 tration of Adriamycin to induce cardiomyopathy were identified and quantified,
 suggesting that ultrasonic tissue characterization may be useful in the 
early detection of cardiomyopathic processes in vivo as well. In concert, 
these results indicate that tissue characterization with ultrasound in a 
I
 fashion ultimately amenable to application in vivo appears to provide useful,
 quantitative information characterizing myocardium exhibiting selected 
pathophysiological manifestations. 
I 
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I Resolution limits of conventional ultrasonic acquisition and display instrumentation were studied both experimentally and via computer simulations. 
I 
The experimental studies used the digital echocardiograph designed and built 
at the BCL (PR 15, A-17) for acquisition of ultrasonic echoes along with 
a TI-980 minicomputer for signal analysis and generation of ultrasonic images. 
The digital echocardiograph, which combines burst-analog sampling circuitry 
1 
I




and a dual Motorola 6800 microprocessor network, can send 256, 8-bit samples 
taken every 5 ms to the minicomputer for storage on disk in real time. 
IThe primary limits on resolution come from the transducer and the 
initial stages of processing. We have studied a 13 mm diameter transducer 
commonly employed in adult echocardiography (2.25 MHz, unfocused) using 
both conventional and automatic digital depth compensation to control the I 
gain applied to the transducer output. To determine spatial resolution 
we used the	 transducer to scan a static target (AlUM 100 mm test object). 
Because we know the gain function, both inherent resolution which is fixed Iby the signal-to-noise ratio of the ultrasonic echoes and the resolution 
in various display formats (transforms from signals to images) can be deter­
mined. Both inherent and display-format resolutions are being studied with 
the help of Digivision (PR 15, G-9) recently interfaced to the TI-980 mini­ I 
computer. 
The minicomputer has also been used to simulate the pressure patterns Igenerated by single-element and linear-array transducers. These patterns 
are plotted in hidden-line perspective views. From the impulse response 
of a single element convolved with an excitation function we can generate Ithe pressure pattern over an area or the pressure along a line as a function 
of time. We have simulated point-reflectors in the medium and calculated 
the received signal at the transducer. This transmit-to-receive simulation 
capability allows us to determine the minimum separation of two points which I 
can be resolved anywhere in the field of the transducer, as well as the 
contamination generated by an arbitrarily-located point reflector. I 
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The development of a microprocessor-based (Intel 8080) cart to perform 
interactive acquisition of EEGs was previously described (PR 15, A-18). I 
This 8-channel system permits collection of all the signals in either the 
standard l2-lead or the Frank lead systems simultaneously, while testing 
for signal quality. It contains a 3-channel, strip chart recorder for wave­ I 
form output and a self-scan display for presentation of alphanumeric messages 
to the operator. The operator enters demographic data on the subject and 
controls the processing sequence through a l6-character keyboard. I 
Two modifications were made to the hardware during the past 'year. 
The floppy disk was replaced as the primary storage medium by an expanded 











of 8 signals sampled at 500 Hz and l2-bit resolution require a minimum of 
36K bytes of memory. The acquisition rate of 6K bytes/sec was at the 
throughput limit for the disk controller. This constraint limited the testing 
for signal quality which could be done during acquisition. Further, signal 
I.
 
quality analysis and lead calculation from disk files is clearly slower
 
and more complicated than from RAM. The second change was to incorporate
 
the Universal Storage Device (PR 15, G-3) into the cart for permanent storage
 
(I
 of the subject file (demographic and ECG data) after all interactive acqui­
sition steps are completed.
 
The issue of lead calculation has been explored further. Because 
the typical resistor networks for lead determination in conventional electro­
cardiographs have been replaced by numbers stored in read-only-memory of 
our cart, we can easily calculate a variety of leads. We hope to be able 
to use the cart to study the possibility of individualizing the lead system 
to the subject, i.e., taking his torso shape into account and to examine 
the clinical potential of leads, such as the moving electrical center, which 
give spatial attributes, as well as strengths of cardiac sources. 
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St. Luke's Hospital East
 
The purpose of the Multicenter Post-Infarction Program (MPIP) was 
described in detail in last year's progress report (PR 15, A-19). Briefly, 
ten hospitals in four cities (New York City; Rochester, New York; Tucson, 
Arizona; and St. Louis, Missouri) have joined together to study patients 
recovering from myocardial infarction (HI) using a common protocol of data 






which will be successful in predicting mortality in other hospitals in this 
country and perhaps in other countries. The diversity of patient populations, I 
geographic regions, and interests of investigators makes this hope plausible. 
Each patient is invited to have three special studies: a 24-hour Holter 
monitor, a low-level treadmill activity test, and a radionuclide angiogram 
to determine left ventricular ejection fraction. One half the Holter recordings I 
are analyzed at the Biomedical Computer Laboratory (A-4) and the other half 
at Columbia University. 
To date, in	 St. Louis, 399 patients with documented MI's have been I 
logged in our data collecting system. Of these, 183 were eligible (less 
than 70 y~ars old, survived hospital stay, and lived in catchment area) I 
and 105 have agreed to participate in the study. Since January 1980, all 
enrolled patients have had the Holter monitor study and measurement of 
ejection fraction. Efforts continue to increase the proportion of patients 
and physicians who agree to the low-level activity test. I 
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The research in this project is designed to noninvasively quantify I 
myocardial perfusion and metabolism with positron-emitting tracers. Studies 
are conducted in isolated rabbit hearts (perfused with a solution containing 
washed sheep erythrocytes) to permit control of many factors that modify Imyocardial perfusion and metabolism and also in intact dogs, prior to imple­
mentation of approaches of proven value in clinical studies. 
The development of accurate, quantitative, noninvasive measurements I 
of myocardial metabolism in patients is dependent on thorough characterization 
of fatty-acid flux in cardiac tissue. Currently we utilize llC-palmitate 
as well as a vascular tracer. In addition to monitoring tracer time-activity I 
curves via coincident detection of the positron emission, a number of meta­
bolic functions are being assessed simultaneously. In this manne~ llC_ 
palmitate washout curves can be analyzed in a quantitative manner. Back Iextrapolation of the monoexponential tail has been found to correlate well 
I 






with fatty acid extraction and the slope of the first order function has 
been found to correlate well with fatty acid oxidation. 
I 
In studies completed during the past year, the residual fraction 
of 13N-labeled ammonia retained by myocardium was studied in isolated per­
fused rabbit hearts under conditions in which flow and cardiac metabolism 
were manipulated independently. In 12 hearts perfused with buffer enriched 
with erythrocytes, residual fraction and half-time of disappearance were 
I not altered despite induction of profound ischemia with a reduction of flow by 75% compared to control flow. This apparently paradoxical phenomenon 
was explained by enhanced extraction fraction of the tracer due to prolonged 
residence time. In contrast, under conditions of constant flow in whichI hearts were exposed to an inhibitor of ammonia metabolism (methionine sulfox­imine), retention of 13N radioactivity was reduced by more than 60% and 
clearance was prolonged despite the absence of anI change in flow. These 
I results indicate that retention and clearance of 3N activity by myocardium are influenced considerably by the metabolic status of the tissue and that 
relationships between retention of tracer and flow are complex, precluding 
I direct estimation of perfusion simply from the amount of tracer sequestered by the heart. 
In related studies, the quantitative dependence of myocardial extrac­I tion and clearance of 201Tl was evaluated. Although altered cardiac work 
I 
and oxygenation did not affect kinetics of the process, myocardial extraction 
increased and clearance became less rapid with decreased flow. These findings 
suggest that thallium scintigraphy in patients may underestimate ischemia. 
I 
To obviate difficulties in quantifying myocardial perfusion with 
conventional radionuclide methods, studies were undertaken and completed 
during the past year with the use of positron-emitting radionuclides and 
isolated perfused hearts. Administration of a tracer selected because of 
its equal partition in blood and tissue (llC-butanol) was infused in a pro­I grammed, exponential fashion, and a derived function reaching steady-state 
I 
value within several minutes was obtained. The value of the derived function 
is quantitatively related to perfusion within the tissue. Correlation co­
efficients between estimates of perfusion and observed perfusion exceeded 
.93 when appropriate corrections were made for residual radioactivity within 
the chambers of the heart. The feasibility of employing this approach in 
I
 vivo was demonstrated with the use of exponential, intravenous infusions
 of tracer in large experimental animals in whom the radiation burden was 
well within the limits encountered in clinical diagnostic nuclear medicine. 
Studies are now in progress to implement and evaluate the quantitative suit­
I ability of this approach for measurement of perfusion in vivo, in which detection of the distribution of tracer will be achieved with the use of 
positron emission transaxial tomography. 
I Completion of additional studies characterizing the fate of IIC_ 
palmitate administered to isolated perfused hearts indicated that the predom­
inant pool of deposition of isotope was in neural fats within the time frameI of the experiments and that the rate of clearance of tracer extracted by the tissue was directly proportional to cardiac work assessed with physiological 
I 





parameters and verified by measurement of radio1abe1ed CO2 released. These 
findings facilitated interpretation of positron emission transaxia1 tomographs I 
obtained in dogs subjected to subcritica1 coronary stenosis (insufficient 
to produce infarction but sufficient to impair myocardial metabolism with 
stress) and in patients with subendocardial myocardial ischemia. Preliminary 
results obtained in vivo indicate that sequential tomography with 11C_ I 
palmitate will localize and sensitively detect myocardium whose metabolism 
is compromised by transitory ischemia and that delineation of subendocardial 
infarction as well as the previously documented delineation of transmural I 
myocardial infarction can be accomplished promptly and noninvasive1y in patients. 
I 
A-21. Multicenter Investigation of Limitation of Infarct Size (MILlS) 
Personnel:	 R. Roberts, M.D., Medicine I 
H. D. Ambos, BCL 
D. R. Bie110, M.D., Radiology 
K. R. Cash,	 Medicine IK. W. Clark, BCL 
E. M. Ge1tman, M.D., Medicine 
R. E. Hitchens, BCL IA. S. Jaffe, M.D., Medicine 
K. A. Madden, BCL 
C. N. Mead,	 BCL 
J. P. Miller, BCL I 
D. S. Payne, Medicine 
B. A. Siegel, M.D., Radiology 
B. E. Sobel, M.D., Medicine IL. J. Thomas, Jr., BCL 
A. J. Tiefenbrunn, M.D., Medicine 
P. M. Wheelock, Medicine I 
Support:	 RR 00396 
HV 72941 
Washington University I 
On August 1, 1978 Washington University, in collaboration with four Iother centers implemented phase II of the collaborative clinical trial of 
therapy to protect ischemic myocardium. The overall goals of the project 
include objective evaluation of the efficacy of administration of hyaluroni­
dase and of	 propranolol in limiting the extent of infarction among patients I 
with acute myocardial infarction and in modifying prognosis. Data are being 
acquired from five clinical centers, including Hashington University, Massa­
chusetts General Hospital, The Medical Center Hospital of Vermont, Parkland I 
Hospital in	 Dallas, and the Peter Bent Brigham Hospital in Boston. Each 
of the clinical units is enrolling patients during a three-year interval 
to provide an overall sample size sufficiently large to st:atisti.ca11y test Ithe hypotheses being explored. 
I 






In addition to the five clinical units participating in the study, 
a series of core laboratories is utilized so that uniform objective analysis 
of data obtained from each unit can be performed in a blinded fashion. 
These core facilities include a CK Reference Laboratory (at Washington Uni­
versity), a Holter Recording Analysis Reference Laboratory (also at Washington 
University), an Electrocardiographic Reference Laboratory (at the Peter 
Bent Brigham Hospital), a Myocardial Infarct Scintigraphy Laboratory (at 
Parkland Memorial Hospital in Dallas), a Radionuc1ide Ventricular Function 
Laboratory (at the Massachusetts General Hospital) and a Pathology Core 
(at Duke University). Data from each core laboratory are forwarded to the 
Data Coordinating Center (Research Triangle Institute; North Carolina) so 
that objectivity in data management and statistical analysis can be assured. 
The Washington University components of this project comprise the 
Clinical Investigation Unit, directed by the Clinical Unit Coordinator, 
Dr. Allan S. Jaffe, the CK Reference Laboratory, directed by Dr. Robert 
Roberts, and the Holter Core Reference Laboratory, directed by Dr. Lewis 
J. Thomas, Jr. 
The final protocol, developed after 18 months of planning, defines 
studies among patients with suspected myocardial infarction identified as 
early as possible after arrival at each clinical unit and specifically within 
18 hours of the onset of acute symptoms leading to admission. The diagnosis 
of infarction is based on electrocardiographic criteria and clinical indexes, 
and confirmed with the use of isoenzymatic criteria. Patients to be excluded 
are those with cardiogenic shock, 75 years of age or older, and those with 
other significant illnesses or conditions that may affect their response 
to therapy. Therapy comprising administration of placebo, propranolol, 
or hyaluronidase is administered in a randornized fashion. For purposes 
of randomization patients are initially divided into two groups based on 
the presence or absence of possible contraindications to propranolol. Manage­
ment of patients participating in the study is standardized by a regimen 
developed during the planning phases, designed to provide maximum safety 
to the patient and to avoid potentially conflicting effects of other unnecessary 
medications. Medical management of each patient ren~ins the responsibility 
of his own personal physician, and adjunctive emergency measures are, of 
course, instituted whenever indicated. 
A series of endpoints is being utilized to assess the effects of 
therapy on the extent of infarction and on prognosis. These include enzymatic 
estimation of infarct size based on analysis of serial changes in plasma 
MB and total creatine kinase activity, the extent of infarction assessed 
from the number of electrocardiographic leads in which initial ST-segment 
elevation is followed by development of criteria of transmural infarction, 
the distribution and extent of impairment of ventricular function assessed 
from radionuc1ide ventricu10grams, and the severity and persistence of dysrhythmia 
assessed from Holter recordings. Additional endpoints include exercise 
tolerance tests six months after the episode of infarction, 99mTc-pyrophosphate 
scintigrams as well as clinical fo110wup recorded on standardized forms 
developed during the planning phases of the project. Radioventricu10grams 






recording. Six months after infarction, myocardial infarct scintigrams 
are obtained, along with a repeat 35-lead precordial electrographic map 
and '24-hour Holter recording. A Pathology Core performs studies among patients Iwho expire during the acute or follow-up phases of the study for whom autopsy 
permission can be obtained. 
Since August 1, 1978 eighty-three patients have been entered into I 
the study by the Clinical Investigation Unit at Barnes Hospital. All studies 
during the acute phase have been completed. Among patients available for 
follow-up, studies are complete in 87%. A site-visit review by the Policy I
Board, the Clinical Coordinating Center and the Data Coordinating Center 
characterized the performances of the Clinical Unit, CK Laboratory and the 
Holter Laboratory as effective. Over 440 patients have been enrolled by Ithe five centers. The operation of the clinical centers and the core lab­
oratories has been extremely successful. Data-bank analysis studies are 




A-22. Clinical Trial of Nifedipine in Cardioplegia 
IPersonnel: R. E. Clark, M.D., Cardiothoracic Surgery 
B. K. Clark, B.S., Cardiothoracic Surgery 
K. W. Clark, BCL 
G. G. Garcia, Barnes Hospital I 
K. A. Madden, BCL 
L. J. Thomas, Jr., BCL ISupport:	 RR 00396 
HL 17646 
HL 24394 I 
The purpose of this study is to determine the efficacy and safety of 
the addition of nifedipine, a specific calcium blocking agent, as an adjunct I 
to current cardioplegic solutions used in clinical cardiac surgery. The 
rationale is to protect against the slow but continual ingress of calcium 
ion which is in response to the efflux of potassium and ingress of hydrogen Iion during ischemia. Immediately upon reperfusion there is a rapid ingress 
of calcium into the ischemic cell, the explanations for which are not clear. 
It has been shown experimentally in rabbit and dog hearts that the administration 
of nifedipine in a perfusate or a cardioplegic solution retards the accumulation I 
of excess calcium in mitochondria and results in less increase in stiffness 
during the post ischemic-reperfusion phase. Consequently, hearts so treated 
have greater left ventricular performance than those with cardioplegic I
solution alone. 
The clinical protocol utilizes radionuclide ventriculograms, pyrophos­ Iphate scans, CK isoenzyme MB, and 24-hour Holter monitoring in the preoperative 
phase, the first three postoperative days, and one week and six weeks after 
operation. I 





Twenty-four hour Holter recordings are analyzed with the Argus/2H
 
system and reports returned promptly for clinical use. Twenty-five patients
I have undergone the complete protocol. The data demonstrate two distinctly
 different patterns. Those patients operated on for coronary artery disease
 
I,
 tend to have a high PVC rate in the first three days in comparison to the
 preoperative recording. By six weeks, the PVC rate is distinctly lower than that observed preoperatively. The data have been highly useful in 
making judgments with regard to the administration of anti-arrhythmics in 
I the postoperative period. The second group of patients are those with valvular disease who frequently require use of a temporary pacemaker during the first 
72 hours postoperatively. The recordings have been difficult to assess 
because of the large pacemaker spike which with the current program is indis­I tinguishable from a true PVC. We have established that for right-ventricular pacing, a modified Lead III gives high-amplitude pacing artifacts which 
we believe can be detected reliably. Work is in progress to develop a new 
I high-speed program which will recognize the large and rapid pacemaker discharge and thus analyze for true PVC's only. 
I The study is to continue for another two years. It is concluded from the early clinical experience that computerized analysis of 24-hour Holter recordings of the electrocardiogram, an important adjunct in the 












B. Quantitative Imaging 
Although ultrasound has proven to be a useful source of diagnostic in­ I 
formation, results of examinations based on current ultrasonic methods are 
primarily qualitative and pictorial. To provide quantitative information in 
addition to a picture, a collaborative effort with the Physics Department has Ibeen undertaken to measure regional paranleters of tissue. A multiple frequency­
attenuation and time-of-flight transmission tomographic reconstruction system 
has been implemented, and the physical limitations of ultrasonic transmission 
tomography have been assessed. Improvements in the measurement of the received I 
signal and in processing to correct for beam-width have been made to this system 
(B-1). The scanner has been used successfully in a series of experimental 
studies on infarcted dog hearts (B-2). Major improvements have also been made I 
in the software used in simulation studies of geometric acoustics (B-3). An 
empirical model for anisotropy has been developed (B-4). Estimation of atten­
uation coefficient with reflected sound has been tested in simulations (B-5). I 
Stimulated by the clinical impact of the EUI transmission tomographic 
scanner in 1973, experimental studies were initiated in collaboration with 
the Division of Radiation Sciences to evaluate the positron coincidence-detection I 
as a method for emission reconstruction tomography. This collaborative activity 
resulted in a prototype scanner called PETT (Positron-Emission Transaxial 
Tomograph). A back projection algorithm was implemented in a mini-computer I to effect reconstruction from coincidence detections. Extensive studies in 
patients and animals were conducted subsequently with the PETT III scanner 
in collaboration with the divisions of Neurology and Cardiology. A subsequent 
scanner, PETT IV, utilized concepts developed with its predecessor but incor­ I 
porated a novel technique for the simultaneous collection of four tomographic 
slices from a single set of detectors. PETT IV is now located in the Cardiac 
Care Unit for use in the SCaR project for the quantification of regions of I 
myocardial ischemia and infarction (B-6) and for liver studies (B-7). Two new 
scanners have been developed that permit luore rapid data collection and improved 
spatial resolution. One of these, PETT V, was used in experimental studies Iin dog hearts (B-3). The newest system, PETT VI, became operational during 
the summer of 1980 and employs new, fast detectors and an entirely circular 
motion for rapid data acquisition in neural studies (B-9). One of the most 
exciting recent possibilities for positron emission tomography results because I 
of new developments in crystal technology and high speed electronics. These 
now permit the propagation time of each of the two photons created in an an­
nihilation to be measured. Theoretical and experimental studies have been I 
initiated so that a new scanner collecting and using these time of flight 
measurements can be built (B-10) - (B-13). IWork accomplished during the past year in one of the Laboratory's on­
going projects, that of developing accurate procedures based on fundamental 
physical principles for computing absorbed dose in clinical radiation-treatment 
planning, is described in this section. Development of algorithms based on I 
the computation, in three dimensions, of the intensity of Compton scatter and 
absorption within an inhomogeneous irradiated region has progressed so that 









I B-1. Ultrasonic Attenuation and Time-of-Flight Tomographic Scanning 
System 
I Personnel: G. H. Brandenburger, BCL 
J. R. Klepper, BCL 
I J. G. Miller, BCL J. G. Mottley, BCL 
Support: RR 00396 
I 
A. Front-end and processing improvements 
I Substantial improvement in the estimation of ultrasonic intensity
 
has been realized by time-integrating the received acoustoelectric pulse.
 
Formerly the ultrasonic intensity was estimated from the peak of the




sonic pulse through an inhomogeneous refracting medium gives rise to
 
phase-cancellation error in piezoelectric receiving transducers of wide
 
aperture l CPR 14, B-1; PR 15, B-1) while the acoustoelectric received
 
pulse is only stretched in time due to the inhomogeneity. Thus the 
peak of the acoustoelectric pulse is less reliable for estimation of 
I attenuation when the medium is refracting while the time-integral of the received pulse remains the same. An analog integrator was applied 
to the acoustoelectric pulse and was demonstrated to yield more reliable 
estimates of attenuation, particularly for propagation through edgesI of refracting media. 
I 
A method was developed for improving the accuracy of the slope 
of attenuation from measurements made with a focused transmitting transducer. l 
I 
Significant improvement in spatial resolution has been achieved with 
the use of a focused transmitting transducer instead of a planar transducer 
of comparable aperture CPR 15, B-1). However, the diameter of the transmitted 
beam in the focal region did exhibit a dependence which is approximately 
inversely-proportional to the ultrasonic frequency. As a result, the 
region of tissue subtended by the transmitted beam varies with ultrasonicI frequency. The computation of the slope of attenuation was predicated
 on the assumption that the same region of tissue is insonified at each
 
frequency. Hence, the slope computation will be compromised, particularly
 
I
 near edges within the object.
 
Figure 1 demonstrates the error in the slope for a homogeneous
 
cylinder of laboratory gelatin which approximates the properties of
I tissue. A 1.2-cm aperture, 10-cm focal-length transmitter was used.




measurements at 3 MHz. Substantial error due to reflection loss at
 




image and in the corrupted values of attenuation reconstructed throughout
 
the object. Panel b) is the reconstruction of the slope of attenuation,
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Figure 1. A comparison of reconstruction methods for attenuation Imeasured in a homogeneous cylinder of tissue-like laboratory gelatin: 
Panel a) attenuation measured at 3 MHz.
 
Panel b) slope of attenuation (uncompensated).
 I 
Panel c) slope of attenuation compensated for the variation of the
 




in the slope image appear to be due to the inconsistencies resulting 
from beamwidth variation with frequency. Panel c) is a reconstruction 
of the slope after the individual projections at each frequency were 
spatially filtered l to correct for the beamwidth frequency dependence. I 
The edge artifact is almost completely removed and the reconstructed 
slope values are consistent throughout the cylinder. I 
We demonstrate further, with a tissue sample, the importance 
of correcting for beamwidth variation with frequency. Figure 2 is a 
comparison of corrected and uncorrected slope reconstructions of an Iintact dog heart. Black corresponds to zero attenuation and white rep­
resents 0.24 cm-1MHz- l slope. The region of infarct (details of the 
tissue preparation and pathology appear in B-2) is clearly visible 
in both images. We note, however, that some apparently false detail I 
appears in the uncompensated reconstruction in Panel a). In particular, 
several apparently highly attenuating objects are visible which are 
not apparent in the beamwidth compensated reconstruction of Panel b) I 















Figure 2. A comparison of beamwidth compensated and uncompensated 
slope reconstructions of a dog heart containing a single myocardial 
infarct at 3 to 4 o'clock. 
Panel a) is the uncompensated reconstruction.
 
Panel b) was compensated for the variation of the beamwidth with
 
frequency. Beamwidth compensation reduces edge artifacts with little
 







B. System enhancements 
Numerous improvements to the CUTARSYS (PR 13, B-3) software were Iincorporated: 
1)	 The time-of-flight data-acquisition algorithm was modified 
to improve edge recognition accuracy and to permit measurements I 
using tone-bursts for up to 8 frequencies. Results of the 
time-of-flight measurements for dog heart appear in (B-2). I2)	 The projection-moments software was rewritten and extended
 
for use in the anisotropy study (B-4).
 
I3)	 The ability to print and display the difference between recon­
structed images was added. This is useful in studies of 
the frequency-dependent indices such as the slope of attenuation 
and was used in the work on beamwidth frequency-dependence. I 
4)	 Software was written to generate spatial filters based upon
 
independent beamwidth measurements and a Gaussian beam-profile
 Imodel. The resulting filters were used in conjunction with 
a modification of the software for spatial filtering of projections 
to implement the correction for beamwidth frequency dependence. I 
5)	 The CUTARSYS software was expanded for conversion of image 
and projection data from external sources such as the Universal 
Storage Device (G-3). Data produced at the Laboratory for I 
Ultrasonics, Department of Physics, were brought into CUTARSYS 
for image display and hardcopy, and for tomographic reconstruction. I 
1.	 J. R. Klepper, G. H. Brandenburger, J. W. t1imbs, B. E. Sobel, and 
J. G. Miller, "Application of Phase Insensitive Detection and Frequency
 
Dependent Measurements to Computed Ultrasonic Attenuation Tomography,"
 I 
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I B-2. Ultrasonic Computed Tomography of Experimental Infarct in In-Vitro 
Dog Myocardium 
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Myocardial infarct in the dog was selected as a model to test 
I the hypothesis that pathologic changes in tissue are accompanied by 
I 
changes in the ultrasonic attenuation or speed of sound in that tissue. 
Accordingly, three dogs were studied in vitro 7 to 9 months after coronary 
artery ligation. Although the techniques described in this report cannot 
be applied directly to the examination of the heart in vivo, the demonstration 
that such techniques can be successful in transmission ultrasonic imaging 
in vitro may provide information that is useful in the eventual applicationI of quantitative imaging techniques to imaging in vivo using reflected 
ultrasound. 
I
 Previous studies from this laboratory have demonstrated that
 the principal artifact in ultrasonic imaging based on attenuation results 
from phase cancellation artifacts exhibited by piezoelectric receiving 
I
 transducers CPR 14, B-1). Consequently, measurements were made using
 a phase insensitive acoustoe1ectric receiving transducer. An example 
of an attenuation-based reconstruction from such measurements is given 
in Figure 1. An optical photograph of the approximate plane imagedI is shown in panel a) and a reconstruction from data taken at 5.1 MHz is shown in panel b). The infarct is visible as the white mass on the 
right hand side of the optical photograph and clearly correlates with 
I
 the white region of the reconstructed acoustic image of the plane in
 panel b). The reconstruction is windowed such that black corresponds 
to zero attenuation and white corresponds to 1.1 cm-1 • The location 
I
 and size of this nearly transmural infarct make it easily detectable
 with a narrowband reconstruction based on the apparent attenuation. 
The location and size of the infarct were traced through severalI image planes of this heart. Figure 2 shows four images of this heart 
I 
in planes separated by approximately 1 cm. The infarct is clearly visible 
in the reconstructions of panels b) and c) and appears to be getting 
successively smaller in planes approaching the apex. No discernible 
I 
infarct appears in the reconstruction of panel d) which corresponds 
to a region approximately 1 cm from the apex. Optical examination of 
this region of the heart after ultrasonic scanning also revealed no 
I
 







a b I 
Figure 1. Cross-sectional images of a dog heart containing a myocardial
 
infarct. Panel a) is an optical photograph of the approximate plane
 I 
imaged in the reconstruction in panel b). The reconstruction is based
 
on measurements of attenuation at 5.1 MHz. White represents high
 





apparent infarct. A comparison of time-of-flight and attenuation images 
of the same plane is shown in Figure 3. The infarct is clearly visible I 
in the time-of-flight scan. 
Although the images shown in Figures 1, 2, and 3 delineate the I 
zone of infarct, the resulting quantitative estimates of attenuation 
are substantially in error. Reconstructed images at a single frequency 
are not always adequate to identify the zone of infarct. In particular, Igeometry-dependent reflection losses which compromise the quantitative 
estimates of the attenuation at a single frequency may be so severe 
as to obscure the zone of infarct. Reconstructions from data taken 
at 3 and 5 MHz on the second heart are shown in Figures 4a and 4b, I 
respectively. The infarct is barely noticeable in the 311Hz reconstruction 
in Figure 4a since the edge artifacts in this reconstruction are equal 
to or greater than the reconstructed values of the attenuation within I 
the infarct. The infarct is less obscure in the 5 MHz reconstruction 
of Figure 4b because the increased attenuation at 5 MHz constitutes 
a larger component of the measurement while the frequency independent Ireflection loss errors remain approximately constant. However, severe 










The reconstruction of the slope of the attenuation coefficient 
computed over a range of frequencies is expected to be better than theI reconstructions made directly from any of the individual narrowband measurements. The slope of attenuation, computed from the same data 
set used to create the images in Figure 4, is reconstructed in Figure 5.I, The slope was estimated from measurements of attenuation over the range 
I 
3 to 5 MHz using beamwidth compensation (B-1). An optical photograph 
of the approximate cross-section of heart images is shown in panel a). 
The subendocardial infarct is the region of white scar located in the 










Figure 2. Reconstructed images of a dog heart containing a myocardial 
infarct from attenuation measurements at 5.1 MHz. Panel a) is the 
same reconstruction as shown in Figure 1. Panels b), c), and d) are 
planes parallel to the image plane shown in panel a) with each being 
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I 
Figure 3. A comparison of time-of-flight and attenuation images of the 
same image plane of a dog heart containing a myocardial infarct. IPanel a) is an optical photograph of the approximate cross-section
 
imaged. Panel b) is a tomogram from attenuation measured at 5.1 MHz.
 
Panel c) is a time-of-flight image of the same plane with white
 

















Figure 4. Reconstructions of a dog heart containing a myocardial infarct. 







I Figure 5. Cross-sectional images of a dog heart containing a myocardial 
I 
infarct. Panel a) is an optical photograph of the approximate image 
plane shown in the image in panel b). The image was reconstructed from 
the slope of attenuation from 3 to 5 MHz; white represents high slope of 
I 
attenuation; dark represents low. The improvement in the resolution of 
the region of infarct is shown by comparison with the single-frequency 
attenuation images of the same plane in Figure 4. 





IB-3. Modeling and Simulation of Ultrasonic Wave Propagation in the 
Context of Ultrasonic Imaging 
Personnel: G. H. Brandenburger, BCL I 
J. R. Cox, Jr., BCL 
Support: RR 00396 IWashington University 
A. Simulation software development I 
The basic framework of the geometrical acoustics simulation software 
system was completed. As a subsystem within CUTARSYS (B-1; PR 15, B-1), I 
the simulation shares all the processing, reconstruction, spatial filtering, 
imaging, graphics, and file-access capabilities of CUTARSYS. Improvements 
include: I 
1)	 A lO-fold increase in speed reduced the time required for
 
ray tracing from the typical 24 hours to 2.4 hours.
 I 
2)	 Each transmitted beam can now be sampled with up to 100 rays 
(instead of 10), as required for more accurate characterization 
of the beam. This allows the simulation of the beam profile I
at the receiver and holds promise for use in the study of 
transmitted beam characterization at the receiver by spatial 
moments of the intensity. The corresponding modifications 
to the ray summing software (PR 15, B-2) for 100 rays are I 
partially completed. 
3)	 Ray tracing is now restartable, permitting recovery from I 
machine failure during long runs, and has been enhanced with 
a command monitor. The monitor is useful in the development 
of new software owing to the ability to enable and disable Ithe exhaustive diagnostic listing features at any point in 
a simulation. Without these features diagnosis of simulation 
or program errors which occur hours into a run can be difficult. I 
Figure 1 demonstrates some of the important effects modeled by 
the system. All images are tomographic reconstructions of attenuation­
based parameters in a simulated dog-heart geometry. Panels a) and b) I 
represent simulations assuming a circular-aperture piezoelectric receiving 
transducer. Panels c) and d) are the corresponding simulations for 
an acoustoelectric receiving transducer free of phase-cancellation error I(PR 15, B-1, B-2). The simulated object has a refractive index 5% different 
from the surrounding medium. Panels a) and c) represent measurements 
of attenuation at a single frequency (3 MHz) and demonstrate significant 
error near edges due to reflection losses. The slope of attenuation I 
over 3 to 6.5 MHz is reconstructed in panels b) and d). While the recon­
struction of phase insensitive measurements in panel d) exhibits eonsiderable 
improvement over panel c), the image corrupted by phase-cancellation Iin panel b) is only marginally improved. Panel e) is a reconstruction 
I 
















Figure 1. Simulated dog hearts showing effects of refraction and phase 
cancellation in a single-element wide aperture piezoelectric receiving 
transducer. Panels a) and b) are reconstructions of data simulating 
measurements of the piezoelectric receiver. Panels c) and d) represent 
comparable reconstructions of data simulating an acoustoe1ectric 
receiving transducer. Panels a) and c) were reconstructed from simulated 
measurements made at 3 MHz. Panels b) and d) were reconstructed from 
the slope of attenuation over 3 to 6.5 MHz and exhibit reduced artifact 
due to reduction of error from reflection. The acoustoe1ectric measure­
ments do not exhibit phase-cancellation error, and corroborate results 
of actual measurements that indicate that phase-cancellation is the pre­






of an identical object free of error due to non-unity refractive index. 
These results are in qualitative agreement with actual observations 
in the laboratory. I 
A new simulation software package was developed for research 
into the effects of anisotropy on tomographic reconstruction. This 
effort was an outgrowth of earlier work and results are detailed in I (B-4). Besides directly simulating a wide range of geometries, the 
software also can be used to modify ray-tracing based simulations of 
linearly-directed anisotropy (B-4). The experience gained during this Idevelopment suggests methods for a number extensions to the ray-tracing 
algorithms, including: a) inclusion of both linearly and tangentially-directed 
anisotropy; and b) accommodation of a wider range of object geometries. I 
B. Theory of geometric acoustics 
The	 literatures of geometric optics, and its mechanical-wave I
counterpart, geometrical acoustics, have been reviewed. The primary 
goals of this effort were: 
I1)	 More detailed modeling of the specularly reflected, refracted, 
and diffracted components of a particular pulse-wavefront 
impinging a surface of refractive-index discontinuity; I 
2)	 A detailed geometrical acoustics model for a focused transmitting 




I4)	 An accurate model for time-of-flight measurements; 
5)	 An extension of the existing finite pulse-duration model,
 
presently used in the ray-tracing, which will also include
 I 
dispersive effects; and 
6)	 A geometrical acoustics (ray) model for media exhibiting Ianisotropic acoustic velocity. None appears to exist at 
this writing. 
The	 outcome of this study will be the identification and/or derivation I 
of a series of models to be applied in the ongoing development of the 
ray-tracing simulation. vfuile the study is far from complete, we have 
already compiled a number of potential refinements to the existing ray- I
model which include: 
1)	 A more detailed model of reflection at a boundary has been
 
identified which accounts for lateral displacement of the
 I 










 2) The classical geometrical acoustics/optics model does not 
account for the diffracted energy components radiating fromI discontinuities in the first-derivative of the refractive 
I 
index (edges). The Geometrical Theory of Diffraction (GTD) , 
which has evolved over the last 25 years, partially overcomes 
this discrepancy. Despite its being a theory which has defied 
formal proof, GTD has been applied successfully to a broad 
range of problems formerly too complicated for analytical 
solution, but of geometry close enough to a wavelength toI preclude description by classical ray optics. GTD has apparently 
I 
not been applied to the modeling of the acoustics associated 
with imaging. We have identified methods via GTD, for extending 
our ray-model to include the effects of diffraction. 
I 
3) A two-part model has been proposed to simulate the transmitted 
beam of a focused aperture. The first part is a refinement 
of the existing focused-beam simulation (PR 15, B-2) which 
permits more accurate representation of the central lobe 
of the beam given a description of the transmitter aperture,I apodization, geometry, and refractive index. Part two augments 
I 
the beam representation with diffracted rays (analogous to 
those of GTD) whose properties are derived from the evaluation 
of the diffraction integral for the aperture. The diffracted 
I 
rays describe the side lobes of the beam and permit more 
accurate modeling of a transmitted pulse beyond the initial 
wavefront described by classical ray-optics. 
The simulation methodology under development appears to be feasible. 
The detailed simulation of the received wavefronts, for both transmissionI and reflection in anisotropic inhomogeneous media, would be important for the design of quantitative clinical ultrasonic imaging methods for 
tissue for the following reasons: 
I 
I 1) Simulation provides a means for evaluating the performance 
of new imaging methods, with the important capability of 
varying specific test parameters with a degree of control 
not feasible in test phantoms. 
I 
2) New models can be tested and refined through the simulation 
by comparisons with laboratory measurements. 
I 
3) Algorithms developed for simulation may also find direct 
application in imaging systems. At the very least, the 
understanding gained in developing accurate models of ultrasonic 
wave propagation should be helpful in the development of 
approaches to quantitative imaging.I 
I 
1. J. R. Klepper, G. H. Brandenburger, J. W. Mimbs, B. E. Sobel, and J. G. 
Miller, "Application of Phase Insensitive Detection and Frequency Dependent 
Measurements to Computed Ultrasonic Attenuation Tomography," IEEE Trans­







B-4.	 Anisotropy in Ultrasonic Attenuation and Its Implications for 
Computed Transmission Tomography 
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Ultrasonic parameters such as attenuation and scattering have 
been shown to be strong functions of the direction of wave propagation I 
relative to an intrinsic direction within various materials. Muscle 
tissue and certain metals and crystals can possess strongly anisotropic 
components of attenuation, acoustic velocity and scattering. Anisotropic I
attenuation and scattering in tissue are reported in the literature 
primarily as pairs of measurements made with orthogonal propagation 
paths. The functional dependence of attenuation on angle does not appear Ito have been characterized for most biological tissue. Similarly, 
the frequency dependence of the anisotropy itself is a largely unexplored 
but potentially useful tissue characterization parameter. The effects 
on various ultrasonic imaging methods of the angular dependence of the I 
parameter being imaged appears to be another important field awaiting 
investigation. IWe developed a model for anisotropy as a continuous function 
of angle of propagation. This model was then fit to an empirical angular 
dependence function for the slope of attenuation in myocardium (Figure 1). 
The effect of this anisotropy on filtered back-projection tomographic I 
reconstruction was analytically derived for simple geometries using 
the model. Effects of anisotropy were further demonstrated for various 
elliptical geometries by computed tomographic reconstruction of simulated I 
data. 
I. An	 Empirical Anisotropy Model I 
We denote the parameter of interest by a(x,y,w); its anisotropic 
character within a volume element dxdydz is modeled as I 
a(x,y,w) = a (x,y)(l + C(W)),	 (1) 
o	 I 
where a (x,y) is an intrinsic isotropic component, W is the angle between 
the vo18me element's anisotropy axis and the direction of wave propagation, 
and C(W) is the anisotropic angular dependence function. On the basis Iof measurements from myocardium, the angular dependence is assumed to 





























I Figure 1. The zero-order moment M (8) of the slope of the attenuation is . 0plotted agalnst angle over 360 degrees. Moments were computed from 
measurements of the slope in an isolated section of dog left ventricle. 







I2C(lj!) 8 cos (lj!)	 (2) 
where lj! = a is the direction of the largest ultrasonic attenuation I (along the muscle fibers). 
II. Tomographic Reconstruction of Anisotropic Projections I 
Images of tissue have been reconstructed from ultrasonic attenuation 
measurements using filtered back-projection algorithms and iterative 
algebraic algorithms. The effects of anisotropy on tomographic recon­ I 
struction are investigated here in the context of filtered back projection 
for the following reasons: I
a)	 Filtered back projection can be expressed analytically, thus
 
permitting the expression of anisotropic effects in closed
 
form for simple geometries.
 I 
b)	 Conclusions about the effects of anisotropy on tomography,
 
based upon models and simulations presented here, can be
 
compared with results for reconstructions of tissue from
 I 
this and other laboratories. 
The	 projections for an annulus were analytically derived for both linearly­ Idirected and circumferential anisotropies (Figure 2). The resulting 
filtered back projection reconstructions were then derived analytically 
for the linearly directed case and were in excellent agreement with 
computer reconstructions of the analytically derived anisotropic projections. I 
The effects of anisotropy for more complicated geometries were demonstrated 
by computer simulations. I 
Figure 3 is a schematic diagram of the superimposed circle-and-ellipse 
geometry to be simulated. All circles possess an isotro~ic attenuation 
of 0.5. The two ellipses are characterized by a linearly directed anisotropy Iparallel to the lines shown. Each ellipse has an isotropic component 
of attenuation of 0.5, equal to the surrounding disks. The 2:1 anisotropy 
magnitude used for the ellipses causes the attenuation measured parallel 
to the lines shown to appear twice as large as measured normal to the I 
lines. 
In Figure 4 an ellipse is reconstructed which illustrates the Ipotential effects on regions neighboring the anisotropic ellipse. The 
substantial positive and negative errors surrounding the ellipse are 
expressed as a percentage of the value reconstructed within the ellipse. IObjects adjacent to the long sides of the ellipse will reconstruct with 
underestimated attenuation values due to the negative errors on either 
side of the ellipse. Near the ends of the ellipse objects will reconstruct 
with overestimated attenuation values. I 
In panel a) of Figure 5 the entire collection of objects (anisotropic 































I Figure 2. Effects of 2-to-1 anisotropy on tomographic reconstruction are 
I 
illustrated for simple object geometries by simulation. Panels a) and 
b) are a disc and annulus with linearly-directed anisotropy; the correct 
values in the objects should be 1.0, and outside 0.0. Panels c) and d) 
are a disc and annulus with tangentially-directed anisotropy; again the 
values should be 1.0 within the objects and 0.0 outside but are severely 







































Figure 3. To demonstrate the effects of anisotropic objects in a 
tomographic reconstruction, the collection of circular and elliptic 
objects, shown schematically here, are reconstructed in Figures 4 and I
5. The circular objects are intrinsically isotropic with a value of 
0.5. The ellipses possess 2-to-l anisotropy with linearly directed
 




























Figure 4. The effect of 2-to-1 linearly directed anisotropy in an 
isolated ellipse is demonstrated in this tomographic reconstruction. 
Reconstructed values outside the ellipse are expressed as a percentage 
of the value reconstructed in the ellipse (1.0); these values differ 























Figure 5. The collection of objects depicted in Figure 3 are reconstructed 
here. Circular objects are isotropic with value 0.5. In panel a) the I
anisotropy of the ellipses causes the isotropic discs to suffer both
 
over and under estimation. Panel b) shows the same objects reconstructed
 
from data in which all objects were intrinsically isotropic; the correct
 
reconstructed values are shown.
 I
 





I of anisotropic objects on adjacent regions. Panel b) is a reconstruction 
of objects with the same geometry, but with strictly isotropic attenuations 
ao = 0.5 (S=O). The grey scale imaging window for panels a) and b) 
was selected with the ao = 0.5 at mid range so as to show both over 
and under estimations of the reconstructed attenuation. 
I III. Implications for Ultrasonic Tomography of the Heart 
I 
The recent tomographic study of dog hearts in vitro (B-2) demonstrated 
the capability of delineating regions of infarct in images based on 
I 
attenuation and on time-of-f1ight measurements. Implications of anisotropy 
for attenuation images of the heart are studied by simulations based 
upon the 2.6-to-1 anisotropy observed in myocardium and the sinusoidal 
model. 
Figure 6a is a schematic representation of a hypothetical sliceI through the ventricles of a dog heart. A photograph of an actual heart, 
I 
in panel b), reveals the right and left ventricular cavities, papillary 
muscles in the left ventricle, and a white fibrous region in the posterior 
left ventricular muscle corresponding to scar tissue from an experimentally 
induced infarct. The plane of the image is oriented approximately perpen­
dicular to the septum, as are many of the published tomograms. 
I Within the layers of the left ventricle, muscle fibers will be 
oriented in various directions, parallel to or oblique to the plane 
of the image. As a simplifying worst case, we model the fibers as parallelI to the page. The papillary muscle fibers are modeled as perpendicular to the plane. 
I Projection measurements of the slice in this plane will view anisotropic myocardium in the ventricles and septum, but the interrogating 
wave propagates approximately normal to the papillary muscle fibers 
for all view angles, and therefore papillary muscle will appear isotropic.I 
I 
In light of the geometry dependence of anisotropy effects, we 
illustrate the potential effects of anisotropy in tomographic reconstruction 
of the heart with a simulated model of an entire heart slice, corresponding 
I 
to the schematic heart in Figure 6a. Illustrated, for comparison, in 
Figure 7 panel a) is a reconstruction of the slope of attenuation for 
the heart model without intrinsic anisotropy (S=O). Slope values correspond 
to independent measurements made in transmission, perpendicular to the 
muscle fibers. The effect of a 2:1 circumferential anisotropy is illustrated 
in panels b) and c). Because the anisotropy of infarct scar has notI been well characterized, we simulate infarct scar with 2:1 circumferential 
I 
anisotropy (S=l) in panel b) and simulate isotropic (S=O) scar in panel c). 
Thp. isotropic components of the slope of attenuation (ao) in all regions 
are equal to the normal-incidence slope values employed in the isotropic 
I 
heart in panel a). The tangentially directed anisotropy model was employed 
with 2:1 anisotropy (S=l) oriented along the circular axes shown in 





































Figure 6. This schematic representation of a hypothetical slice through 
a dog heart in panel a) is to be compared with a photograph of an 
actual heart in panel b). The white fibrous region of the heart in I
panel b) corresponds to scar tissue from an artificially induced
 
infarct. The values shown in panel a) represent values of the slope
 
of attenuation from the literature. Anisotropy axes in panel a)
 
represent the tangentially-directed anisotropy geometry values used
 I
 
in the simulations in Figure 7. 
I
 















Figure 7. Simulated projections of a hypothetical dog heart are reconstructed 
to form images: Panel a) is an intrinsically isotropic model of a heart. 
Panel b) is a tangentially-directed anisotropic heart with infarct modeled as 
anisotropic. Panel c) is a tangentially-directed anisotropic heart with 
infarct modeled as isotropic. Panel d) is a reconstruction of the actual 






tissue in d), based upon the slope of attenuation measured in the heart 
shown in Figure 6b. 
IWe conclude: 
1)	 Many of the errors encountered in tomographic reconstruction
 
of the heart (such as underestimated values of attenuation
 I 
in papillary muscle) derive from anisotropy. 
2)	 Anisotropy constitutes a potential source of error in all I






B-5. Adaptive Beamforming_for Quantitative Ultrasonic I1!!.~ 





Linear phased-array imaging systems have become commonplace in I 
many clinical settings. Several advantages are gained by segmenting
 
the transducer and controlling the delay or phasing of the elements
 
in the array. Perhaps the most important advantages are that the beam
 Ican be steered over a larger area than the projection of the transducer
 
and that it can be focused in the plane of the array. In order to
 
steer and focus the beam delays are introduced between signals from
 
the various elements before the signals are added to form a beam, which
 I 
has been steered toward and focused on a region of interest. These
 
delays are determined geometrically by assuming the medium is homogeneous.
 
For qualitative imaging the homogeneous-medium assumption is satisfactory.
 I 
We tested the homogeneous-medium assumption for quantitative
 
imaging and found that, even for simple geometries such as a two-layer
 Imodel, it leads to large errors. In this case we assumed a 6-MHz source
 
with a half-sine envelope had been produced by reflection at point P.
 
Point P was 10 cm in front of the array and 5 cm to the side of its
 
axis into the medium of interest. The layers were each 5 cm thick.
 I 
That next to the transducer had an attenuation coefficient of 0.02 Nep/cm/MHz
 
and a phase velocity of 1057 m/s. Corresponding values for the outer
 
layer were 0.1 and 1536, respectively. The linear receiver was simplified
 I 
to three points separated by 1 cm. We compared the results of combining
 
signals from the receiver elements using the homogeneous-medium delays
 
and of combining signals after properly aligning (or delaying) the signals
 
with an adaptive beamformer. The peak amplitude of the two beamformer
 I 
outputs varied by more than 6 dB. 
I 






Since the ultrasonic source was known, we could calculate its 
spectrum as shown in Figure lao To estimate the attenuation of that 
region as a function of frequency, we also calculated the spectrum after 
I 
the ultrasound has passed through a tissue region. The result of this 
test is given in Figure lb for the two-layer model described earlier. 
The adaptive beamformer estimates the attenuation coefficient to be 
0.059 Nepers/cm/MHz. The average value along the three rays from source 
to receiver elements is 0.060 Nepers/cm/MHz. The homogeneous-medium 
beamformer, however, gives an estimate of the attenuation coefficientI of 0.092 Nepers/cm/MHz, which is 3.7 dB too high. Thus even for very 
I 
simple geometries the homogeneous-medium assumption appears to be inadequate 
for quantitative imaging. On the other hand, adaptive beamforming, 
at least in this example, permits an accurate assessment of attenuation 
as a function of frequency. 
I In our approach to adaptive beamforming the actual delays encountered by the ultrasonic field reflected from a particular point in the medium 
are estimated in order to correct the delays predicted by the homogeneous­
medium assumption. The estimator can be implemented in several ways.
I Choice of the appropriate algorithm and technology for the estimator is a key goal of our on-going work. 
I The estimator we have tested and used to obtain the results in Figure 1 was a transversal filter with a length equal to the duration 
of the ultrasonic pulse. The received signal was shifted through the 
filter at uniform (10 ns) intervals. The filter was designed so thatI at each interval the filter output gave the amplitude of the characteristic 
I 
frequency (6 MHz in this case) of the signal within the filter. A peak 
in this output corresponds to exact alignment of the pulse within the 
filter and thus estimates the actual delay of the pulse from the reflector 
to a given array element. Repeating this operation for each array-element 
signal permits the proper delays to be applied in each case. Thus 
I phase cancellation across the array of the field from a particular reflector can be significantly reduced. 
The primary assumption which governs the validity of this approachI is that the field arriving at the receiver comes from a single point. 
I 
To insure that only a small region generates a reflection, the insonifying 
beam must be tailored to focus the transmitted beam only on the region 
of interest. Development of the two-dimensional transducer as part 
of this work will permit such beam tailoring. 
I The two-layer simulation of inhomogeneous tissue used to illustrate the value of adaptive beamforming was based on a dispersive tissue model 
which links attenuation and phase velocity. While the effects of dispersion 
are small (1-2%) and can be neglected in the frequency domain, the inclusionI of dispersion is essential for time-domain descriptions of tissue. 
I 
The usual assumption of linear phase (constant phase velocity) leads 
to a non-causal impulse response. We developed a causal impulse response 
function using the Hilbert transform. The frequency response of a tissue 




H(w) = e 0 e-j8 (w) (1)27T 









outp~t() Attenuation,a	 = 0 1 o input o • 







2	 4 6 8 10 12 14 16 
a) Spectra of input (6 MHz with 
half sine envelope) to and 









in ut _ model loutput 
(from a = 0.06 










~ = 0.059 
o 
frequency, MHz 
1	 2 3 4 5 6 789 
b)	 Attenuation measured by comparing 
input and output signals 
II	 \ \ 
---i nput 
I I \+16 x output 
Figure 1. Effects on signals of a) Ultrasonic pulse propagation through 





1 The assumption of constant phase velocity makes 8(w) a linear function of frequency. If IH(w)1 satisfies the finite energy and Paley-Weiner 
I, 
conditions, then the Hilbert transform gives a minimum-phase expression 
for 8(w). The phase velocity becomes a function of frequency and ao 
given by 
w _ 
Vp (w) w (2) 
r!­
t 




where T is the constant of proportionality in the linear phase expression, 




If the Hilbert phase term is substituted into the frequency response 
(Eq. 1), then a causal impulse response can be found by inverting H(w). 
1 
Estimates of ao from the RMS duration of the non-causal impulse response 
are about 3 dB low. The attenuation coefficient is correctly predicted 
from the causal impulse response. 
We have generalized the procedure for linking attenuation and 
phase velocity in a dispersive model, so that the frequency response1 is not restricted to the functional form of Eq. (1). By polynomial 
1 
fitting any measured magnitude of H(w), then extracting roots of the 
polynomial, we can find the poles and zeros of H(w) under minimum-phase 
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This project is designed to determine whether positron emission 
transaxial tomography (PETT) permits delineation of regional myocardial I 
metabolism in vivo, with particular emphasis on zones of jeopardized 
ischemic myocardium and infarction. The overall objective is to provide 
a diagnostic modality quantitatively superior to conventional procedures I 
based on assessment of cardiac biochemistry in vivo and to provide an 
investigative tool that will permit objective assessment of the efficacy 
of therapeutic interventions in diminishing the progress of ischemic Iinjury to myocardial necrosis. Previously we have demonstrated that 
llC-palmitate is a particularly useful radionuclide for external assessment 
of myocardial metabolism. Fatty acid is the preferred substrate of 
the heart for a variety of reasons, including the high cytoplasmic ratio I 
of carnitine to CoA which leads to conversion of activated fatty acids 
to species that can ingress into the mitochondria where oxidation takes 
place. We have previously demonstrated that the externally detectable I
reduction of llC-palmitate accumulation in perfused hearts correlates 
closely with hypoxia and its metabolic sequelae despite the maintenance 
of constant flow. In addition, we found that the distribution and extent 
of myocardial infarction detectable tomographically with llC-palmitate I 
administered intraveneously into intact dogs correlates closely with 
myocardial infarction quantified morphometrically at necropsy and delineated 
with the use of enzyme assays applied to contiguous cross sections of I 
the heart. A series of completed studies has defined the consistency 
of lipid pools in heart muscle, the relationships between altered retention 
of llC-palmitate and metabolic integrity reflected by generation of IC02' and physiological determinants of myocardial oxygen requirements 
in relation to oxidative rates of llC-palmitate detected externally. 
IThe feasibility of tomographic delineation of healed myocardial 
infarction was demonstrated first in studies with PETT III. Initially, 
we found that the distribution of llC-palmitate in cross sections of 
the heart from normal subjects was homogeneous but that zones of diminished I 
uptake characteristically occurred in patients with healed myocardial 








I of the infarct. More recently, studies performed with PETT IV demonstrated 
that 'delineation of the blood pool after inhalation of 11CO enhanced 
recognition of the endocardial border and facilitated quantification 
of the extent of jeopardized, ischemic myocardium based on its diminished 
uptake of 11C- pa1mitate. During the past year, a close correlation 
I was observed between enzymatically and tomographically estimated infarct size among patients with either transmural or subendocardial infarctions. 
I
 
Among 11 patients with non-transmural infarction defined electrocardiograph­

ically who were studied one to eight weeks after the onset of symptoms,
 
regional depressions of 11C-pa1mitate accumulation «50% of maximum
 
mural uptake) were detected with sagittal, coronal, and transaxia1 recon­
structions and quantified based on activity in 14 transaxia1 sections 
I obtained from each patient. Since regional wall motion abnormalities detectable by conventional scintigraphy corresponded to zones of metabolic 
impairment, these results indicated that regional wall motion disorders 
I depend on irreversible metabolic dysfunction to a considerable extent in patients with ischemic heart disease. 
I 
Studies in progress are designed to clarify the extent to which 
metabolic abnormalities of fatty acid metabolism characterize and perhaps 
I 
contribute to the pathogenesis of entities other than ischemic disease 
such as cryptogenic cardiomyopathy, to determine whether regional myocardial 
perfusion can be assessed with the methods developed and undergoing 
evaluation in experimental animals in correlative studies with PETT V, 
and to localize regions of ischemia manifested by metabolic impairment 
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I A new radiopharmaceutical, 68Ca-iron hydroxide colloid, for hepatic 
imaging by positron emission tomography (PETT) was prepared from the 






Ithe administered dose of colloid localized in the liver and 4.6% accumulated 
in the spleen. Initial imaging studies in normal dogs showed close 
correspondence of he findings by PETT and transmission computed tomography6S(CT). PETT	 with Ga-co11oid was performed in 10 patients9~th hepatic I 
metastases demonstrated by conventional scintigraphy with mTc-su1fur 
colloid images were demonstrated by PETT. The positron tomographic 
images were compared with those obtained by CT in seven patients; the I 
two studies showed comparable findings in five patients, whereas PETT 
more clearly showed multiple lesions in two. Our results suggest that 
PETT is a suitable technique for obtaining high-contrast, cross-sectional 
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The overall	 goal of this project is to implement and evaluate Iprocedures required to translate to intact animals the results obtained 
with selected positron-emitting tracers used to characterize metabolism 
and perfusion in isolated hearts in which the distribution of tracer Iand the time course of its clearance from myocardium can be quantified 
by fast-scan positron-emission tomography. Such studies are intimately 
related to the clinical activities being undertaken with PETT IV in 
which static imaging is possible. On the other hand, it has become I 
clear to us that a great deal of additional information can be obtained 
with sequential positron emission tomography utilized to characterize 
the time course of uptake, accumulation, and clearance of tracers whose Iphysiological behavior has been characterized in well controlled preparations. 
Since regional metabolism of exogenous fatty acid extracted by 
myocardium has been shown to depend primarily on oxidation, a recent I 
study was performed to determine whether viable but ischemic tissue 
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I of its impaired fatty acid metabolism. Regional clearance of 11C-pa1mitate 
was assessed by sequential tomography in 15 anesthetized dogs. Clearance 
I was consistently exponential from 5 to 15 minutes after administration of tracer intravenously. In the absence of coronary stenosis, clearance 
I 
was homogeneous throughout the heart with an average coefficient of 
variation (CV) of only 11 + 2%. Homogeneity persisted when heart rate 
was increased by pharmacological agents from 84 + 6 to 222 + 11 beats/min. 
With subcritica1 left circumflex coronary stenosis (reduction in vessel 
I 
diameter of 70% or less) homogeneity of 11C-palmitate clearance under 
control conditions and with tachycardia did not differ from that seen 
I 
in hearts without coronary stenosis. However, with critical stenosis 
(reduction in vessel diameter exceeding 70%) sufficient to induce ischemia 
without gross infarction, regional 11C-c1earance became markedly heterogeneous 
under control conditions and even more strikingly so with induced tachycardia. 
The heterogeneity resulted from a reduction of 11C-c1earance in regions 
supplied by the stenotic vessel compared to clearance in well perfusedI zones. Thus, sequential positron emission tomography after intravenous
 injection of 11C-pa1mitate delineated zones of viable, ischemic myocardium
 







Studies are in progress to analyze errors likely to be encountered
 
with this approach in patients with coronary artery disease. Computer
 
simulation is being employed to define errors related to limitations
 
of resolution, movement artifact, changes in wall thickness, and diffus­
ibility. 
I 
I The studies with 11C-pa1mitate address the question of whether 
or not altered metabolism is a consistent consequence of ischemia (under 
conditions of rest or with stress) and to determine whether or not such 
alterations can be used to localize jeopardized tissue in a reproducible 
fashion. Additional work is evaluating the need to quantify regional 
I perfusion with a noninvasive technique devoid of the difficulties encountered with single photon scintigraphy. Such difficulties include superposition 
of myocardium in several dimensions on a two-dimensional display, the 
I 
non-physiological nature of tracers employed, variation in tracer extraction 
fraction as a function of flow due to altered residence time, and variable 
I 
attenuation as a function of depth in non-homogeneous biological systems. 
The tomographic studies in progress with PETT V are predicated upon 
results obtained in studies of isolated perfused hearts. With the use 
of a tracer selected to partition evenly between blood and tissue (11C-butano1) 
and programmed exponential infusion to achieve a steady-state value 
of a function derived from the monotonically increasing tissue concentrationI of tracer measured over time, we were able to demonstrate in isolated 
I 
perfused hearts that myocardial perfusion could be assessed accurately 
and quantitatively by external detection of accumulated radioactivity. 
Application of this approach to intact experimental animals and ultimately 
I 
to patients will require the use of very rapid scanning instrumentation 
with sensitivity sufficient to avoid large radiation burdens and provide 
adequate resolution despite the need for gating. Presently a quantitative 
I
 





analysis is in progress employing computer simulation of potential errors 
that might be encountered in such an approach including those attributable 
to diffusibility of tracer. limitations of resolution of the instrument. 
movement artifact. and contributions of tracer within the blood pool I 
to activities within the field of view (partial volume effects). In 
addition. experiments are being undertaken to compare regional estimates 
of perfusion based on sampling myocardium and assay of the distribution I 
of radiolabeled microspheres to estimates of perfusion derived from 
positron-emission tomography coupled with programmed. exponential infusion 
of tracers administered intravenously. I 
In order to assure that interpretations of the results of tomography 
are consistent with actual events within the tissue. correlative studies 
are being undertaken with the use of a probe applied to the surface I 
of the heart that is capable of detecting the emitted positrons per 
se rather than the gamma radiation due to annihilation. With the use 
of the probe. and with an experimental design that permits imposition I
of selected rates of perfusion in specific regions of myocardium with 
verification employing electromagnetic flowmeter determinations and/or 
assessment of the deposition of radiolabeled microspheres. determinations Iof error bounds likely to apply to interpretation of results of tomographic 
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The newest generation of positron emission tomographs is represented 
by PETT VI. As was the case for its predecessor. PETT V (PR 14. B-5; I 
PR 15. B-5). the development of PETT VI is targeted at producing fast 
dynamic scans which exhibit high spatial resolution and sensitivity 
in human cerebral and small animal studies. I 
lPETT VI features cesium fluoride (CsF) scintillation detectors. 
Count rate limitations imposed by the deleterious effects of random 
coincidences have been greatly reduced if not practically eliminated I 







II Due to relatively low light output from the CsF and the desire 
to maintain fast timing, individual detectors and associated electronics 
have been chosen in favor of the positioning circuit implementation 
I 
of both PETT IV and PETT V. In order to achieve an economy of space 
and interconnecting hardware, a gantry-mounted electronics channel has 
been developed whereby each CsF detector has its own photomultiplier 
tube, wideband amplifier, constant fraction discriminator, and timing 
delay. 




of the machine is essentially complete. Final debugging, calibration,
 
and programming will continue through the third quarter and formal studies
 
are planned for the fourth quarter of 1980.
 
I 1. N. A. Mullani, D. C. Ficke, and M. M. Ter-Pogossian, "Cesium Fluoride: A New Detector for Positron Emission Tomography," IEEE Transactions 
on Nuclear Science, vol. NS-27, no. 2, pp. 572-575, 1980. 
I Table 1 








I Slice Thickness 
I Aperture size Field of View 
I Sensitivity 








Circular array consisting of 4 rings 
of 72 detectors yielding 7 simultaneous 
slices 
CsF (2.0 x 2.4 x 6.5) cm 
Wobble and rotate 
Integrals of 1 sec 




7 slices of 12 x 14 mm resolution yield 
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Positron-emission transaxial tomographic scanners produce cross­
sectional images of the body showing the spatial distribution of positron­ Iemitting radionuclides which are concentrated by biochemical or physical 
processes in regions of interest. Utilization of PETT for dynamic imaging 
within the thorax and the head have necessitated technological developments 
which improve instrument sensitivity as well as decrease radiation dosages I 
to patients	 and provide shorter scanning durations. 
The current	 development of a new instrument, Super PETT, utilizing I 
scintillators of cesium flouride l (CsF) and a high-speed acquisition and 
preprocessing system will utilize information about the differential time 
of flight of annihilation photons to achieve a sensitivity improvement Iof a factor of ten or better over the current thoracic scanner PETT IV. 
Experiments and theoretical studies of reconstructions based upon time­
of-flight data have been initiated (B-ll, B-12, B-13). I 
A new approach to data acquisition is required to achieve high 
precision (sub-nanosecond) coincidence-timing resolution and to cope with 
high data rates to be generated by a proposed instrument configuration Iin which detectors are to be grouped in four rings of 96 units each. Initial 
design studies have been conducted to establish the feasibility of including 
preprocessing tasks for both projection and time-of-flight data within Ithe acquisition system. Partitioning the acquisition system on a processor­
per-slice basis reduces the anticipated data rate to less than 200,000 
events-per-second per processor. A specialized processor architecture, 
based on bipolar bit-slice technology, will provide on-line detector-pair I 
sensitivity normalization, wobble-position correction, position-coordinate 
transformation, time-of-flight correction, and accumulation of both and 
time-of-flight arrays. The collected arrays will then be transferred I 
to a supporting computer system for data reconstruction and display. 
I1.	 N. A. Mullani, D. C. Ficke, and M. M. Ter-Pogossian, "Cessium Flouride: 
A New Detector for Positron Emission Tomography," Journal of Nuclear 
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I At least two approaches can be identified for deriving reconstruction 
algorithms for differential time-of-flight data in positron emission tomography. 
The first uses a deterministic model for the data, which is equivalent 
I 
to assuming an infinite "signal-to-noise ratio" or an infinite number 
of coincidence detections. This approach has been used by investigators 
in France at the Laboratorire d'Electronique et de Technologie de l'Informatique 
to give an intuitive argument for an algorithm in which the image is 
generated by two-dimensional filtering. During data acquisition, an unfiltered 
time-of-flight "pre-image" is created by adding each coincidence eventI into a preimage array at the location indicated by the line connecting 
I 
the two scintillation detectors involved with the position along this 
line indicated by the differential time of flight measured. This procedure 
produces a blurred pre-image which has a resolution between that along 
I 
the coincidence line due to the uncertainty in the time of flight and 
that perpendicular to the coincidence line due to the line-spread function 
for the detectors and collimation being used. This blurred pre-image 
can then be filtered two dimensionally to reduce the blurring and produce 
I 
the final reconstructed image. A two-dimensional filter can be specified 
intuitively using a deterministic model; it consists in the spatial frequency 
domain of a Ipl filter, to compensate for the projection process, cascaded 
I 
with a filter to compensate for the time of flight uncertainty. This 
approach is presently being investigated with experimental data, and the 
results are quite encouraging (see B-13). There are at least two potential 
disadvantages with this approach. One is that a deterministic model for 
time-of-flight data does not appear to lead to a mathematically unique 
algorithm as it does with conventional tomography. The second difficultyI is that two-dimensional filtering has not proven to be sufficiently efficient 
I 
to be useful in tomographic reconstructions from projection data, so it 
may not be for time-of-flight data either. Another approach is simply 
to derive projection data from time-of-flight data and then use any existing 
1 
tomography algorithm, which in effect ignores the additional useful information 
in time-of-flight data but without any performance loss in the infinite 
signal-to-noise ratio limit. 
A second approach for developing algorithms for time-of-flight 
data is to use nondeterministic models. This approach has the advantageI of allowing the large uncertainty in time-of-flight data, the fluctuation 
,I 
statistics in annihilation event times, and the finite but random number 
of coincidence events to be taken into account. We have initiated an 
effort to develop an algorithm by postulating a probabilistic model and 





parameters. Our preliminary results are briefly summarized as follows. 
The ·data for a single coincidence event is (Di j'u), where Di j identifies 
the detector pair and u is the measured positi~n of the event' along the 
line that connects detectors i and j. This measured position is in error I 
by an amount E along the connecting line; we let geE) denote the probability 
density of this error. We assume that the image to be reconstructed consists 
of the piecewise constant MxM array; the unknown parameter Ai in the ith Ipixel is the concentration of tracer in that resolution cell. Additionally, 
we assume that coincidence detections are mutually independent events, 
that coincidence detections occur as a Poisson point process, and that 
there are no random detections due to photon pairs not originating from I 
annihilations. The last assumption is the most severe but can probably 
be removed as the study proceeds. The algorithm results by solving the 
following problem. Given geE), the above assumptions, and the time-of­ I 
flight data 
(D. ,. ,u : n=l, 2, ••. , n ), I1 J n t 
n n 
where n is the total number of detection events, find the parameters
t I 
A = (A A •.. , A 2)l , 2 , M Ithat maximize the probability of acquiring this data. Our preliminary 
findings in solving this problem are as follows. Without loss in performance, 
the data can be processed as they are acquired to form the same pre-image 
as used in the deterministic algorithm described above; thus, in the ith I 
resolution cell, there will be a total of ni detection events measured.
 
If A denotes the maximum likelihood estimate of the M2 image parameters,
 
the; we find that i = !-l~/nt, where I
 
n (n , n , 
... , n 2)'l 2 IM 
2 2
and A is an M XM precomputable matrix with k,m element given by 
I2N(k,m)ff ) )a(k,m) = .. , __ , geE Ik(U + EVk,m dE,t::. 
m 
t::.where is the dimension of a resolution cell, N(k,m) is the number of I 
lines connecting detector pair that pass through cells k and m, N(m,m) 
is the number of these lines passing through cell m, Ik(u) = 1 if u is 
in cell k and Ik(U) = 0 otherwise, Urn is the center position in cell m, I 
and vk ,m is a unit vector from cell k to cell m. It is important that 
the inverse of A is precomputable because this matrix is of large dimension, 
and the computation of !-l will require care and considerable computation. IWe are presently investigating the properties of the matrix!. It appears 
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I	 for its inversion exist. Further study is needed to discover what benefit 





 B-12. Signa1-to-Noise in Positron Emission Time-of-F1ight Tomog~ 
I Personnel: D. L. Snyder, BCL N. C. Cheng, BCL 
M. M. Ter-Pogossian, Ph.D., Radiology 
I	 Support: RR 00396 
HL 13851 
I We have initiated an effort to predict the signa1-to-noise ratio 
performance of the maximum likelihood algorithm described in (B-11). 
Our preliminary results in predicting the performance of this algorithmI	 indicate that if Oi2 is the mean square error in estimating the ith pixel 
value Ai' then the noise-to-signa1 ratio is given by 
I	 2 2M M2	 2
o.2/A.2 = E(l/n)[L b (i,m) L a(m,j)A.A: - 1], 
1 1 t m=l j~l J 1I 
where b(i,m) is the i,m element of ~-1. At the present time we are attempting 
to evaluate this expression as a function of the time-of-f1ight uncertainty
I and to compare the result with the corresponding performance for a conventional tomography reconstruction of the same image. 
I 
B-13. PETT Time-of-F1ight Experimental StudiesI Personnel: J. Harkham, BCL 
N. A. Mu11ani, BCL 








I	 A feasibility study was conducted to demonstrate the improvement 
I 
in image quality with the use of time-of-f1ight (TOF) information in positron 
emission tomography (PETT). In conventional tomography, events along 
a coincidence line can occur anywhere along that line; in TOF tomography, 
the location of the origin of the annihilation can be estimated from the 
I 




difference in the times of arrival of the two photons at opposing detectors. 
Due' to present technological limitations, the uncertainty in the measured 
time difference is 500-1000 picoseconds or an uncertainity in position 
of several centimeters. I 
Two experiments were conducted using two fast cesium-fluoride 
detectors with a time resolution of 600-800 picoseconds FWHM (full width Ihalf maximum) equivalent to an uncertainity in position of 9-12 cm. For 
the first study a point source was scanned every 0.5 cm for 2 cm yielding 
5 parallel projection or coincidence lines. Each projection line was 
divided into intervals of 0.67 cm, and the time-of-flight information I 
was used to place each coincidence event in the appropriate interval. 
The time-of-flight resolution along each projection line was 9 cm FWHM 
and the physical resolution in the direction perpendicular to the projection I 
lines was 1.6 cm FWHM. A time-of-flight image was generated from these 
5 projection lines by using the same set of data for different projection 
angles, i.e., by rotating the data about the center of the point source. IThe resolution of the resulting unfiltered TOF image was 2.2 cm FWHM, 
0.6 cm more than the physical resolution of 1.6 cm FWHM. 
IThe second experiment utilized a 42-cm phantom consisting of three 
concentric rings with relative activity levels of 1, 0, 5. The TOF resolution 
for this study was 12 cm FWHM. A single scan of 22 parallel projections, 
1 cm apart, was performed with each projection line divided into intervals I 
of 0.83 cm for the TOF data. Because of the symmetrical nature of the 
phantom, the same scan data were used at 90 different angles to reconstruct 
an TOF image with a 50 cm field of view (100 x 100 elements). After recon­ I
struction, a two-dimensional filter was applied to the TOF image. The 
same scan data were used to reconstruct an image in conventional mode 
using filtered back-projection. The cutoff frequency for the two filters 
was the same. Figure 1 shows the two reconstructed and filtered images. I 
The TOF image shows significant improvement in the reduction of background 
activity in areas of no activity. I 
We have shown that an improvement in image quality can result from 
using TOF information, even with the present uncertainty of several cm 
in the measured position of the annihilation. This improvement will be Iespecially important for whole-body scanning where the amount of scattering 



















Figure	 1. Reconstructed images of a 42 cm phantom consisting of three 
concentric rings with relative activity levels of 1, 0, and 5. 
a. Conventional reconstruction using filtered back-projection. 


















B-14. Algorithm Development for Radiation-Treatment Planning 
Personnel:	 K. B. Larson, BCL IR. J. Arnzen, BCL and Computer Systems Laboratory 
W. C. Chen,	 BCL 
R. E. Hitchens, BCL 
C. A. Perez, M.D., Radiology I 
S. C. Prasad, Ph.D., Radiology 
J. A. Purdy, Ph.D., Radiology 
F. U. Rosenberger, D.Sc., Computer Systems Laboratory IL. J. Thomas, Jr., BCL 
Support:	 RR 00396 
Washington University I 
We have previously established the physical validity of our "data-volume" I 
method of co~puting three-dimensional absorbed-dose distributions in inhomo­
geneous media using differential scatter-air ratios (PR 13, 1-3; PR 14, G-6; 
PR 15, G-4). Accordingly, we have shifted our attention to the objective Iof applying advanced digital systems to render our method practical in a 
clinical setting. As a result, our algorithmic work during the past year 
has consisted of identifying and making appropriate modifications that 1), 
allow computations to be made with electron-density matrices of clinically I 
realistic sizes and shapes, including those obtained by computed-tomography 
scans of the RAIIDO phantom (PR 14, G-6) and 2), decrease the total time re­
quired to compute an individual three-dimensional dose distribution by measures I 
such as replacing all function evaluations by equivalent table look-up pro­
cedures, eliminating redundant computations, and incorporating efficient 
means for computing coordinates of volume elements in the electron-density 
matrix. With the expectation of using macromodu1es1 to realize a practical I 
implementation for these algorithms, we have rewritten all our programs in 
fixed-point arithmetic, and have demonstrated resulting computational accuracies 
comparable with those achieved previously using floating-point arithmetic. I 
Our most efficient algorithms for computing absorbed-dose distributions 
require the use of three-dimensional rectangular coordinates to form memory I
addresses for the electron-density and differential scatter-air-ratio (SAR) 
matrices. Because the available SAR data are presented in the right circu1ar­
cy1indica1 coordinate system, we are currently transforming these data to 
the Cartesian system so that we can use them in our algorithms. I 
1. C. E. Molnar, F. U. Rosenberger, and R. A. Arnzen, "Macromodu1ar Computer I 
Design. Part 3: Restructured Macromodu1es," Final Report, Contract SD-302 
(ARPA), Computer Systems Laboratory, Washington University, St. Louis, 
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I B-15. Macromodu1ar System and Array Processor'Imp1ementations for Absorbed­
Dose Calculations in Radiation-Treatment Planning 
I Personnel: R. J. Arnzen, BCL and Computer Systems Laboratory 
W. C. Chen, BCL 
I v. W. Gerth, Jr., BCL R. E. Hitchens, BCL K. B. Larson, BCL 
I Support: RR 00396 
I Development of a restructured macromodu1e system for implementation of the "delta-volume" algorithm CPR 13, 1-3; PR 14, G-6; PR 15, G-4) will 
permit three-dimensional dose computations to be carried out in a timely 
I
 manner for the radiation therapist engaged in developing a treatment plan.
 The macromodu1ar system currently under development for this purpose will be working in conjunction with a Texas Instruments 980 computer. This system 






Currently, the primary role of the macromodu1es in the system is to
 
compute the exponent of the attenuation function for all primary and scattered
 
rays. Simultaneously, the TI-980 will process the previous macromodu1ar
 
computation. Splitting the processing task at this point allows us to achieve 
similar execution times for the two processors of approximately 40 ~s. ItI will therefore require us about six minutes to complete an entire dose distri­
bution for a 163-cm3 volume.
 
I




tory of types. The kernel of the macromodu1ar system consists of three sections,
 
each of which is allocated a specific processing task, with all operating in
 
parallel. One section, which incorporates a macromodu1ar memory containing
 
electron-density information from computed-tomography scans, computes the
 
line integral of the electron density for the exponent of the attenuation
 
factors. For this purpose, it utilizes a newly developed algorithm for voxel
I identification. This process, which is the slowest of the three, requires
 approximately 15 ~s to complete a voxe1-pair computation. The second process
 
is a simple table look-up to determine the size of the differential element
 
I
 of ray-path length for the line integral. A single macromodu1ar memory is
 used for this look-up. The address is formed by the concatenation of the 
I 
x, y, and z increments for the particular voxe1 pair. This process takes 
about 1 ~s to complete. The third process determines the K1ein-Nishina 
electron cross-section for the scattered ray. This process requires determi­
nation of the cosine of the angle between primary and scattered rays. For 
this determination, a coordinate-transformer module designed for use with 
I the MMS-X Modeling System is ideally suited. The coordinate transformer 
I 
is provided the x-, y-, and z-components of the primary and scattered rays. 
It then performs a vector dot-product operation and a scaling to produce 
the cosine of the angle between these rays. This quantity is then used as 
an address to a macromodu1ar memory whose contents are the Klein-Nishina 
cross-sections. Approximately 10 ~s are necessary for this operation. 
I 




Following the calculation of the line integral, differential element 
size, and electron cross-section, a second coordinate transformer is used 
to form the product of these three quantities. This product is then delivered 
to the TI-980 computer for updating the absorbed dose for the dose voxel. I 
Currently, the integration of the various pieces of the macromodular 
subsystems is under way. In addition, facilities for initial loading of I 
macromodular memories and system initialization are being planned. 
Along with our macromodular implementation efforts, we have also carried I
out a preliminary investigation of another implementation based on using our 
array processor working with its host computer. The array-processor memory 
would contain all data arrays and would do all calculations in floating-point 
arithmetic" except for pixel identification, which would use a fixed-point I 
algorithm (B-14). As in the case of the macromodule system, the array processor 
would operate concurrently with the host computer. At this time, we have made 
no accurate estimate of total run time, but expect that we can achieve perfor­ I 
mances	 comparable with those of the macromodule system. 
I 
B-16.	 Three-Dimensional Display of Absorbed-Dose Computation for Radiation­
Treatment Planning I 
Personnel: R. J. Arnzen, BCL and Computer Systems Laboratory 
V. W. Gerth, Jr., BCL I 
Support: RR 00396 I 
The MMS-X Modeling System has proven itself to be an effective tool 
for the crystallographer for visualizing complicated three-dimensional struc­
tures. An extension of the uses of the MMS-X for presentation of three-dimen­ I 
sional functions was carried out in an effort to determine whether or not 
this system will be suitable for visualization of computed dose distributions 
throughout an irradiated volume of tissue. I 
The method investigated employed a defocused CRT beam to give a diffused 
spot on the screen. The intensity of the spot is directly proportional to 
the computed dose at that point in space. The composite dose distribution I 
then consists of "hot" and "cold" areas representing areas of high and low 
dose, respectively. The MMS-X graphics capabilities allow the resulting 
image to be rotated in space, thus providing the clinician with a view from I 
any angle. In addition, a "zoom" or magnification function allows close-up 
views of areas of particular interest. IResults of initial experiments indicate that the use of a defocused 
beam for three-dimensional function representation is an effect iva technique 
for visualization. However, it is also desirable, if not essential, to include 









requirement demands a sharply defined beam. A possible solution to these 
conflicting goals is dynamic focusing under computer control. A study ofI this problem has been undertaken and it appears at this time that such a feature can be readily implemented. As yet no hardware has been constructed 
to this end. 
I 
I B-17. Ventricular Boundary Extraction 
Personnel: C. N. Carlson, BCL 
I G. J. Blaine, BCL G. H. Brandenburger, BCL 
J. G. Dunham, BCL 
I P. A. Ludbrook, M.D., Medicine D. L. Snyder, BCL 
L. J. Thomas, Jr., BCL 
I Support: RR 00396
 
I
 The analysis of angiographic images is used to establish the patho­
physiologic implications of altered pressure-volume relations in ischemic 
myocardium. From the angiographic information, indices of both "global" 
I
 function (ventricular volume, stroke volume, ejection fraction) and "localized"
 function (regional myocardial dynamics) of the ventricle may be obtained. 
Semi-automated analysis systems, which use operator "sketched" ventricular 
borders, have moved from research environments into a commercial computer­I based catheterization laboratory system. A variety of algorithmic approaches specifically directed to the identification of the ventricular border have 
been reported in the literature, and the viability of computer-assisted de­
terminations of left-ventricular borders has been demonstrated in the clinical 
I 
I environment at Latter Day Saints (LDS) Hospital. The LDS algorithml and 
the Modestino algorithm2 have been identified as promising candidates for 
study, implementation, and extension. 
Both algorithms have been analyzed in some detail and timing estimates 
have been calculated. The estimates are summarized in Table 1. The tree­I search estimate was based on a best-case performance and would be expected 
I 
to increase with increasing image noise. Reported computation times for 
the LDS algorithm range from early results of 55 seconds per image to later 
results of 10 seconds per image for a CDC 3300 computer. Opportunities 
for concurrent computation were identified in both algorithms. 
I Availability of a moderately priced, high-performance raster-scan graphic processor, the Lexidata Model 3400, has enabled us to move the algorithm 
evaluation work to a PDP-II based system for continued development. A software 
environment is evolving using RATFOR, the "RATional FORtran" preprocessor,
I FORTRAN, and MACRO-II the PDP-II assembly language. Image, image sequence, contour, and contour sequence file structures have been designed,' implemented, 
and documented. 
I 
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Table 1 I 















IAn initial experiment using the Vanguard X-34 35 rum film projector 
and a GE charge-injection-device (CID) camera was utilized to digitize repre­
sentative ventricular contours to qualitatively assess the images reconstructed 
and displayed on the Lexidata display system. Results indicate the approach I 
could be utilized for acquisition of a test set suited to algorithm performance 
verification. IInitial study has suggested several possible improvements in components 
of both algorithms. For example, the usage of forward-and-backward frame­
to-frame information should enhance overall robustness. Local edge detectors 
provide information used in the pseudo-probability function of the LDS algo­ I 
rithm and the cost function of the Modestino algorithm. Any improvements 
in the local detection of edges should yield improved performance for both 
algorithms. I 
Although the literature is extensive, the quantitative design and 
performance evaluation of local edge detection has received little attention. IA new class of radially invariant, non-linear two-dimensional filters based 
upon a composite hypothesis testing was identified for study and development. 
I 
1.	 P. D. Clayton, L. D. Harris, S. R. Rumel, and H. R. Warner, "Left 
Ventricular Vidiometry," Computers and Biomedical Research, vol. 7, 
pp. 369-379, 1974. I 
2.	 J. W. Modestino, G. P. Ashkar, R. W. Fries, and H. Kaufman, "Computer 














 C. Systems for Pathophysiologic Studies 
I BCL activities addressing pathophysiologic studies began in 1970 
I 
when a minicomputer-based patient monitoring system was developed to aid 
in understanding and improving the postoperative management of cardiothoracic 
surgical patients. The prototype monitoring system used for seven years 
I 
in Barnes Hospital demonstrated the value of on-line digital processing 
to clinical investigators, and the computer has since become a commonplace 
and valuable tool in many biomedical research activities. The increasing 
demands for digital computing have encouraged us to develop more flexible 
I 
and enduring solutions to better satisfy pathophysiologic research needs. 
The Clinical Physiologic Research System (CPRS) offers a generalized approach 
to meeting a significant class of such needs with modular system elements 
I 
and distributed processing. In addition to providing a method for implementing 
instrumentation systems in a local environment, the CPRS approach provides 
a convenient means for interfacing local instrumentation systems to more 
global networks where expanded computational and storage capacity reside. 
During the past year, research activities have dealt with the developmentI of instrumentation systems and measurement techniques for pathophysiologic 
I 
studies in ophthalmology and cardiac electrophysiology. Included in these 
activities were the design and implementation of a system for acquiring 
multiple epicardial and endocardial electrograms from the left ventricle 
I 
of acute canine preparations. An objective of this study is to measure 
patterns of local ventricular activation during repeated coronary occlusions. 
The feasibility of adapting this existing system to include chronic experiments 
of prolonged duration is currently being accessed. Collaboration between 
the Department of Ophthalmology and BCL has resulted in the development 
of an acquisition system for achromatic visual-field data. Automatic featureI extraction algorithms have been created to process these visual-field records 
I 
and to provide early detection of the visual-field defects associated with 
glaucoma. Work was begun on a color display system for mapping the spatial 
distribution of defects in chromatic visual function. Another system has 
been designed and is being used to study the dynamics of the fluid inflow 












C-L Clinical Physiologic Research System 
Personnel: R. W. Hagen, BCL I 
Support: RR 00396 
I 
The Clinical Physiologic Research System (CPRS) is a tool which has 
been used in several laboratory and clinical research applications to provide 
data acquisition, feature extraction, control, information storage and/or Iinformation display. The system employs a distributed and modular architec­
ture which spans hardware, software and packaging. The identification of 
relatively independent tasks that can be performed asynchronously is an 
important first step in the application of the CPRS. Each independent task I 
is usually implemented in a separate module and intermodu1e communications 
is accomplished through an IEEE standard-488 digital interface. I 
During the past year, the CPRS has been applied in the two research 
activities described in C-6 and F-4. These activities have used the CPRS 
for a variety of functions including user interface, signal sampling, infor­ Imation storage and microscope stage control. User interface functions have 
been implemented by programming a commercially available personal computer 
(Commodore PET). Another user interface function, tailored to a particular 
application, has been developed with a special hardware configuration. I 
Signal sampling tasks have been accomplished by reprogramming the previously 
designed signal processing modules (SPM). The Universal Storage Device 
(G-3) was modified to incorporate an IEEE-488 interface in order to provide I 
for information storage. A microscope stage control function was implemented 
using CPRS packaging and software modules. ITo expedite the design and construction of CPRS modules, the wire-
list system (G-8) has been expanded to accomodate the locally designed TM-500 
wire wrap panel and a stock of these panels is maintained. Table 1 summarizes 
the CPRS hardware and software modules which have been implemented in conjunction I 
with clinical and laboratory research activities at BCL. In addition to 
the locally designed modules, experience has been gained with the implementation 
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:~modules physiologic IEEE-488 general hardware signal communication purpose modules processing functions mathematical 





signal • pulsatile perfusion • pulsatile perfusion . elec trogram 
processing 
• patient monitoring • electrogram acquisition (SPM) 
aC'l.uisition 
user • Dulsatile perfusion .pul~atile perfusion 
interface 
(UIM) 
signal • elec trogram 
generation acquisition 
(SGM) 
IEEE-488 • pulsatile perfusion 
controller 
microscope • silver grain 







flexible disk drive 
a.nd controller 
A/D conversion 
d igita 1 1/0 
4K bytes l\A'1 
programmable 
32 character disnlav 
and 8 function keys 
O/A converter 
digital I/O 




controls X, Y, 
and focus of 
precision microscop( 
implements IEEE-488QRS detection 
R-R interval talker } 
listener functionsSystoliC}
diastolic pressure controlle 






C-2. Constant-Area Tonography System 
Personnel:	 R. J. Arnzen, BCL IW. J. Grodzki, Jr., D.D.S., Ophthalmology 
R. W. Hagen, BCL 





The purpose of the constant-area tonography system currently in use 
in the Barnes Hospital Ophthalmology Department is to study the dynamics Iof the inflow and outflow mechanisms which control intraocular pressure. 
The system allows measurement of the time course of intraocular pressure 
for a period of four minutes following displacement of a fixed volume of 
aqueous humor resulting from flattening and maintaining a constant diameter I 
of contact between the cornea and a pressure transducer. Data obtained 
during the course of the experiment are recorded on a strip chart for immediate 
analysis and on a Universal Storage Device (G-3) floppy disk for subsequent I 
computer processing. To date, no system failures have been encountered. 
Data are being collected on patients with known intraocular pressure Iabnormalities as well as on normal eyes in order to provide a database from 
which statistically meaningful conclusions may be drawn. To date, 66 patients 
have been studied. Currently, the data are being analyzed and models proposed 
to explain the observed phenomena. Some of the initial analysis problems I 
to be resolved are the separation of the arterial pressure component from 
the composite record obtained in these experiments as well as the component 
of pressure	 which may arise from muscular contraction during the measurement Iperiod. 
yf I 
C-3. Visual-Field Data Acquisition System I 
Personnel:	 R. K. Hartz, BCL 






During the past year, the M6800-based data acquisition system interfaced 
to a Goldmann perimeter in the Department of Ophthalmology has been in active I 
use for patient examinations. The system has also been upgraded to include 
its use as a recording instrument during static perimetry. For this purpose, 
the perimeter has been modified to include a static fixation device for Ithe pantographic arm and the software has been expanded and generalized 
I 







to include local floppy-disk storage of static-field results. Local communi­

cations between the data-acquisition system and the host minicomputer (PDP-ll/34)
 
have been generalized so that data may be transmitted to the minicomputer
 
operating under either versions 3.1 or 3.2 of RSX-ll. 
I 
C-4. Visual Fields and Ocular HypertensionI Personnel: W. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
R. K. Hartz, BCL 
I 






The graphic database of visual-field records of patients being followed




In addition to recording results of kinetic visual-field examinations,
 
software has also been developed for storage and display of static visual­





areas of the visual field and the results are displayed, using a hidden-

line algorithm, to construct a three-dimensional surface. In this manner,
 
fine structural detail of central visual field defects, are graphically
 
displayed as shown in Figure 1.
 
Pw 
Automated feature-extraction algorithms for processing records ofI kinetic visual-field examinations, have been largely completed. These algo­
I 
rithms have now been incorporated into a generalized data-retrieval program, 
such that records may be searched for specific shape attributes, as well 
as for matches to demographic keys. The feature extraction algorithms are 
now being applied to analysis of the earliest detectable visual-field defects 
I 
in a population of individuals who 







are known to have acquired glaucomatous 
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C-5. Color-Perimetry Studies 
Personnel:	 W. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
R. K. Hartz, BCL 
Support:	 RR 00396 
EY 00336 
EY 02044 
Work was initiated during the past year on the development of an 
M6800-based controller for a color video display to be used in color perimetry. 
Visual field examinations in the past, have been largely confined to mapping 
visual thresholds with target background lights that depend on brightness 
differentials. The use of colored lights as either targets or backgrounds 
has, in the past, met with limited success in the clinical setting, due 
to conflicts in determinations of thresholds that are based on color perception 
versus those that are largely determined by brightness differences. The 
visual system can make a true physiological distinction between perceptions 
of brightness, versus those of color per se (hue or saturation). Therefore, 
for color perimetry to be helpful, a technique must be devised to isolate 
the color properties of the visual target, while controlling its brightness 
differences with any background light. 
Heterochromatic brightness matches, however, must be determined sub­
jectively, and require the use of flicker photometric techniques. Because 
of this feature, and the fact that target and background lights must be 
mutually exclusive in space in order to independently control color and 
brightness attributes, it was felt that a video display system would be 
an ideal stimulus-presentation device. 
An initial prototype display generator for a color television monitor 
has been constructed. This employs D-to-A converters for independently 
generating the voltage signals to each of the three primary phosphors of 
the video display screen (red, green and blue). Target-background pattern 
combinations are generated, consisting of diffusely illuminated backgrounds 
with a square or rectangular target which can be varied in size, shape, 
and position. In addition, target presentation is controllable either 
manually, or automatically in a flicker mode. Flicker rates, dictated by 
the 60-Hertz scan rate of the monitor, can be preset at 30, 15, or 7.5 Hertz. 
A manual potentiometer can be used to selectively vary the voltage to one 
or more of the phosphors within the target area during the flicker presentation. 
The instrument has initially been calibrated in arbitrary units, 
using a photomultiplier detector, and initial experiments have been run 
to determine flicker photometric brightness matches between targets of varying 
colors and neutral-gray backgrounds of fixed levels of brightness. These 
experiments have confirmed that brightness matches can be obtained that 





The great~t problem thus far encountered in the initial development 
of this instrument has been in the calibration of the light output of the 
video monitor. Brightness response of the phosphors, as a function of input 
voltage is highly nonlinear, and varies markedly with any variation in con­ I 
vergence and calibration contrast setting of the instrument. Consequently, 
a brightness recalibration technique must be developed that employs a feed­




C-6. Data	 Acquisition System for Extracellular Cardiac Potentials 
IPersonnel:	 B. H. Tanaka, BCL 
G. J. Blaine, BCL 
R. W. Hagen, BCL 
B. R. Hieb,	 M.D., Jewish Hospital I 
R. Ruffy, M.D., Jewish Hospital 
C. D. Shum,	 BCL ISupport:	 RR 00396 
American Heart Association, Missouri Affiliate, Inc. 
Buder Peters Scholar Award I 
Coronary artery occlusions produce substantial changes in the amplitude, 
duration and shape of left ventricular electrograms. Several acute canine I 
experiments have been performed to investigate the repeatability of these 
ischemia-induced changes as a function of time for consecutive periods of 
occlusion. During two-minute and five-minute occlusive periods, multiple Iepicardial and endocardial electrograms are acquired using a data acquisition 
system tha~ was designed around the modular Clinical Physiologic Research 
System architecture (C-l). The data acquisition system includes eight 
signal-processing modules (SPM), a user-interface module (UIM) and a data­ I 
storage module (DSM). The UIM programs the sampling sequence in each SPM 
by specifying sampling rate (20 to 20,000 sps), delay after trigger (1 to 200 
milliseconds), and sampling window size (1 to 100 milliseconds). The sampling I 
sequence in each SPM is initiated by UIM synchronous with cardiac stimulation. 
Each SPM stores digitized electrogram samples in an internal memory until 
the data can be transferred to the DSM. I 
A small personal computer (the Commodore "PET") was selected as the 
UIM. The capability to program in BASIC and assembler code, the use of 
the CRT display for prompting and protocol specification, an IEEE-488 interface, I 
availability, and low cost were considerations in this selection. The user­
interface function was implemented in BASIC. To specify sampling protocol, 
the user chooses from a menu and keys in appropriate responses. Use of I
the screen-editing and cursor-control capabilities of the PET result in 
an efficient interaction with system users by eliminating redundant tasks 
in the protocol-specification procedure. The IEEE-488 control functions 










and deficiencies in the PET's pseudo-IEEE-488 interface. After the sampling 
protocol is specified, the BASIC program jumps to assembler code and the 
I PET enters the4!ontro1 mode. In the control mode, the PET checks for a 
I 
cardiac stimulation pulse. When a valid pulse is detected, the PET synchronously 
initiates the specified sampling sequence in each SPM. Once the sampling 
process is completed, the PET supervises the transfer of data from each 
SPM to the DSM for storage on a floppy diskette. The acquired electrogram 
data are transported via the floppy diskettes to a minicomputer system for 
I




The DSM is based on the Universal Storage Device (G-3) with an IEEE-488
 
interface port added. The use of tight assembler-code routines to communicate
 
through the interface and the interleaving of sectors results in a worst-

case data-transfer rate of greater than ten thousand bytes per second. The 
storage capacity of the double sided/double density diskettes (1.25 ~fuytes) 
I
 is proving to be insufficient for certain experimental protocols. We are
 examining the possibility of changing the present DSM to take advantage 
of the Winchester disk technology. Work continues on a signal-generation 
module (SGM) capable of displaying any two of the sixteen sampled e1ectrogramsI on an oscilloscope. This module has been designed and construction is in 
I 
progress. Display, refresh and communication routines are being written. 
Work is also being done to update and modify the routines in the UIM and 
DSM to enhance error checking and debugging capabilities and to include 
changes that were suggested by the data acquisition system users. 
I 
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R. W. Hagen, BCL 
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L. J. Thomas, Jr., BCL 
RR 00396 
American Heart Association, Missouri Affi1itate, Inc. 
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I A data acquisition system for signals generated during acute canine e1ectrophysio1ogic experiments has been developed (C-6). The system acquires 
data from multiple bipolar electrogram probes for short periods. We are 
I investigating the feasibility of adapting this system to chronic canine experiments extending over prolonged periods of time. The proposed chronic 
e1ectrophysio1ogic data acquisition system (CEDAS) must be capable of handling 
e1ectrophysio1ogic recording episodes extending over periods of months.I In addition to acquiring e1ectrophysio1ogic signals, the CEDAS system must 
I
 




be able to process the outputs of transducers measuring other parameters 
including pressure, cardiac mechanical activity, potassium ion concentration, 
and neural activity. I 
In order to define the requirements for the CEDAS system, we have 
performed studies on the data acquired during the acute experiments. Specifi­
cations for electrogram signal data analysis have been established and work I 
is proceeding on an an automated system for electrogram analysis. The different 
types of electrogram signals are being analyzed to provide information on 
the frequency content of each. I 
A survey of both implantable and external telemetry units was conducted 
to determine the practicality of using a radio-telemetry link for transmitting 
data from chronically instrumented dogs to a data acquisition system. This I 
survey showed that neither experimental nor commercially available systems ~ currently meet the needs of the proposed study. Telemetry systems which
 
are compatible with these needs in terms of size and power consumption
 I 
have insufficient bandwidth. Other researchers-with similar needs have 
successfully used flexible, lightweight cables to provide a simple and 
versatile solution. Therefore, it was decided to utilize a tethered dog Iwith a cable for the initial system configuration. The potential benefits 
of various data-compression schemes for data storage, data analysis and 
data transmission requirements are being evaluated. Preliminary studies 
examining the effects of autonomic neural stimulation on electrophysiologic I 
parameters have been performed in the animal laboratory. An evaluation 
of methods for measuring and recording autonomic neural signals in both 

























D. Databases for Disease Hanagement and Research 
The need for database facilities in several BCL projects became com­
pelling in the early 1970s. Prior experience underscored the desirability 
of interactive data entry in order to assure adequate quality and to provide 
easy access to up-to-date information. Primarily through external funding, 
a minicomputer-based system (MUMPS) capable of supporting database activities 
was imported, rewritten for the PC-1200, and applied in radiation oncology. 
This application has developed into an installation, the Oncology Data Center 
(ODC) , located within the Mallinckrodt Institute of Radiology. A fee-for-service 
installation, the Medical Computing Facilities (MCF), was organized within 
the Medical School to provide MUMPS service to those who do not desire to operate 
their own installations. BCL, itself, operated a MUMPS facility for training 
purposes and investigation into database characteristics until 1978. 
In the previous year the Medical Computing Services Group (MCSG) was 
defined as a new activity of the Computing Facilities to serve the Medical 
School campus. MCSG provides a broad spectrum of facilities and services in 
order to assist researchers with data-management requirements. MCSG, which 
was established officially on July 1, 1980, supports access to both MCF's MUMPS 
system and to the University's IBM System/360-370. 
Current activity in the Laboratory includes the development and operation 
of several information systems for the support of ongoing research projects. 
Almost all of these databases concentrate on chronic diseases because of the 
importance of a long-term database to clinical investigators studying long­
standing illnesses. The emphasis of the database projects has shifted from 
the development and operation of several databases to the development, operation, 
and study of one database (D-5) and its related special-study files. Two of 
the Laboratory's databases, MIPI (D-2) and PIM (D-3), have been terminated; 
MCSG will serve as a resource in addition to MCF for the development of such 
databases in the future. The Laboratory will continue to concentrate on the 
development and operation of the Neonatology Database and its related files 
in conjunction with the goals of the Information Systems Group (D-l). 
Following the long-standing tradition of the laboratory, an increasing 
emphasis has been placed on allocating the appropriate computer resource to 
each information-processing task. As the databases that are described in this 
section mature their analyses become of increasing importance. Because of 
the richness of the software development and because of the overall suitability 
of a general-purpose large-scale computer for analysis tasks, these have been 
performed largely on the University's IBM System/360-370. SAS, a popular 
statistical-analysis/data-management package, has provided the primary vehicle 
for the analyses of databases originally managed on other computing systems. 
Experiences with disparate applications and with the instrumentation 
of conventional information systems continue to benefit design activities. 
Development activities directed toward a high-performance information system 
capable of smooth growth have been federated within the Information Systems 





D-1.	 Information Systems Group 
Personnel:	 J. R. Cox, Jr., Computer Science, BCL, and Computer Systems Lab 
G. J. Blaine, BCL I 
M. W. Browder, BCL 
R. E. Hitchens, BCL 
M. M. Maurer, Jr., BCL IP. Moore, BCL 
S. R. Phillips, BCL 
L. J. Thomas, Jr., BCL I 
Support:	 RR 00396 
HS 03792 
Washington University I 
The Information Systems Group provides the collaborative structure I
within which participants from the Department of Computer Science, the 
Department of Electrical Engineering, the School of ~1edicine, and the 
Biomedical Computer Laboratory are addressing the development of a methodology 
for the design of composite medical-information systems. The development I 
activities encompass specification of an abstract model for a database 
system, design and implementation of software modules for a generalized 
medical-information system, operation and analysis of a database designed I 
for clinical research, performance modeling and evaluation, and architectural 
design studies based on VLSI-design techniques. IThe tightly knit interdisciplinary team ensures an environment 
based on direct experience with the operation of a complex medical-information 
system which contains data on real patients and which is used by real 
decision-makers to facilitate realistic model development and architectural I 
considerations. 
Primary emphasis and progress during the past year is related to Idevelopment	 of the abstract database model; studies of a relational database 
system	 designed for the PDP-ll; operation, enhancement, and analysis of 
the Neonatology Database (D-S); and initiation of VLSI-design studies Ifor a name-searching processor unit which was recognized as an important 
kernel for implementation based on the model. Specific details of these 
activities are summarized elsewhere. l I 
1.	 "A Medical Information Systems Design Methodology," HS 03792-02 








 D-2. Myocardial-Infarction Patient-Information (MIPI) Database 
I Personnel: P. Hoore, BCL L. L. Brandenburger, BCL 
K. W. Clark, BCL 
I E. M. Friedman, BCL J. R. Humphrey, R.N., Jewish Hospital 
R. E. K1eiger, M.D., Jewish Hospital 
R. J. Krone, M.D., Jewish HospitalI J. P. Miller, BCL G. C. Oliver, M.D., Medicine 
C. J. O'Rourke, BCL 
I M. A. Province, BCL R. Roberts, M.D., Medicine 
S. Thanavaro, M.D., Jewish Hospital 








I The Myocardial Infarction Patient Information (MIPI) system (PR 12, A-1; PR 13, D-2, PR 14, D-2; PR 15, D-2) provided data management for the Sudden-Death Study. During the past year, the system has ceased 
to function since all data were passed to a SAS database (PR 15, D-10)
I and the project has entered the statistical-analysis phase. Generalized routines have been retained to support future activities and they have 
aided in the development of other databases. 
I The gathering and management of data for the study can be classified 
into three categories: 1) the recording of Coronary-Care-Unit (CCU) ad­
missions for Barnes- and Jewish-Hospital patients (10/27/75 - 03/31/78)I and the gathering of relevant clinical data for all myocardial-infarction 
I 
(MI) cases, 2) the scheduling of ambu1atory-ECG recordings and the acquisition 
of related data elements, and 3) the follow-up done on all surviving MI 
patients. 
I 
All patients admitted to the Barnes CCU or Jewish Medical Intensive­
Care Unit were initiated in the system via a registry-enro11~ent form, 
and then, depending upon the admitting and final diagnoses, the system 
controlled the entry of data relevant to the in-hospital phase of the 
study. The major emphasis of the data-collection process was on patientsI diagnosed as definite MIs. The CCU stays of these patients were documented and an attempt was made to recruit those surviving their CCU stay into 
the monitoring program. For patients recruited into the monitoring program, 
I two recordings were made. The first recording was made 10 to 14 days post-MI, followed by another 2 to 3 months post-MI. Thereafter, the 
I 
recordings were continued for qualifying patients at three-month intervals 
for a minimum of one year. The MIPI system noted patients to be scheduled, 




generated applicable correspondence, and handled the diverse sources of 
data related to each recording. All surviving MI patients were followed 
at six-month intervals to document their post-MI status. The MIPI system Iaided the follow-up process by providing appropriate lists and correspondence. 
During the past year, the MIPI system has supported four final 
study-management activities. The following of all surviving MI patients I 
has been completed; thus, the status of most patients as of March 1, 1979 
is known. Final results for 19 of 1152 Study I cases and 9 of 1079 Study 
II cases could not be obtained. All of these results have been sent to Ithe SAS database. The protocol under which the measurement of CK values 
was made was established, the values were keyed and then sent to the SAS 
database. The 12-lead ECG data, which were collected in connection with 
the ambu1atory-ECG monitoring, were checked extensively and also passed I 
to the SAS database. Finally, the contents of the SAS database were verified 
using a record index created by the MIPI system. I 
The MIPI system has aided project personnel both in the collection 
of data and its conversion to codes. Because the system guides the user 
through the entry procedure and flags errors immediately, the number of Ierrors due to omissions has been few. This application has confirmed 
the benefits of a study-management strategy that separated the protoco1­
management and statistical-analysis functions. I
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D-3. Protection of Ischemic Myocardium (PIM) Database 
Personnel:	 P. Moore, BCL IM. Bland, R.N., St. Louis University 
L. L. Brandenburger, BCL 
A. E. Dyer,	 R.N., St. Louis University 
R. G. Evans, B.A., St. Louis University I 
E. M. Friedman, Biostatistics 
S. A. Kaiser, R.N., St. Louis University 
J. P. Miller, Biostatistics IH. S. Mueller, M.D., St. Louis University 
Support:	 HV 62960 
St. Louis University I 
The MUMPS-based Protection of Ischemic Myocardium (PIM) system I (PR 13, D-3; PR 14, D-3; PR 15, D-3) coordinated the double-blind proprano101­
intervention study for the reduction of myocardial-infarct (MI) size run 
by St. Louis University and two collaborating institutions, St. John's IMercy Medical Center and the Veterans Administration. During the past 
year, the system has ceased to function since all data were passe~ to 
a SAS database (PR 15, D-10) and the project has entered the statistical-analysis 
phase. Generalized routines have been retained to support future activities I 
and have aided in the development of other databases. 
I 

















The data-collection protocol for this study is complex. From each 
of three institutions, data are collected concerning the hospitalization 
and especially the Coronary-Care-Unit (CCU) stay of any patient admitted 
with a diagnosis of rule out MI. The designation of which forms are to 
be completed is determined by the patient's classification: 1) recruited 
for study, 2) eligible but not recruited, 3) not eligible but MI was 
diagnosed, or 4) not eligible and no diagnosis of MI. 
The major thrust of the system revolves around recruited patients 
for whom a minimum of sixty-five forms are completed. Besides data similar 
to those obtained by the Myocardial-Infarction Patient-Information (MIPI) 
system (D-2) , hemodynamic measurements are made for 72 hours, metabolic 
measurements for 4 days, propranolol blood levels for 10 days, and creatine­
kinase measurements for a maximum of 126 hours. Tha11ium-201, technecium­
99m-1abe1ed stanous pyrophosphate, and labeled human-serum albumin (HSA) 
scans are made at various scheduled intervals during the hospital stay. 
Additionally, six Holter recordings are taken. All medications administered 
during the first 14 days of the hospital stay are recorded with a code 
number indicating the reason for administration and the dosage. Any sig­
nificant events occurring during that time are noted by time of occurrence 
and by a numerical code. Recruited patients are scheduled for follow-up 
visits at 3, 6, and 12 months post-MI, at which time five procedures 
are done (stress test, HSA scan, electrocardiograph (ECG), ambu1atory-ECG 
recording, and chest X ray) and a follow-up form is completed. 
During the past year, the PIM system has supported final study­
management activities for the project. The enrollment of patients was 
terminated March 31, 1979. Data for all patients were entered and checked 
by September 1, 1979. These checks included cross-matching responses 
on various forms. All free-text data were then converted to codes. In­
hospital data on all patients and data concerning most outpatient visits 
were sent to the SAS database by October 1, 1979. Then the system was 
deactivated. In April, 1980 the PIM system was reactivated for an additional 
month in order to process the data accrued on outpatient visits that 
took place after October 1, 1979. 
This application reinforced our belief in em~hasizing study management 
and allowed us to incorporate additional features in the evolving protoco1­
management system. More checks were applied through table-driven routines 
rather than as special cases and checks were done on items within and 
among forms. Incorporating these consistency checks at the inception 
of the study improved data quality. Additional checks were incorporated 
as new relations among items were defined. This application also required 
better protoco1-adherance skills because much attention was directed toward 
the proper completion of the patient's recruitment form, the correct assign­
ment of a patient's category, and the inclusion of all data items required 
by the protocol. 
Appropriate coding lists have been retained from this application. 
Three particularly useful items of cardiologic data are a list of typical 
medications along with expected dosages and schedules, a list of ceu occur­





D-4. scaR	 Patient Information Database 
Personnel:	 K. B. Schechtman, BCL IH. D. Ambos, BCL 
E. Gaelig, R.N., Medicine 
E. M. Geltman, M.D., Medicine 
A. S. Jaffee, M.D., Medicine I 
J. Markham,	 BCL 
A. T. Marmor, M.D., Medicine 
R. Roberts,	 M.D., Medicine IB. E. Sobel, M.D., Medicine 
Support:	 RR 00396 
HL 17646 I 
The Specialized Center of Research (SCaR) database (PR 15, D-4) I
currently contains information pertinent to 602 patients who have suffered 
acute myocardial infarction. The variables contained therein describe 
the patients' cardiovascular history, in-hospital physical condition, Iand long-term progress as assessed through follow-up examinations. During 
the year immediately after each index coronary episode, the progress of 
each patient is assessed at three-month intervals. Follow-up interviews 
are then continued on a yearly basis. The data records are entered onto I 
disk using the Interdata computer in the Coronary Care Unit and then transferred 
via magnetic tape to the IBM System/360-370 at the University's Computing 
Facilities. There, a permanent SAS database is maintained for analysis I
of the results of a variety of clinical studies. 
The SAS database consists of about 240 variables, resulting in about I2800 data items because measurements of some variables can be obtained up 
to 21 times during the patient's hospital stay. The database is maintained 
on seven separate tape files. These contain information on patient history, 
daily clinical status, serum enzymes and blood chemistry, hemodynamic parameters, I 
dynamic ECG recordings and cardiac-output reports, graphic measurements, 
and follow-up data. Those variables that are required for a particular 
clinical investigation are copied from the tape files and merged into I 
a single disk file in order to expedite statistical analysis utilizing 
the IBM System/360-370 computer. 
IPatients with diabetes mellitus have been reported to have a high 
incidence of congestive heart failure and cardiogenic shock in association 
with acute myocardial infarction. Since in addition to their coronary 
artery disease, such patients may suffer autonomic dysfunction, renal I 
failure, or	 cardiomyopathy, the relative contribution of these abnormalities 
to the production of congestive heart failure and/or cardiogenic shock 
is unclear. In order to clarify these issues, a comparison of diabetics Iand non-diabetics with respect to several variables in the SCaR database 
is being performed. A subset of patients without a history of previous 








I Male diabetics were of approximately the same age and have infarct 
sizes similar to those in controls. However, female diabetics were significantly 
younger and had smaller infarcts than their non-diabetic counterparts. 
At the .01 level of significance, diabetics had a higher incidence of 
pulmonary congestion as well as higher clinical (MIRU) class. Surprisingly, 
diabetics with myocardial infarction comparable to controls had consistentlyI fewer and less complex PVCs than non-diabetics. 
I 
A total of 200 patients with acute myocardial infarction have been 
studied for at least 14 days after onset in order to determine those factors 
which predispose an individual to a repeat infarction during the initial 
hospitalization. The association between repeat infarction and 10 dichotomous 
I and 2 continuous variables were examined. Those which proved significant were infarct location (p = .0001), recurrent chest pain prior to the recurrent 
infarction (p = .0001), gender (p = .0040) and obesity (p = .0241). Although 
only 18% (35/200) of the overall group suffered recurrent infarction,I 43% of the patients with subendocardial infarction, compared to 8% of those with transmural infarction, exhibited early recurrence. Forty-one 
percent of those with at least three episodes of prolonged recurrent chest 
I pain antedating suspected recurrent infarction exhibited recurrence compared to 5% of those without such pain. Women were more likely than men (29% 
I 
compared to 12.3%) and obese patients more likely than non-obese patients 
(28% compared to 14%) to exhibit recurrent infarction. These results 
identify a subset of patients at high risk for recurrent infarction requiring 
appropriate prophylactic interventions. This subset will be evaluated 
objectively in ongoing studies.I
 
I D-5. Neonatal Database 
I Personnel: P. Moore, BCL L. L. Brandenburger, BCL M. M. Buckley, Pediatrics 
R. E. Marshall, M.D., Pediatrics 
I M. M. Maurer, Jr., BCL J. L. Roberts, M.D., Pediatrics 
S. M. Scott, M.D., Pediatrics 




I St. Louis Children's Hospital
 
I Day-to-day clinical experience with sick newborns stimulates many questions based on historical, clinical, and/or laboratory data. The 
Neonatology Database (PR 12, D-16; PR 13, D-5; PR 14, D-5; PR 15, D-5) 
I was designed to allow the easy formulation of queries and their rapid response. Data are collected on all admissions to the Newborn Intensive­
Care Unit (NICU) of St. Louis Children's Hospital. Admission data, including 
I 




maternal history, perinatal history, immediate post-delivery data, and 
initial admission evaluation are gathered soon after an infant's admission. 
For in-hospital data, the onset and termination dates (if known) of occurrences 
are noted and relationships among objects are encoded with a problem/concurrent­ I 
event/complication approach. In order to summarize the entire hospital 
stay, codings are made under 23 broad categories which encompass organ 
systems, diseases, laboratory values, therapies, procedures, and other I 
events of interest. Exact laboratory data are entered for patients of 
special interest. IThe system provides a useful means of evaluating relationships 
via tabulation and simple statistics and allows for growth both in number 
and type of data. A generalized format has been provided so the system's 
features can be transferred to other medical contexts and one special I 
study on premature infants is being established (D-7). 
This MUMPS-based database has existed on three separate computer I
systems since its inception in June 1975. The database was first developed 
on an Artronix PC-1200 system as a pilot study to determine coding strategies. 
The relative stabilization of encoding techniques coincided with the decision 
to transfer to an Artronix MODULEX system in June 1977. Since the data I 
collected had varied, the features of the system were transferred but 
the data were not retained. I 
In June 1979, the demise of Artronix, Inc. and consequent operational 
problems with the MODULEX system resulted in the decision to transfer 
the 953-patient database to a TANDEM system operated by the Pathology IDepartment of St. Louis University. Since bit functions did not exist 
in this version of MUMPS, the development of a different search method 
to achieve rapid retrieval was devised. The entire system was regenerated 
in six weeks in order to satisfy demanding needs for information. All I 
programs were recoded because of the new searching technique, because 
of improvements made to all file designs, and because of other system 
enhancements. I 
The alternate searching method was satisfactory for temporary use, 
but it was unacceptable for long-term use since excessive disk space was Irequired for the inverted file, search times varied greatly, and the more 
demanding searches degraded overall system performance. The author of 
the local MUMPS interpreter was persuaded to incorporate bit functions, 
the system was redone, and a comparison of the two methods was made. I 
Required disk storage decreased, search times and overall system performance 
improved, and coding for quick retrievals was less obscure. The amount 
of time dedicated to these changes was substantial but the quality of I
the system improved with each overhaul. 
The system has been stable since December 1979 and new software Ihas been developed to extend its use. Appropriate changes have been made 
in preparation for quick searches of in-hospital data where elements of 
time such as duration, precedence, or offset are included. Programs dealing 
with time-oriented queries are in preparation. Greater attention has I 
been paid to data checking and unique checks have been identified. Many 
of these checks are defined by users through the system's software. I 




I In addition to the experience gained and clinical research done 
with the Neonatology Database, it serves as a tool for modeling medical­
information structures and for studying users' needs. The system has 
I 
been instrumented so that all queries are logged in an on-line file to 
characterize usage. Several preliminary studies have used the database 
to examine data relations in medical information and to check various 
iterations of the database model. The "recognizer" concept has been examined 
in terms of admission data and the definitions used to encode in-hospital 
data were studied to determine where they could be computerized. TheI interactions of in-hospital items have been characterized and a classification 
I 
scheme is being devised to identify each term's "type." Interim tabulations 
based on these categorizations have accentuated the variety of types and 
relations present in medical data. These efforts have emphasized both 
improving data quality and categorizing various types of expressions that 
connote relationships having medical implications. 
I The patient population has finally become sufficiently large to 
I 
entice a variety of users. There are 1800 patients in the database and 
1228 have in-hospital data entered. Plans now center on the development 
of an active user community and on increasing the number of patients with 
in-hospital data complete. 
I 
D~6. Methodological and Technical Developments for Risk-Function AnalysisI Personnel: J. P. Miller, BCL and Biostatistics 
E. M. Friedman, BCL and Biostatistics 
I J. Y. Lee, Ph.D., Biostatistics M. A. Province, BCL and Biostatistics 
L. J. Thomas, Jr., BCL 
I Support: RR 00396 
HL 18808 
HV 62960I Washington University 
I The development of statistical models for assessing the probability 
I 
of some future event, such as death, given a set of data for a patient, 
is of continuing interest for the analysis of data obtained on chronic 
diseases. During previous years efforts were directed towards implementing 
software to evaluate several statistical models for risk-function analysis 
I 
(PR 13, D-18; PR 14, D-13; PR 15, D-ll). During the current year these 
models were applied to the analysis of the natural history of sudden death 
(A-7). 
I 
The in-hospital morbidity and mortality of nontransmural and transmural 
myocardial infarction (MI) were compared in patients hospitalized with 
their first infarction. Log-linear analyses indicated that when patients 
I 





were stratified by the peak level of SGOT, the type of infarct did not 
contribute to the assessment of risk of mortality and morbidity.l,2 IIn studying long-term mortality we examined 610 patients who had 
survived their hosptialization. 3 During the first year, and especially 
during the first six months, the clinical features of the acute event, 
especially those reflective of the extent of the infarct, but not of the I 
type of infarct, were powerful predictors. We were able to determine 
that the ratio of the failure rates of transmural and nontransmural infarcts 
did not remain constant over the three year follo~-up period. This indicates I 
a violation of the Cox proportional hazard model, and forced our analyses 
to be repeated for varying time periods, e.g., 0 to 1 year post-MI, 1 
to 2 years post-MI, 2 to 3 years post-MI. These analyses indicated that Ias the MI became more remote, the utility of the features observed during 
the acute event decreased. In fact, for some of these features the direction 
of their influence was reversed. Thus, in the 2- to 3-year period, patients 
who had suffered a nontransmural infarct appeared to be at greater risk I 
than those with transmural infarcts, a reversal of the first-year result. 
These findings, if replicated, call into question the prevalent practice 
of utilizing in an uncritical manner the Cox model for evaluating the Ilong-term prognosis of patients following their MI. 
Analyses of the relationships between events observed during the 
acute MI and subsequent runs of premature ventricular contractions (PVCs) I 
observed using Holter monitoring during the year following the infarct 
indicated that severe cardiac disease made manifest by poor left-ventricular 
function, high serum-enzyme levels, and certain types of cardiac arrhythmias, I 
are associated with an increased prevalence of ventricular runs during 
the post-hospital phase. 5 Utilizing a multivariate logistic function, 
we found it possible to divide the patients into quartiles of risk with Ithe prevalence of runs ranging from 4% in the lowest quartile to 49% in 
the highest one. Although the rate of sudden death was not different 
in each quartile, patients in the highest quartile had significantly higher 
rate of death from all causes, suggesting that the increased mortality I 
was related to severe cardiac disease rather than to the presence of the 
PVC runs themselves. I 
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D-7. Mineral-Homeostasis and Mineralization Database 
I Personnel: P. Moore, BCL 
L. S. Hillman, M.D., Pediatrics 
I	 L. A. Martin, CPNP, Pediatrics M. M. Maurer, Jr., BCL 
S. J. Salmons, PNP, Pediatrics 
I Support: HD 09998 HS 03792 
St. Louis Children's Hospital 
I 
I 
The Neonatology Database (D-5) provides a generalized format so 
that self-contained patient subsets can be established quickly in the 
database, a variety of tabulations and simple analyses can be performed, 
and data can be shared between files. One special file is serving as 
a test case. Dr. Laura Hillman is studying a subset of the neonatal popu­I lation as well as additional patients treated at the Barnes Hospital Premature Nursery. These infants have been studied on a series of protocols 
to evaluate bone mineralization and calcium-phosphorous homeostasis. 
I	 Under the first protocol, 80 premature infants and 32 small-for­
gestational-age (SGA) infants were serially studied at three-week intervals 
I with X rays and chemistries. Daily intakes and weight gains as well as weekly lengths and head circumferences were recorded. Prenatal, neonatal, 
I 
and hospital-course data were collected. Now, two new protocols for evaluating 
the effectiveness of therapeutic interventions are employed; these are 
designed to reverse abnormal calcium metabolism. The infants are followed 
in a special clinic where long-term follow-up data, including growth parameters, 
I 
I.Q. testing, and dental evaluations, will be collected and added to the 
database. 
Dr. Hillman's studies dealing with premature infants serve as a 
test case for this feature, and those involved with her project have foundI the new system easy to use. To date, the only probleIns have been entry 
of the backlog of patient data and the development of the desired types 
of statistical tests. Research laboratory data and admission data have 
I
 been entered for a subset of her patients. Other data that remain to









and follow-up information. The full value of this system will be realized 
when complete admission, in-hospital, and laboratory data have been entered 
for all infants included in this study. I 
Dr. Hillman's study has improved those components of the system 
dealing with data entry and analysis of quantitative data. The original 
Neonatology Database had emphasized the occurrences of coded data, whereas I 
her primary concern to date has been with quantitative data. Adding features 
such as new time-frame calculations and statistical routines have improved 
the overall appeal of the system. Other features for analyzing both Iquantitative data and encoded data, for calculating derived parameters, 





D-8. Databases to Complement Ambu1atory-ECG Tape Processing 
Personnel: P. Moore, BCL IK. W. Clark, BCL 
K. A. Madden, BCL 
J. P. Miller, BCL 
M. A. Province, BCL I 
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Protocol-management systems monitor the analysis of ambu1atory-ECG 
recordings which are done for the MILlS (A-21) and MPIP (A-19) studies. IData are keyed into these management databases and checked as steps in 
the protocol are completed. In this way, the system tracks the progress 
of each recording analyzed. The data include appropriate dates; thus, 
the completion date of each event in the protocol is recorded. Also entered I 
is information concerning the arrhythmic content of each recording as 
determined by automatic analysis, editing, and cardiologic review. The 
protocol-management systems assist local activities by allowing a user I 
to retrieve data on any recording, to determine the status of any recording, 
and to generate lists of recordings whose status in the protocol are similar. 
Three report generators allow retrospective studies of the analysis process Iand the definition of internal and external bottlenecks by noting the 
durations between events. User-specified searches including queries about 
durations can determine extreme cases. I 
These two databases were established and are maintained with relative 
ease since table-driven software from the MIPI (D-2) and PIM (D-3) systems I 




I could be used. Data-checking and data-tracking features were quickly 
established to utilize this pre-existing software. Activity in the current 
year has concentrated on extending the reporting and searching capabilities 
of the system. These capabilities were added so that the local data manager 
could report general trends and document extreme cases. 
I The protocol-management system that supports recording analysis 
I 
for the MILlS study is more extensive since patients are monitored three 
times and the results of Argus/2H analysis are stored in a statistical 
database. Since the BCL Holter Core Laboratory is notified of both patient 
registrations and terminations, the protocol-management system anticipates 
the receipt of recordings. 
I These two systems are in routine use, with 798 recordings presently 
















E. Speech and Hearing 
Early collaboration with Central Institute for the Deaf resulted 
in the development of digital instrumentation suited to speech-and-hearing I 
research. The first systems that were developed, a Random-Access, Programmable 
(RAP-I) digital recorder, a computer system for processing sampled speech, 
and a RAP-II system that is interfaced to the LINC computer in the physiology I 
laboratory, continue to be used in a variety of research applications, 
including the analysis of sampled speech sounds and glottal source waveforms 
and the synthesis and tailoring of speech sounds for psychoacoustic Iexperiments with human and animal subjects. 
The proven usefulness of these first systems has led to the develop­
ment of newer RAP systems that can be programmed to accommodate a variety I 
of psychoacoustic experiments and a central computer system with increased 
sampled data capability. This work is finished and laboratories at 
Central Institute for the Deaf have been renovated to accommodate these I 
new systems. 
More recently a major emphasis has been directed towards certain 
basic questions related to hearing and deafness, that require the digital I 
instrumentation available through the collaboration. These areas of 
study include the following: 1) measurements of psychophysical characteristics 
of e1ectrocutaneous stimulation to determine if this sensory modality I 
can serve as a substitute input for speech for profoundly deaf patients, 
2) the measurement of glottal source characteristics of normal and deaf 
talkers, 3) the development of methods for generating rapidly changing I
visual displays that can be used in lipreading studies, and 4) psychoacoustic 
studies related to questions of speech perception. 
IA major focus of the psychoacoustic studies is to understand 
the acoustic and neural transformations that are important in speech 
perception that occur in the cochlea and other parts of the auditory 
system. Towards this goal, we have studied, this year, the spectral I 
characteristics of natural vowel sounds with a psychophysically-based 
model of hearing (E-6) and have undertaken a comprehensive study of 
proposed methods of vowel normalization to determine their relative Imerits (E-7, E-8). This work has suggested certain directions to be 










I	 E-l. Computer System for Auditory Research 
I Personnel: A. M. Engebretson, BCL and Central Institute for the Deaf R. G1aesner, Central Institute for the Deaf 
M. T. Hakkinen, Central Institute for the Deaf 
I,








The last of the RAP-III systems has been installed in the Psychoacoustics 
Laboratory. This system has been in general use for listening to and 
recording speech sounds and for engineering checkout and program development. 
The psychoacoustic installation includes four subject terminals, an 
8-channe1 audio system with independently controllable attenuation,I and an interface between the RAP-III system and a system of Grason-Stad1er 1200 series logic. 
I	 A program has been written for this installation to do dichotic 
I 
studies of auditory function. The program presents stimuli consisting 
of fragments of natural speech sounds, cues the subjects when a response 
is requested, scores the subjects response, and provides visual feedback 
as to the correctness of the response. Session parameters, number of 
subjects, stimuli, and trials, and stimulus duration can be specified 
by the experimenter. Response data are stored in separate disk filesI for each subject to facilitate data analysis at another time. Monaural
 identification trial types have been implemented first. The program
 






The design of a RAP-IV system for the Signal Detection Laboratory 
at Central Institute for the Deaf has been completed and parts are on 
order. This system will eventually replace the aging PDP 8/1 system 
currently in use. The RAP-IV system includes a NOVA 4-X computer with
 
256k bytes of memory, multiply/divide hardware, and a Model 8388 floating




two Pertec 3400 series disk drives that can be used for program and
 
data storage and that are compatible with other systems at CID and BCL,
 
two 2-channe1 analog subsystems, and a laboratory station driver subsystem.
 
ALGOL subroutines have been developed to facilitate programming
 
of the RAP-III systems for behavioral testing. These subroutines support
I RAP functions such as "record" and "play," the timing and I/O functions




Programs are written using Data General's ALGOL 60 language which greatly
 
reduces the time and complexity of program development and results in
 
software that is easier to maintain and modify. The structured nature 
of the language lends itself to rapid implementation of most experimental 
I procedures in addition to providing a common language for data analysis and system utility programs. 
I
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IE"'2. Speech Microscope 
Personnel:	 N. R. Vemula, D.Sc., Central Institute for the Deaf 
A. M. Engebretson, BCL and Central Institute for the Deaf I 
J. L. Lauter, Ph.D., Central Institute for the Deaf 
R. B. Monson, Ph.D., Central Institute for the Deaf ISupport:	 RR 00396 
NS 03856 
I 
Two options have been added to the speech microscope program 
described in PR 15, E-2. The first one is a bandpass filtering option 
to compute the filtered signal corresponding to a specified speech segment. I
The user specifies the speech segment using the analysis-window-cursors 
and types in the lower and upper limits of the passband in the frequency 
region 0 Hz - 10 kHz. Then, the program computes the discrete Fourier Itransform of the specified segment and synthesizes the filtered signal 
using the amplitude and phase information of the harmonic components 
in the passband region. I 
The second option computes the center of gravity, expressed in 
Hz, of the discrete Fourier transform of a speech segment. Each spectral 
line is considered as a mass element located along the frequency axis, I
with its mass equal to the dB value of the line. The user again types 
in the lower and upper frequency limits between 0 Hz and 10 kHz, and 
the program determines the center of gravity of the specified spectral 
segment with an optional linear or logarithmic frequency scale. I 
We have also studied the accuracy of measurement of formant frequency 
using the linear predictor (LP) analysis option of speech microscope. I 
These measurements are important in the study of speech production and 
form a basis for synthesis of speech. To assess the accuracy of formant 
estimating, vowels were synthesized with both a parallel and serial Isynthesizer model and a typical glottal source function. Parameters 
that are known to influence the accuracy of measurement such as fundamental 
frequency, formant bandwidth, and proximity of one formant to another 
were varied by synthesizing five different vowels (Iii, lae/, I~/, Irl, I 
and lui) that represent all of the extremes which can be encountered 
in vowels. The vowel lael has widely spaced formants in approximately 
the middle of each formant frequency range. The vowels Iii and lui I 
represent the extremes of high and low first and second formants. The 
vowel I~I represents the case of close proximity of the first and second 
formants, while the vowel Irl represents the case of the close proximity Iof the second and third formants. Tokens of these vowels were synthesized 
with ten different fundamental frequencies, from 100 to 500 Hz. In 
addition, tokens of the vowel lael were also synthesized with four different 










I These tokens were analyzed using the LP option and the results 
compared with the original values of synthesis. For tokens of fundamental 
frequency between 100 and 300 Hz, LP analysis estimates formant frequencies 
I 
of parallel synthesis plus or minus 50-70 Hz; formants of serially synthesized 
tokens are estimated to within plus or minus 20-35 Hz. As might be 
expected, the accuracy of the formant frequency estimation deteriorates 
rapidly in the presence of (1) fundamental frequency higher than 350 Hz; 
I 
(2) bandwidths wider than 100 Hz; and (3) close proximity of any two 
formants. The vowels used for this study represent the most difficult 
measurement cases, so that these estimates are undoubtedly the extremes. 
Natural speech probably falls somewhere between the parallel and serial 






E-3. Determination of Vocal Tract Shape During Phonation from Input/Output 
Measurements of Throat-Wall Vibration Near the Glottis and Sound 
Pressure at the Lips 
Personnel: N. R. Vemula, D.Sc., Central Institute for the Deaf 




I Work has been completed on this project and a manuscript is currently in preparation. 
I As mentioned in PR 15, E-3, earlier attempts to obtain the vocal tract shape during phonation using the linear predictor (LP) procedure 
on the speech signal making some simple assumptions about the glottal 
source did not give consistent results, which prompted the present study. 
I 
I It is hypothesized that the vibration on the neck near the glottis 
consists of two components: the "acoustic" component due to the supraglottal 
sound pressure and the "mechanical" component due to the force exerted 
by the vibrating vocal folds on the thyroid cartilage. 
I The acoustic transfer function characteristic of the throat-wall (relating the supraglottal pressure and the acoustic component of vibration) is experimentally determined by applying an external force on the neck 
with a vibrator and measuring the resulting inside response of the wall 
I with a reflectionless terminator tube at the lips. During the experiment the subject held his glottis closed while holding a neutral tract shape. 





wall have shown that the wall has a low-pass characteristic, falling 
off at about 10-12 dB/octave in the frequency region 90 Hz - 2 kHz. 
A lumped-parameter mechanical model for the throat-wall was developed I 
based upon the physiology of the larynx, existing data on the elastic 
properties of larnygeal muscles and ligaments, and also on measurements 
on scaled physical models for the larynx and subject's neck. The model I 
agrees well with the above experimental measurements. 
The throat-wall is considered as a 3-port network with "acoustic," I
"mechanical" and "output" ports, corresponding to the supraglottal pressure 
excitation, mechanical excitation by the vocal folds and vibration measure­
ment on the neck, respectively. One element of the 3x3 symmetric network 
matrix corresponds to the measured acoustic transfer function of the I 
wall. A second element, corresponding to the driving point impedance 
at the output port, is measured by applying a mechanical force on the 
neck with the vibrator and measuring the resulting vibration of the I
outside surface of the neck. The remaining 4 unknown elements are evaluated 
using a computer simulation of the above mechanical model. 
IFourier analysis of the simultaneous measurements of the pressure 
on the inside surface of the wall and external vibration on the neck 
while the subject phonates into the terminator tube holding a neutral 
tract shape has shown that the transfer function characteristic of the I 
wall relating the inside pressure and the external (total) vibration 
varies within -7 to -10 dB from that at normal pitch and intensity. 
On the other hand, repeated measurements at normal pitch and intensity Ihave indicated a comparable variation in the measurement of the vibration, 
probably due to the variation of the compliance of the skin on the neck. 
Not inconsistent with these facts, the wall is modeled as a linear, 
pole-zero model, the parameters of which are evaluated using a maximum I 
likelihood scheme. This model is used in determining the vocal tract 
shape. I 
Simultaneous measurements of the sound pressure at the lips and 
the vibration on the neck are made for vowel phonation at normal pitch 
and intensity. An approximation to the glottal source signal is determined Ifrom the measured vibration. The vocal tract shape is determined using 
an all-pole model for the tract. To compare the input/output and linear 
predictor procedures two experiments are performed. In the first experiment 
measurements are made with and without a tongue hump made at the lip-end I 
of the subject's tract. In the second experiment, measurements are 
taken with and without a cylindrical wooden piece of known dimensions 
placed within the tract. Comparison indicates that the input/output Iprocedure gives more consistent results than the linear predictor procedure. 
It is also shown that the input/output procedure gives reasonable tract 
shapes for vowel phonation. I 
This work comprises Vemula's D.Sc. dissertation, Department of 
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I E-4. Voice Source Characteristics 
I Personnel: R. B. Monsen t Ph.D' t Central Institute for the Deaf A. M. Engebretson t BCL and Central Institute for the Deaf 
N. R. Vemula t D.Sc' t Central Institute for the Deaf 
I Support: RR 00396 NS 03856 
I 
I Our equipment is unchanged from previous reports (PR l5 t E-4). 
In the previous year t we collected samples of different types of pathological 
phonation simulated by a speech pathologist. In addition to phonation 
in normal t soft t and loud voice modest samples of functionally deviant 
voice production were collected and studied: soft-breathy voice t breathy 
voice t dry-hoarse voice t ventricular-hoarse voice t and harsh-hoarseI voice. These samples of functionally deviant voice were compared with 
I 
normal voice with regard to the appearance of the glottal waveform t 
the amount of perturbations of frequency and intensitYt including diplophonic 
perturbations t and the amount of noise in the spectrum. Each of these 
different types of voice appear recognizably different either by the 
appearance of the waveform t its periodicitYt or the amount of noise 
I in the spectrum. The reflectionless tube thus appears to provide a potentially useful tool for investigating voice disorders. During the 
coming year t we plan to collect samples of functionally deviant phonation 






E-5. Acoustic Analysis of /ra/, /la/ t /ma/, /na/, /ja/ t and /wa/ Spoken 
by Female Talkers 
Personnel: R. G. Karzon t M.A' t Central Institute for the Deaf 





Six continuant sounds (viz., frat la t mat na, wa t and ja/) are 
being analyzed with the Speech Microscope (E-2 and PR l5 t E-2) to obtainI the center frequencies of formants It 2 and 3 as a function of time. 
I 
The speech microscope also provides fundamental frequency as a function 
of time. To date t analysis has been completed for /ra/ and /la/. In 
general t the formant values obtained agree with values of formants for 









The information obtained with the Speech Microscope will provide 
some of the guidelines for sound synthesis. The synthetic tokens of 
these sounds will then be used as stimuli in future experiments studying 




E-6. Spatial-Frequency Analysis of Psychoacoustically-Processed Sounds I 
Personnel:	 J. D. Miller, Ph.D., Central Institute for the Deaf 
A. M. Engebretson, BCL and Central Institute for the Deaf 
N. R. Vemula, D.Sc., Central Institute for the Deaf I 
Support:	 RR 00396 
NS 03856 I 
Spatial frequency analysis is a procedure developed and implemented 
on the PC-1200 speech-and-hearing system in connection with our study I 
of processing of vowel sounds by the human auditory system and the normal­
ization of vowel sounds spoken by men, women and children. As a part 
of this study we have developed a spatial filter characteristic of the I
auditory system based upon the existing experimental data on the psychophysical
ltuning curves. The following steps constitute the spatial frequency 
analysis procedure: (1) select a speech segment of two (male) or three I(female) pitch periods, (2) apply a Kaiser-Bessel window to the samples 
of the segment to reduce the effect of end-point mismatches on the final 
results, (3) compute the discrete Fourier transform of the windowed 
samples, (4) take every second or third Fourier component from the computed I 
transform depending upon whether a 2- or 3-pitch-period-long segment 
has been chosen for analysis, (5) convert the real and imaginary parts 
of the Fourier components into amplitudes in dB and phases in degrees, I(6) convert the frequen~ies of the components into Mels, (7) apply Stevens 
ear-response-correction to the dB values, (8) compute the spatial wave 
for the sound by sweeping the spatial filter along the Mel axis and 
determining the response of the filter at each position due to the compo­ I 
nents that fall under the filter characteristic, (9) apply a cosine 
tapering window on the spatial wave to reduce the effect of the end-point 
mismatches, (10) take 500 evenly spaced samples of the windowed spatial I 
wave, (11) compute the discrete Fourier transform of the samples of 
the wave, (12) convert the real and imaginary components of the transform 
into amplitudes and phases, (13) display the amplitude and phase lines Ias functions of component number, (14) display the first ten components 
as waveforms with appropriate phases along the Mel axis, and (15) display 
the cumulative sums of the components as waveforms with appropriate 
phases along with the windowed spatial wave. Using this procedure, I 
a study of spatial frequency components of male and female Iii, III, 
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E-7. Vowel Normalization: Differences Between Vowels Spoken by Children, 
Women, and Men 
Personnel: J. D. Miller, Ph.D., Central Institute for the Deaf 




I	 Peterson and Barneyl measured certain acoustical properties of vowels spoken by 33 men, 28 women, and 15 children. They characterized 
each token of a vowel by its fundamental frequency, the center frequencies 
I of the first three formants, and their relative levels. The measures were obtained from spectrographic sections taken near the presumed centers 
of the vowels. For each of ten vowel categories, mean values of the 
measurements are given for each of the three talker groups. 
I 
I We have sought transformations of the frequency scale and rules 
of combination so as to eliminate differences between talker groups 
while maintaining the differences between vowel categories. Otherwise 
said, we seek to maximize the differences between vowel categories in 
relation to the talker-group differences within vowel categories. 
I	 For this purpose, we have used nine (9) vowel categories (Ii, 
I
 
I, E:, ce, A, ';);V-, u, and "Sf): three talker groups (children, women,
 
men); and the mean values of four measures of the spectrum (FO, Fl,
 
F2, F3). We have examined transformations of these variables to technical
 
Mels (Fant, p. 48)2 to a special Mel~ scale based on the critical ratio 
(Hawkins and Stevens) ,3 and to position (P) along the cochlear partition 
(Greenwood).4 In each case we have considered combinations as followsI	 [(Xl' X2), (X2/ Xl ) , (log Xl' log X2), and (log X2/Xl)]. This pattern has been extended to include similar combinations of Xl' X2 , and X3 
and, again, similar combinations of Xo, Xl' X2' and X3• 
I 
I If no correction is made for talker groups per se, then plotting 
the vowels in the space log (X2/Xl) by log (X3/X2) gives excellent separation 
between vowel categories. For example, if one uses log (F2/Fl) by log 
I
 




(F3/F2) then the root-mean-square distances between vowel categories 
is 11.2awc ' while the separation between the two closest categories 
is 2.4awc • The is, of course, the standard deviation of the withinawc 
vowel differences between talker groups. Less good, but similar results I 
are obtained for the logs of the ratios of the formants expressed as 
M, M~, or P. Notice that this method of viewing the vowels does not 
require any normalization parameters. I 
A similar, but slightly better clustering of the vowels is achieved 
if one takes the vector [log (Fl/FO), log (F2/Fl, log (F3/F2)] as the 
descriptor of the vowel. (Here one must multiply all Fa's for the male I 
group by 1.43.) In this case, root-mean-square separation between vowel 
categories is 10.6a while the minimum separation is 3.2a • 
wc wc I 
To state the result in another way, the mean descriptions of 
the vowels spoken by men, women, and children are essentially identical 
if the male Fa is multiplied by 1.43 and each vowel is described as I
a point in the three dimensional space, log (Fl/FO) by log (F2/F3) by 
log (F3/F2). 
INoting that shape of the amplitude spectrum of a speech sound 
when plotted on log axes will be determined by the spectrum of the glottal 
wave, formant locations, and their bandwidths, we interpret the above 
findings to mean that the vowels are characterized by their spectral I 
"shapes" when plotted on log axes. Over the usual range of absolute 
spectral differences between men, women, and children the absolute 
location of the spectrum along the log frequency axis is unimportant. I(In this view, the male Fa is lower in relation to Fl, than is the similar 
relation for women and children because their glottal spectra demand 
this difference if the spectral shapes of the vowels are to be maintained.) I 
Results of this and other studies, along with the literature 
taken as a whole, suggest certain directions for a theory of vowel per­
ception. It seems to us that any theory that requires the listener I 
to find the values of formants will have difficulty for the following 
reasons. (1) In many situations formants are nearly impossible to locate 
by simple inspection of the amplitude spectrum. (2) Often extra formants 
are introduced as when the nasal cavity is opened. (3) Synthesis experiments I 
show that satisfactory vowel perceptions can be achieved with many different 
formant locations, formant ratios, and numbers of formants. Our results, 
described above, suggest that it is somehow the spectral shape, in I 
logarithmic dimensions, that is most important for vowel recognition. 
We further note, however, that natural expressions of vowels I
often do not have a spectral shape that is constant over the duration 
of the syllable. Therefore, information obtained at different moments 
in time must be combined so that the intended vowel can be identified. 
It is also true that vowel identification cannot be badly disrupted I 









I We are planning to pursue the notion that the spectral shape 
of pieces of speech of 20-50 msec duration are processed by some kind 
of a template-matching operation. This processing results in the description 
of the piece in phonetically-relevant space. Points in the space are 
stored until there is a silence, or a sudden change in locus, or a long 
I period of time, such as 200 msec, has elapsed. The stored points are "examined" and "averaged" in some unknown way to arrive at the intended 
vowel. We will attempt to develop this model so that it is relatively 
insensitive to the frequency response of the transmission path from 
I
 talker to listener, is relatively insensitive to the exact locus of
 
I 
the spectral patterns in log I by log F space, and is insensitive to 
changes in tempo, pitch, and phonetic environment. We see no need to 
normalize the spectrum in relation to talker's vocal tract as the "spectral 
shape" in logarithmic dimensions appears to be unaffected by this. 
I 1. G. E. Peterson and H. L. Barney, "Control Methods Used in a Study 
of the Vowels," Journal of the Acoustical Society of America, vol. 
24, pp. 175-184, 1952. 
I 2. G. Fant, Speech Sounds and Features, MIT Press, Cambridge, MA, 1973. 
I 3. J. E. Hawkins, Jr. and S. S. Stevens, "The Masking of Pure Tones and of Speech by White Noise," Journal of the Acoustical Society 
of America, vol. 22, pp. 6-13, 1950. 
I 4. D. D. Greenwood, "Critical Bandwidth and the Frequency Coordinates of the Basilar Membrane," Journal of the Acoustical Society of America, 




 E-8. Frequency Transposition of Synthetic Vowel Sounds 
I Personnel: J. D. Miller, Ph.D., Central Institute for the Deaf A. M. Engebretson, BCL and Central Institute for the Deaf 
N. R. Vemula, D.Sc., Central Institute for the Deaf 




I In an earlier pilot study one of us attempted to transpose 2-formant 
representations of the vowels Ii, re, a, ul along the human cochlea by 
maintaining the distances between formants and their widths in millimeters. 
I 
I Shifts of .± 3 mm from so-called "target" values were studied. In this 
case, however, vowel color was not maintained as the absolute locations 
of the formants were shifted. 
I
 




We have now synthesized complete vowel spectra in a manner which 
is outlined as follows. A serial synthesizer is used. Glottal waves 
have been developed for male and female voicer which follow the spectral 
envelope described by Monsen and Engebretson. The bandwidths of the I 
first three formants are specified by a curvj fitted to the combined 
data of Dunn2 and of Fujimura and Lindqvist. Separate but similar 
curves are derived for men and women. Finally, the geometric means I
of the ratios (F2/Fl), and (F3/F2) are found tor the mean data of men, 
women, and children from Peterson and Barney. The ratios of Fl/FO 
are geometrically meaned for women and children and calculated separately 
for men. Higher poles and their bandwidths and the general method of I 
synthesis are as specified in Burdick and Miller. 5 
So-called normal vowels are synthesized for a talker group by I 
taking mean values of Fl from Peterson and Barney and then calculating 
or "looking-up" all other parameters (Le., F2, F3, etc.) as described. 
This is done for the vowels /i, I, E:, ce, A,:> ,V, u ,~/ • These sets Iare then transposed by multiplying all synthesis parameters by the desired 
fraction. This method maintains the spectral shape of the vowels when 
plotted as log axes. I 
The so-called normal vowels are highly intelligible. Transposition 
appears to work well over the range required to explain the common vowel 
qualities of vowels spoken by men, women, and children. Previous research I 
with naturally spoken syllables (Daniloff et al.)6 is perfectly consistent 
with this interpretation. Of course, this evidence converges with that 
from our studied of vowel normalization in that the common vowel qualities Iof vowels spoken by men, women, and children can be explained in terms 
of their similar spectral shapes when plotted on log axes. 
I 
1.	 R. B. Monsen and A. M. Engebretson, "Study of Variations in the 
Male and Female Glottal Wave," Journal of the Acoustical Society 
of America, vol. 62, pp. 981-993, 1977. I 
2.	 H. K. Dunn, "Methods of Measuring Vowel Formant Bandwidths," Journal 
of the Acoustical Society of America, vol. 33, pp. 1737-1746, 1961. I 
3.	 O. Fujimura and J. Lindqvist, "Sweep-tone Measurements of Vocal-tract 
Characteristics," Journal of the Acoustical Society of America, 
vol. 49, pp. 541-558, 1971. I 
4.	 G. E. Peterson and H. L. Barney, "Control Methods Used in a Study 
of Vowels," Journal of the Acoustical Society of America, vol. 24, Ipp.	 175-184, 1952. 
5.	 C. K. Burdick and J. D. Miller, "Speech Perception by the Chinchilla: 
Discrimination of Sustained /a/ and /i/," Journal of the Acoustical I 









I 6. R. G. Daniloff, T. H. Shriner, and W. R. Zemlin, "Intelligibility 
of Vowels Altered in Duration and Frequency," Journal of the Acoustical 
Society of America, vol. 44, pp. 700-707, 1968. 
1\ 
I 
E-9. Computer-Controlled Testing of a Hearing-Impaired Person's Ability 
to Identify the Sounds of English 
Personnel: J. D. Miller, Ph.D., Central Institute for the Deaf 
I
 G. Friedman, M.S., Central Institute for the Deaf






A hearing-impaired client was tested with the MEGS system, which 
has been described in earlier reports (PR 11, G-7; PR 12, G-7). The 
patient listened to speech sounds delivered by the MEGS system to a 
special hearing aid developed at CID. The aid allows frequency selective 
control of both gain and maximum outputs. This was accomplished by 
dividing the spectrum from 266-6000 Hz into 9 channels with independent
 
control of gain and limiting in each channel. The gains were adjusted
I to bring the average level of speech in each channel to the listener's
 most-comfortable-listening level and maximum outputs were adjusted to
 
just match the listener's threshold of discomfort. The aid was further
 
I
 manipulated so that three passbands could be obtained. These were:
 (1) 266-6000 Hz; (2) 353-4242 Hz; and (3) 530-2121 Hz. 
I Three tests of the MEGS system were used. "Incon" includes all 53 possible beginnings of English words combined with the vowel /a/. 
"Fincon" includes all of the 55 single morpheme endings of monosyllabic 
I 
words that can occur in English. Again these are combined with vowel 
/a/. "Vownu" includes the twenty syllabic nuclei that can occur in 
English. These are spoken in an /hVd/ context. The speech of one female 
talker is used. 
I The MEGS system begins the test by drawing from an entire list 
randomly. Sounds that are correctly identified are assigned to an "out" 
list from which items are chosen less frequently. Sounds that are incorrectlyI identified or used incorrectly as responses remain in or are transferred to the "in" list. Items on the "in" list are presented more frequently. 
In this way the testing quickly converges on those items that are most 
troublesome for the listener. 
The subject learned the task quickly and was given about 30 minutes 





a 150-trial test on each test for each bandwidth. Bandwidth effects 
were revealed in overall percent correct-identifications, the average 
size of the "out" list in percent, and in the rate of growth of the 
"out" list. Error analysis pinpoints those sounds that are most difficult I 
for the listener. For example, the percent of correct identifications 
from wide to narrow bandwidths were 37, 22, and t5% for Incon; 20, 17, 
and 10% for Fincon; and 39, 37, and 19% for Vownuc. The most difficult Iitems were consonant cluster involving /r/ and /1/ such as /gra/, /ra/ 
and /fa/ for Incon; final voiceless fricatives and stops and their blends 
with /1/ and /n/ for Fincon, and the r-colored vowels for Vownuc. These 
results and discussion with the subject, herself, suggest that this I 
method will be extremely useful for clinical research, but would need 
considerable simplification to be useful in routine clinical work. I 
1.	 J. D. Miller, A. M. Engebretson, S. A. Garfield, and B. L. Scott, 
"New Approach to Speech Perception Testing," Journal of the Acoustical ISociety of America, vol. 57, supplement, p. 548, April, 1975. 
I 
E-lO. Implementation of the Stevens & House Articulatory Model for I 
Speech Synthesis 
Personnel: N. R. Vemula, D.Sc., Central Institute for the Deaf IA. M. Engebretson, BCL and Central Institute for the Deaf 
J. D. Miller, Ph.D., Central Institute for the Deaf 
Support: RR 00396 I 
NS 03856 
IIn order to analyze and evaluate the acoustic performance of 
the vocal tract during vowel phonation, Stevens and Housel have considered 
the tract as a nonuniform, cylindrical tube excited at the glottal end 
and terminated in an appropriate radiance impedance at the lip-end. I 
Our goal in the implementation of the model is to study the effect of 
systematic changes in the articulatory parameters on the first and the 
second formant frequencies in connection with the study of vowel normalization I 
described in E-4. The tube has three parts: (1) the glottal part which 
is assumed to be fixed and consist of two pieces: the first piece with 
a parabolic radius function from the glottis up to 3 cm along the tract I
and	 the second piece with a constant radius of 3 cm to the middle part, 
(2) the middle part corresponding to the tongue constriction with parabolically 
increasing radius on either side of the constriction, and (3) the cylindrical 
lip piece. For a fixed length of the lip piece the model has three I 
parameters: (1) the location of the tongue constriction from the glottis, 
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I The lip area/length ratio is taken as a parameter rather than the area 
because it is the area/length ratio or conversely the length/area ratio 
I
 that determines the mass reactance at the lips. In our implementation
 of the model the lips are assumed to be terminated with an infinitely long terminator tube. The first and second formant frequencies are 
determined as follows. The tube is discretized into 0.5 cm long sectionsI and each section is represented by a uniform cylinder with a cross­
I 
sectional area such that the cylinder has the same mass reactance as 
the original nonuniform section. The all-pole transfer function of 
the tube is then determined from the reflection coefficients at each 
section. The formant frequencies are computed from the roots of the 
transfer function and then converted into Mels. The results indicate 
I that logarithmic decrements in the lip area/length ratio combined with corresponding change in the distance of the constriction from the glottis yield approximately straight lines in the Mel Ml-M2 plot that correspond 
to certain vowel categories.I 
I 
1. K. N. Stevens and A. S. House, "Development of a Quantitative Description 
of Vowel Articulation," Journal of the Acoustical Society of America, 
vol. 27, pp. 484-493, 1955. 
I 
I E-ll. General Software Development 
Personnel: N. R. Vemula, D.Sc., Central Institute for the Deaf 
I Support: RR 00396 
NS 03856 
I 
I A number of FORTRAN routines have been written and added to the 
speech and hearing system software library. They can be classified 
as (1) scope display routines, (2) mathematical routines, and (3) miscellaneous 
routines. The previous scope display routines enable us to look at 
the spectral information corresponding to a speech segment in the following 
I ways: (1) spectral lines with amplitudes expressed in dB corresponding to the different harmonic components displayed on linear frequency scale, (2) spectral lines on logarithmic frequency scale, and (3) phase lines 
in degrees on linear frequency scale. The present scope display routinesI show t~e spectral information in a variety of ways: (1) spectral lines 
I 
on Mel scale, (2) spectral lines on logarithmic Mel scale, (3) energy 
levels in dB in different 1/3-octave filter bands covering the frequency 
range 0 Hz - 10 kHz on logarithmic frequency scale, where the center 
I 
frequencies and bandwidths of the filters correspond to those of the 
Bruel and Kjaer audio frequency spectrometer, (4) specified number of 
first several spectral lines displayed with their harmonic numbers shown 
I
 




at the bottom, (5) specified number of first few harmonic components 
displayed as sine waves with appropriate phase as functions of time, 
(6) cumulative sums of first few components and the original speech 
segment as functions of time. Another display routine takes x and y I 
coordinates for specified number of points and displays them on the 
scope with specified scales for the axes. I 
A number of routines written in connection with the psychoacoustics 
of speech sounds are among the mathematical routines. The Mel routine 
gives the Mel value for a given frequency, whereas the "MELTOHZ" routine Idoes the reverse operation. GREENWOODIMP and AMEMAP are subroutines 
that calculate mapping functions of distance along the cochlea as a 
function of frequency. The first subroutine implements a Greenwood2 
mapping function. The second routine implements a modified Mel function I 
that yields a closer fit to critical bands at low frequencies. EARCORCTN 
computes the Stevens ear-response correction3 in dB for a given frequency 
to determine the perceived sound level from the actual one. "HSCRBAND" I
computes the critical band in Hz for a specified frequency usin~ a 7th 
degree polynomial fit to Hawkins and Stevens critical band data at 
different frequencies. A number of routines have been written to compute 
the	 spatial wave along the cochlea corresponding to a specified speech I 
segment. 
The	 cluster analysis routine takes points corresponding to different I 
categories for different experiments or groups and gives the variance 
between categories, variance within categories, and also minimum sphere­
to-sphere distance and minimum center-to-center distance for spheres Irepresenting the categories. Each point can have up to four coordinates. 
Among the miscellaneous routines are the improved versions of 
waveform zero-crossing routines, which perform a linear interpolation I 
between samples to determine the zero-crossing time. These routines 
give a very accurate measurement of the fundamental frequency of the 
waveform. I 
1.	 G. Fant, Speech Sounds and Features, MIT Press, Cambridge, MA, 1973. I 
2.	 D. D. Greenwood, "Critical Bandwidth and the Frequency Coordinates 
of the Basilar Membrane," Journal of the Acoustical Society of America, 
vol. 33, pp. 1344-1356, 1961. I 
3.	 S. S. Stevens, "Perceived Level of Noise by Mark VII and Decibels 
(E)," Journal of the Acoustical Society of America, vol. 51, pp. I575-601, 1972. 
4.	 J. E. Hawkins, Jr. and S. S. Stevens, "The Mashing of Pure Tones 
and of Speech by White Noise," Journal of the Acoustical Society I 









I	 F. Central Nervous System Diseases and Electroencephalogram Analysis 
I The Biomedical Computer Laboratory's involvement in clinical neurology, neurosurgery, and in neurophysiological research reaches back to the Laboratory's 
I, 
beginnings. In 1965 and 1966 a LINC computer at BCL was applied in processing 
radioisotope brain-scan data transmitted over telephone lines from the hospital 
radiology unit, and in 1966 a LINC-controlled evoked-response display system 
was installed, providing neurosurgeons in the operating room with continuous 
EEG monitoring capability via closed-circuit television. In 1969 and 1970 
1 a LINC computer was interfaced to a six-probe system designed by the radiology department	 for in-vivo cerebral blood-flow and oxygen-metabolism studies 
employing cyclotron-produced radioisotopes. The next two years saw further 
1 development of this approach with the construction of a twenty-six-probe brain blood-flow and metabolism unit capable of increased spatial resolution. 
At this juncture it was recognized at BCL that new initiatives inI central nervous system and other radio tracer studies must stem, in part, 
1 
from an improved understanding of the manner in which the underlying physiological 
phenomena reveal themselves through gamma rays and annihilation photons 
to the external data-gathering instruments. Thus, in collaboration with 
scientists	 at Washington University and at other institutions, the Laboratory 
undertook a substantial augmentation of its program in tracer kinetics by 
I
 expanding its activities in physiological modeling and parameter estimation.
 These collaborative efforts led to successful quantitative methods of studying 
in-vivo such diverse processes as brain-glucose transport and metabolism, 
blood-brain-barrier permeation of water, alcohols, ammonia, and carbon dioxide,I	 and the autoregulation of cerebral blood volume and blood flow. 
I 
Research efforts at BCL in application of computers and mathematical 
models to CNS disease management and EEG analysis, reported last year in 
I 
PR 15, have continued to be productive: advances have been made in all 
the projects previously described. A system to simplify the collection 
and processing of averaged visually evoked potentials has been developed 
and successfully tested. Progress has continued in the development of com­
puterized systems for automatic processing and monitoring of signals generated 
in the neurophysiology laboratory and during neurosurgical procedures. TheI computerized autoradiographic-image-processing system for neuroanatomy begun 
I 
last year is now nearing completion. Our long-standing collaboration with 
scientists at Washington University and at other institutions in studies 
of CNS function using cyclotron-produced radiopharmaceuticals has continued 
to be fruitful. Progress in this and in our other involvements in CNS research 





F-l. Visual Evoked Response 
Personnel:	 G. J. Blaine, BCL 
M. W. Browder, BCL I 
L. A. Coben, M.D., Neurology 
J. K. Montrose, BCL 
S. R. Phillips, BCL I 
H. W. Shipton, BCL and Electrical Engineering 
L. J. Thomas, Jr., BCL ISupport:	 RR 00396 
MH 31054 
I 
The visual evoked response (VER) or potential (VEP) is used as an 
indicator of cerebral physiology. Electrophysiological responses evoked 
by repeated visual stimuli are separated from other ongoing electrical activity Iby a signal-averaging process. Features extracted from the averaged responses 
to stationary white-flash and to reversing black-and-white checkerboard 
patterns are to be included with behavioral measures and cerebral structure Imetrics in a temporal study of patients with senile dementia. 
A system to simplify the collection and processing of averaged visual 
evoked potentials (AVEPs) has been developed. The overall system can be I 
described as a "loosely coupled" distributed processing system. The coupling 
between components of the system is in the form of data transfer via machine­
readable magnetic storage media, i.e., flexible diskette and industry-compatible I
nine-track magnetic tape. 
A microprocessor-based system was developed to provide flexible param­ Ieterization of clinical protocols and to permit collection of AVEPs.l The 
salient features are summarized in Table 1. Feature-detection algorithms 
were developed on a minicomputer system to simplify and improve the accuracy 
of previously used manual scoring methods. An editing system was also developed I 
to allow operator verification and editing of the features located by the 
automatic system. 2 The parameters of interest are then included in a statistical 
database for further analysis on a large computer. I 
In order to evaluate the performance of the automatic feature-extraction 
(AFE) system, data concerning the operator editing of AVEPs is captured. 
These data are used to monitor the amount and type of editing being performed I 
and will aid in the further tuning of the AFE algorithm, if necessary. 
AVEP data from 50 subjects have been analyzed. As expected, peak P2 I 
is the most consistent and has required the least amount of editing. Due 
to the contextual nature of the other peaks, a larger number of them required 













I Acquisition-System Parameters 
Sampling Rates: 




I Stimulus Rates: 0.25 to 3.60 Hz 
Number of Epochs Averaged: 1 to 256 
Epoch Length: 200 to 1000 msI Resting EEG Duration: 0 to 64 sec 
I 
Pre-Stimulus Delay: 8 to 184 ms 
Rejection Levels: 0 to 100% of full scale 
Triggers: Internal or External 
Stimuli: Randomized or Periodic 
I 
Table 2I AFE Performance Study
 
(data from 50 subjects, 400 AVEPs)
 












1. J. K. Montrose, "Acquisition and Processing of the Visual Evoked Response," 
Master of Science thesis, Sever Institute, Washington University, St. Louis,I Missouri, December 1979; also BCL Monograph No. 373. 
I 
2. M. W. Browder, G. J. Blaine, J. K. Montrose, L. A. Coben, and L. J. 
Thomas, Jr., "Visual Evoked Potential: Computer-Assisted Acquisition 
and Processing," Proceedings of the Fourth Annual Symposium on Computer 












F-2.	 Development of an Automated System for the Monitoring of Epileptic 
Patients with Indwelling Electrodes 
IPersonnel: C. F. Pieper, M.S., Neurological Surgery 
S. A. Golden, B.S., Neurological Surgery 
S. Goldring, M.D., Neurological Surgery I 
Support:	 NS 14834 
Washington University I 
The crosspoint matrix (PR 15, F-2) has been expanded to allow monitoring 
of arrays with 52 electrodes. The full matrix has been used with eight 
patients and has performed well. Grounding the matrix outputs as they I 
enter the low-level EEG amplifiers was found to adequately quiet the pen 
writers during electrical stimulation of the brain. A prototype of the 
previously proposed EEG amplifier (PR 15, F-3) has been satisfactorily I
tested, and a bank of such amplifiers has been constructed. Software for 
their control is under development. IA MINC [Digital Equipment Corporation (DEC)] system has been delivered 
and plans are being formulated for a sixteen-channel peristimulus averaging 
system. Accordingly', a sixteen-channel AID converter has been constructed 
for use with our EEG amplifiers and the MINC. This portion of the system I 
will make possible the collection of the averaged sensory evoked response 
(SER) to median-nerve stimulation. IPlans are also being developed for a digital communication system 
to permit recording the SER from the operating room and various patient 
areas without transporting the MINC. The communication system will have Isufficient capacity to permit simultaneous monitoring of seizure activity 
and for collection of the SER. The monitoring system will be based on 
a PDP 11/34 (DEC) and will permit retention and display of sixteen channels 
























F-3. In-Vivo Measurements of Regional Blood Flow and Metabolism in Brain 
Personnel:	 M. E. Raichle, M.D., Neurology and Radiology 
R. L. Grubb, Jr., M.D., Neurological Surgery 
C. S. Higgins, A.B., Radiology 
S. Lang, Ph.D., Physiology and Biophysics 
K. B. Larson, BCL 
J. Markham,	 BCL 
N. A. Mullani, BCL 
M. M. Ter-Pogossian, Ph.D., Radiology 
T. J. Tewson, Ph.D., Radiology 
M. J. Welch, Ph.D., Radiology 




We have continued our previously reported efforts in the study of 
central-nervous-system hemodynamics and metabolism. Our immediate objective 
has been the development of techniques employing biochemically significant 
compounds labeled with cyclotron-produced isotopes CPR 15, F-3), suitable 
external-radiation-detection systems CPR 15, B-5; B-9), and appropriate 
mathematical models CPR 15, F-3) for the in-vivo and regional study of 
basic biological processes and pathology within brain. Our ultimate goal 
is to use these techniques to provide the quantitative physiological and 
biochemical measurements in humans necessary to understand central-nervous­
system disease, as well as to formulate specific therapies and monitor 
their results. 
Our previously reported studies of ammonia transport and metabolism 
in brain CPR 15, F-3) have led to a new distributed-parameter regional 
model of the cerebral circulation that takes into account the effects on 
tracer transport of capillary heterogeneity within an external-detector 
spatial-resolution element. This model permits, apparently for the first 
time, interpretation of externally acquired radiotracer count-rate data 
in terms of regional-average or voxel-average parameters describing hemodynamics 
and tracer transport, thus avoiding previous inconsistencies arising from 






F-4. Studies of an Image-Processing System for Neuroanatomy 
Personnel: A. J. Gray, BCL IG. J. Blaine, BCL 
J. G. Dunham, BCL and Electrical Engineering 
V. W. Gerth, Jr., BCL 
E. G. Jones, M.D., Ph.D., Anatomy I 
J. S. Massey, BCL 
J. L. Price, Ph.D., Anatomy 
L. J. Thomas, Jr., BCL I 
T. A. Woolsey, M.D., Anatomy 
Support: RR 00396 INS 15070 
Morphological studies of the organization of the central nervous I 
system utilize.radiolabeled precursor substances to visualize nerve-cell 
connectivity. Radiolabeled substances injected into or around nerve-cell 
bodies are incorporated into macromolecules and are transported down the I 
axons to accumulate in their terminals. The spatial distributions of the 
radiolabels are then revealed using autoradiography, a technique in which 
photographic emulsions are exposed in close contact with tissue sections. IThe resulting images, consisting of silver grains formed in the emulsion 
by action of the ionizing radiation, represent the radiolabel distributions 
in the tissue sections. Since the silver grains are relatively uniform 
in size and confined to the plane of a photographic emulsion, the images I 
are particularly amenable to quantification using a combination of bright­
field and dark-field microscopy. For quantification of the autoradiographs, 
a second-generation microscopy-based instrument is being implemented. IThe instrument, which has been previously described (PR 15, F-4), will 
provide a computer-assisted means for silver-grain counting and specimen 
review. I 
The instrument consists of an automatic stage-control processor 
(ASCP) that positions the microscope stage, a video processor and image 
analyzer (VPIA) that accepts video data from the imaging device and extracts I 
grain-count densities and other image parameters, an operator control panel 
(OCP) from which the user can interact with the system in an efficient 
manner, and a supervisory processor that coordinates the network. All Iof these elements are interconnected by the IEEE-488 instrumentation bus, 
a key feature of the design. The IEEE-488 bus provides a standardized 
interface protocol, guarantees that the various modules can function independ­
ently, and allows for easy modification and expansion. Currently, the I 
ASCP has been completed. Both the hardware and software for its Motorola­
6802 microprocessor have been built, tested, and documented. Modifications 
and additions to the Zeiss universal microscope are likewise complete, I 
with a motorized focus control and XY overtravel limit switches being the 
major items. A charge-injection device (CID) television camera has been 











The supervisory processor, consisting of an LSI 11/2 processor with
 
a 64-kbyte MOS memory, a dual double-density floppy diskette, a "smart"
 
CRT terminal, and a printer, has been configured and is in routine use.
 
The supervisory processor also includes an IEEE-488 I/O card and software 
driver for its RT-11 operating system. A library of FORTRAN-callable sub­
I
 routines supports communication over the IEEE-488 bus with the ASCP, OCP,
 and video processor. Initial tests of communication between the ASCP and 
supervisory processor have been quite successful, and work has begun on 
the software design of the grain-counter system executive. Emphasis isI on a modular and highly structured design due to the potentially large size of the program and the desire to accommodate modifications easily. 
I The OCP circuitry has been designed, and most of the wirewrapping has been accomplished. The layout of the control panel has been established, 
the enclosure fabricated, and most of the hardware (alphanumeric display, 
I push buttons, joystick, etc.) has been mounted. Final assembly work, panel wiring and hardware verification are in progress. Software generation 
for the OCP will be under way shortly. 
I A General Electric television camera with a 242-by-236 picture element (pixel) Cln imager is used for image acquisition. The Cln has very low 
lag, virtually no shading, and no burn problems compared to conventional 
I tube imagers. Compared with charge-coupled devices, Cln imagers are reported 
I 
to have better sensitivity, lower dark current, and lower crosstalk between 
pixels. This particular camera also has built-in outputs for digital video 
and timing signals, which simplify interfacing the camera to digital equipment. 
A detailed analysis and verification of the digital interface has been 
completed, and a slow-scan interface to a pnp-11/34 has been built and 
tested, allowing images to be loaded into the minicomputer for evaluation.I Preliminary analysis of the video data has also been completed. Several discrepancies between camera documentation and test results were discovered 
and reported to General Electric. 
I 
I The video processor's structure has been designed; it features extensive 
use of off-the-shelf equipment, which is expected to enhance its exportabi1ity 
and reliability. Image storage (8 bits/pixel), analysis, and display will 
be performed primarily by one device - a Lexidata 3400 image-processing 
system. This commercially available unit contains a 256-by-256-by-10-bit 
image memory, circuitry for generating a raster-scan display of the imageI on a color CRT along with color graphics and text, and a high-speed 12-bit programmable processor. The Lexidata unit is controlled by an LSI 11/23 
processor with a 64-kbyte memory. The LSI 11/23 communicates with the 
I




supervisor, and configures the Lexidata unit to perform the desired operations,
 
either by invoking PROM-based utility routines, or by downloading specia1­

application microcode to the Lexidata unit's writable control store. Image
 
acquisition from the Cln camera, contrast enhancement, thresholding operations,
 
filtering and grain counting are examples of typical video processor tasks. 








The design of the switching hardware between the LSI 11/23, the 
camera, and the Lexidata unit is only just beginning due to the delays 
in verification of the camera's interface timing by General Electric. The 
goal is to design this high-speed switch with flexibility sufficient to I 
permit the addition of a disk storage device for archiving images in digital 
form. I 
Initial studies of image-processing algorithms are well under way, 
although considerable work remains. Present plans call for first-generation 
grain-count algorithms that are modest improvements on those used in the 
first-generation grain counter. l I 
I1. D. F. Wann, J. L. Price, W. M. Cowan, and M. A. Agulnek, "An Automated 
System for Counting Silver Grains in Autoradiographs," Brain Research,
 




F-5. A Correlation Technique for the Study of Visually Evoked Potentials 
Personnel:	 H. W. Shipton, BCL and Electrical Engineering I 
Support:	 RR 00396 
Washington University I 
Using the visual-stimulus generator previously described (PR 15, F-5), 
a small number of recordings has been made in a volunteer population (N = 4) Iwith equivocal results. There is reason to think that the method will provide 
information regarding the topology of the visual cortex. The present stimu­
lator, while adequate for initial studies, will be modified to provide a 
larger stimulus area. 
For administrative reasons, 
until Spring 1981. 
I 











G. Supporting Activities 
I Activities at BCL which contribute to the goals of more than one major program of the laboratory or to the needs of individual users who 
I,
 can benefit from the special expertise of the staff and the inventory
 of computer and test equipment are called supporting activities. Service to users does not follow the usual computation-center pattern. No fee 
schedule has been established, nor is there a centralized facility. Instead, 
I senior laboratory staff members consider requests from investigators for assistance in addressing biomedical computing problems. Investigators 
may be directed to commercial vendors or existing fee-for-service facilities. 
Other researchers m~ be advised of the unavailability of appropriateI technology. The remaining investigators may have problems that match the special capabilities within BCL. Usually, such a project is assigned 
to a staff member with similar experience. If the project can be completed
1 quickly, the investigator has his or her results and a short note describing the work will appear in the annual report and in the open literature if 
appropriate. Other projects occasionally prove impractical and the best 
I
 alternative is recommended. A few of the user projects may develop into
 major initiatives within the laboratory. Most of the major projects began 
in this fashion and we value the opportunities that supporting activities 
provide. 
I 
I Although the projects reported in this section span a variety of 
topics, they can be grouped conveniently as biomedical applications, system 
development aids, and digital hardware designs. The biomedical applications 
represent new initiatives in which basic exploration is being conducted, 
which mayor may not ultimately result in a major, long term program. 
I Two examples are the continued collaboration with the Department of Biochemistry relating to the development of microcomputer systems for laboratory automation 
and a new collaboration with the Department of Genetics studying the re­
striction map of DNA sequences. The previously reported radiation treatment 
I planning project has matured to the extent that is now reported under 
I 
Quantitative Imaging (B-14, 15, 16). Even in cases where an extended 
effort does not materialize, the relationships which are cultivated frequently 
prove beneficial to future work. 
I 
System development aids mostly benefit the BCL staff, but also 
are utilized by other groups where appropriate. An excellent example 
here is the microprocessor development support system which, although 
still evolving, is an almost routine tool used in data acquisition, signal 
processing, and control applications. System software development for 
the PC-1200 and the AUGAT wirelist program reported here are also widely 
used in supporting a variety of projects. 
The digital hardware designs reported in this section are frequently 
one-time, special purpose designs. The design of the ECG cassette recorder 
is an example of such a project. In contrast, other designs may have 
wide appeal and construction of multiple copies can easily be envisioned. 
The USD (Universal Storage Device) is such a design and is widely applied 
by users with a need for off-line data acquisition and local mass storage. 
- 156 ­
I 
IG-l. Microprocessor Development Support 
Personnel:	 M. W. Browder, BCL 
R. J. Arnzen, BCL I 
R. M. Arthur, BCL 
G. J. Blaine, BCL 
W. D. Gillette, Ph.D., Computer Science ID. W. Goldfarb, Computer Science 
R. K. Hartz, BCL 
S. A. Phillips, BCL I 
Support:	 RR 00396 
Washington University I 
Our microprocessor development support includes a FORTRAN-based 
cross-assembler, FOCRAS, intelligent console (InC) and a small library Iof "standard" M6800 system modules. At present FOCRAS provides cross­
assembler support for the 6800, 8080, and 6502 instruction sets and is 
currently operational on Texas Instruments Model 980B, Artronix Modulex, 
and Digital Equipment Corporation Model PDP-II minicomputers. A collection I 
of generally useful subroutines into a shared microprocessor library which 
is accessed by the FOCRAS linking loader has been established. The Intelligent 
Console is itself a microprocessor-based instrument which is used to assist I 
both hardware and software development of microprocessor-based systems. 
New target-dependent hardware and software were implemented to Iupgrade the InC to provide support for development of systems utilizing 
the M6802 microprocessor. The InC now supports development of systems 
based on the M6800, M6802, and Intel 8080 microprocessors. I 
Investigation into the architectures of l6-bit microprocessors 
such as the M68000 and the Intel 8086 showed that a considerable redesign 
effort would be required to extend the InC to support these processors. IBased on this finding and the commercial availability of satisfactory 
support products, it was decided to not expand the InC to support 16-bit 
microprocessors at this time. I 
The design phase of a cross-assembler for the M68000 based on FOCRAS 
has been completed. Implementation of the cross-assembler will proceed 
during the coming year. I 
A software floating point package for use with the M6800 has been 











 G-2. System Software Development for the PC-1200 
I Personnel: D. W. Stein, Jr., BCL G. H. Brandenburger, BCL 
I Support: RR 00396 
Software development for the PC-1200 was limited to making user­I requested additions and changes to the existing BDOS operating system (PR 15, G-2). This policy reflects a commitment to provide a level of 
support for the system equivalent to the system's level of use. 
I The software development is divided into two categories: commands 
and subroutines. 
I I. Commands 
1) The magnetic tape read command has been updated to provide optionalI EBCDIC to ASCII character translation and a logical record length parameter. 
I 2) The magnetic tape write command has been updated to provide optional user specified blocking of logical records. 
I
 3) A "command generator" command has been added to enable easier con­
struction of run files from an index.
 
II. SubroutinesI The following subroutines have been added to the BDOS library. 
I
 1) A subroutine to perform binary-coded decimal subtraction.
 
2) A subroutine to perform EBCDIC to ASCII character translation. 
I 3) A subroutine to perform general purpose reads and writes to the 
universal storage device (G-3). 
I 4) A package of seven subroutines to perform standard FORTRAN sequential file input/output functions for LINC tape and BCL disc files. 
Highlights to this package are: 
I a) rewind, backspace, and end-of-file handling capabilities; 
b) multiple files may be in use concurrently; and
 
c) input/output is invoked with standard READ and WRITE instructions.
I All existing documentation files have been updated to reflect the 
changes and new documentation files have been written for the new software. 
I 
I The updated versions and new software are contained on a separate 
LINC tape so that only the users desiring the updates need modify their 
existing BDOS system. 




G-3. A Universal Storage Device 
Personnel: R. W. Hagen, BCL IR. J. Arnzen, BCL 
G. H. Brandenburger, BCL 
M. W. Browder, BCL 
B. R. Hieb, M.D., Jewish Hospital I 
R. E. Olson, A.A.S., Computer Systems Laboratory 
S. R. Phillips, BCL ISupport: RR 00396 
IThe Universal Storage Device (USD) is a convenient, portable instrument 
for acquiring, storing and transferring the data associated with a variety 
of research activities. The acquisition of analog signals is achieved 
through the USD's four analog input channels. Analog voltage signals I 
are digitized to twelve bits of precision and stored on flexible diskette 
media. Signal sampling rates of up to two thousand (2000) samples per 
second are available. Digital information can be stored on and/or retrieved Ifrom a diskette through the instrument's RS-232 serial communication inter­
face. Eight USDs have been constructed and several research activities 
have benefitted from the use of the instrument. I 
During the past three months a USD has been in operation at the 
Jewish Hospital, Department of Psychology where it is used to load data 
into a psychiatric interview system developed by the Computer Systems I 
Laboratory of Washington University. This system is used daily and has 
worked reliably since its installation. Another USD is kept at the Computer 
Systems Laboratory to support ongoing programs including the constant Iarea tonography system (C-2) and psychiatric interview system. The constant 
area tonography system has been in use for over a year in the Department 
of Ophthalmology where a USD serves as a bootstrap loader for a minicomputer 
system as well as a means for collecting the analog data developed during I 
the course of the constant area tonographic studies. 
The USD has also been used to transfer digital data between the I 
Laboratory of Ultrasonics at the Department of Physics and BCL. Ultrasonic 
measurements such as tomographic projections and C-scan images, acquired 
by a HP 9825 calculator system, are transferred to the USD using the RS-232 Iserial link. These data are later transferred from the USD to a PC-12 
where they are processed and displayed using CUTARSYS (B-1) software package, 
on video monitors with Digivision (G-5) or on paper using a Versatec electro­








 G-4. A Low-Cost ECG Cassette Recorder 
1
 Personnel: H. D. Ambos, BCL and Medicine (Cardiology)
 T. L. Weadon, BCL 
I,
 Support: RR 00396
 HL 17646 
I An eight bed Hewlett-Packard computerized telemetry system has been installed in the Barnes Hospital Coronary Care Unit step-down facility. 
Since it is crucial for the computer system to accurately detect ventricular 
1 tachycardia, ventricular fibrillation, asystole, and supraventricular tachycardia, a device was needed which could easily perform daily tests 
on the entire system. To accomplish this, a standard audio cassette recorder 
1 was modified to record and play back five minute segments of ECGs ending in these critical arrhythmias. A separate ten minute segment of supraventricular 
tachycardia, ventricular tachycardia, and asystole was also recorded. 
I A voltage-controlled oscillator transforms the ECG waveform into a 1.11 kHz frequency-modulated sine wave which is then recorded on tape. 
A phase-locked loop is used to demodulate the playback signal and a 30 Hz 
I
 low pass filter conditions and attenuates the signal. The output to the
 bedside telemetry transmitter is a two to five millivolt ECG signal. 
The test system parts cost was about ninety dollars, including the cost 
I




G-5. A General-Purpose Digital Display System: Digivision 
I Personnel: G. H. Brandenburger, BCL 
R. M. Arthur, BCL 
I D. W. Stein, Jr., BCL J. R. Thompson, BCL T. L. Weadon, BCL 
I Support: RR 00396 
Digivision (PR 15, G-9) was augmented with an additional two bit­
planes to bring the total grey-scale resolution to 6-bits. Grey-scaled 
images now exhibit considerably less contouring artifact due to undersampling 
of the grey-scale range. 
Software and hardware upgrading has accomplished the following: 
a) the TI-980 computer associated with the adaptive beamforming for quantitative 
ultrasonic imaging (B-5) can now access digivision. Tests using previously 
recorded M-mode images have demonstrated the value of the 6-bit grey-scale 
resolution. The 512 by 480 spatial resolution also appears adequate for this 






G-6. A System for Multiplexed Cinemicrography of Cultured Cells 
Personnel:	 R. J. Arnzen, BCL IV. W. Gerth, Jr., BCL 
R. R. Heye,	 M.S., Radiology 
L. J. To1mach, Ph.D., Anatomy and Radiology I 
Support:	 RR 00396 
CA 04483 I 
In recent months the hardware and software development for a system 
that will permit multiplexed time-lapsed cinemicrography of cultured cancer Icells (PR 15, G-10) has been completed and is currently being evaluated 
in a 'warm room' where it will ultimately be used for its intended research 
work. Installation has proceeded to the point where trial exposures have 
been made and evaluated. I 
Among the objectives completed over the past year were the following: I1)	 Completion of the unique cine camera for multiplexed cinemicrography. 
2)	 Adaptation of a motorized stage and focus control to a microscope. I 
3)	 Construction of a pedestal for optically and mechanically coupling 
the microscope and camera. I 
4)	 Completion and initial testing of software to control the system. 
5)	 Installation and initial testing of the system in its final Ienvironment. 
Initial evaluations of the system have suggested some modifications 
to software and hardware. Software changes are being made to avoid resonance I 
points in the camera stepping-motor drive while a dish holder used as 
an environmental chamber for the cultured cells on the microscope stage 
is being modified to eliminate a problem of condensation of water vapor I 
on the lid which interferes with contrast optics. This work is currently 
under way, and full scale experiments with the micrography system will 









 G-7. Microcomputer Systems for Biochemistry Laboratory Automation 
I Personnel: M. C. Jost, BCL W. F. Holmes, BCL 
I Support: RR 00396 
This project has been concerned with the development of a flexible
I set of hardware and software modules for use in automation of control,
 data collection, and data processing for certain analytical instruments
 
used routinely in biochemical research, such as amino acid analyzers,

I




cations typically require on-line data acquisition and control with modest
 
speed requirements. Most applications require relatively simple on-line
 
data reduction, although some require more sophisticated post-run calculations.
 
Costs must generally be kept to a few thousand dollars, even less for
 
the simpler instruments. 
I Previous reports (PR 12, F-l; PR 13, F-l; PR 14, G-12 and G-19; and PR 15, G-13) have described the selection of components for a stand­
alone LSI-II-based microcomputer system and the development of hardware 
I and software modules for analog input, keyboard entry, and printer and plotter output. Development of additional data acquisition and graphic 
display software modules suitable for use in the initial application and 
I
 automation of a high speed, sensitive amino acid analyzer developed in
 the Department of Biochemistry also was reported.
 
These previous reports discussed the combination of all system
I components with a dual floppy disk system to form a development system
 housed in a 24-1/2" x 25-1/2" x 36-1/2" mobile cart. This cart is easily
 
moved to the site of the laboratory instrument and is of a size and shape
 
I




without excessive interference with routine laboratory and instrument
 
operation. It was anticipated that once an application was complete,
 
hardware for that application would be housed in a box with a control
 




and digital I/O and whatever peripheral devices are required, e.g. keyboard,
 
alphanumeric printer, and/or plotter. This dedicated system would be
 
left at the instrument site.
 
I 
In the past year, however, the Department of Biochemistry has installed 
a Digital Equipment Corporation VAX 11/780 computer to serve as a departmental 
resource. This development has caused us to re-examine the goals and 
direction of this project in view of the altered needs of departmental 
investigators, technological advances, and experience gained since thisI project began. 
I 
The VAX functions as a large multi-user system with adjustable 
access priorities. Adequate memory, disk, and tape storage is available 








plotter output are available. The VAX is not configured for high speed 
real-time data acquisition or control. On-line instruments must therefore 
have a data buffer with preprocessing and control capabilities. All users I
are connected to the VAX via serial (RS-232) links. 
The most obvious and immediate effect of the availability of the 
VAX in the area of laboratory instrument automation is that, in the majority I 
of cases, it eliminates the need for a stand-alone dedicated mini- or 
microcomputer-based controller and data acquisition system such as we 
have been developing. What is needed is a type of intelligent terminal I 
which communicates with the VAX and which relies on the VAX, to a greater 
or lesser extent, depending on the needs and resources of the individual 
investigator and the instrument being automated. I 
A VAX satellite terminal for use in biochemistry research laboratories 
to connect laboratory instruments to the VAX computer should have, depending 
upon the circumstances, some or all of the following features: I 
1) Eight or sixteen bit CPU
 
2) At least 4 Kbytes of RAM memory
 I 
3) Some type of permanent program storage, either PROM memory,
 
minifloppy disk, floppy disk, or cassette recorder
 
4) Serial (RS-232) link to the VAX
 I5) Analog input and output, with the sensitivity in certain 
applications as low as 50-100 mV 
6) User-accessible clock 
7) Keyboard and CRT or LED-type alphanumeric display for communication I 
with the user
 
8) Local graphic display or plotter capability
 
9) Local program development capability
 I10) Support for at least one higher level language
 




In a minimal system in which the microcomputer is used only as 
a dedicated controller or preprocessor and where no further system development 
or additional use of the system is anticipated, having only PROM memory I 
for permanent program storage would be sufficient. Local graphic display 
or plotter capability, local program development capability, or higher 
level language support would not be necessary. Ease and extent of system Iuse, as well as user interest, user acceptance, and user development of 
new applications for the system would be greatly enhanced by inclusion 
of these additional features, however. I 
We have examined in detail possible VAX satellite terminal configurations 
based on the Rockwell AIM-65 single board microcomputer, the Digital Equipment 
Corporation LSI-II microcomputer, the Apple Computer, and the Hewlett Packard I 
1~-85 personal computer. In each case it is possible to configure a terminal 
having the necessary performance and capability. The cost and ease of 
use for a biochemist vary considerably, however. Cost of a VAX satellite Iterminal would be approximately $2000 with the AIM-65, $2000 - $4000 with 
I 




 the Apple Computer, $4500 - $5500 with the Hewlett Packard HP-85, and 
$4000 - $9000 with the LSI-II microcomputer. The Apple Computer or HP-85­I based satellite terminal would be easiest for a biochemist to use. 
Again, which of these alternatives is selected will depend on the 
needs and both the financial and technical resources of the individual 
investigator. Furthermore, it must be concluded that the LSI-II-basedi:l, 
microcomputer system which we have been using, developed along the guidelines 
outlined above for VAX satellite terminals, represents but one of a spectrum 
of equally attractive solutions to the problem of automating instruments 
present in biochemistry laboratories. 
G-8. A Wiring-List System for Augat and TM-500 Hardware 
Personnel: M. W. Browder, BCL 
C. A. Branyan, BCL 
R. E. Hitchens, BCL 
Support: RR 00396 
The wiring list system remains a viable tool in the implementation 
of hardware designs. Due to the expanded use (C-l, C-6, C-7) of TM-500 
modules, the wiring list system was expanded to provide support for these 
modules. The system currently supports designs for Augat cards, TH-500 
modules as well as a translation facility for use with design configurations 
other than these two layouts. 
G-9. Solid-State Video Camera Characterization 
Personnel: J. S. Massey, BCL 
G. J. Blaine, BCL 
V. W. Gerth, Jr., BCL 
Support: RR 00396 
In recent years, television cameras with solid-state imagers have 
become commercially available and economical. The imagers in these cameras 
use charge transfer technology, such as charge coupled devices (CCD) or 
charge injection devices (CID) , to obtain an image. Lack of phosphor 
burning, short image lag, and relative absence of shading are among the 






Several CCD and crD cameras have been introduced recently which also have 
resolution approaching that of standard television devices. Thus, there 
is reason to believe that the unique characteristics of these cameras Imake their use in biomedical imaging systems desirable. 
A General Electric Model TN-2500 solid-state camera has been used 
for several image acquisition experiments (B-16, F-4, G-14). The GE imager I 
utilizes a CrD array of 244 by 248 elements. The imager array is scanned 
at TV frame rates and each element is sampled and digitized to a resolution 
of 8 bits. The camera unit provides digital outputs for data and control. I 
Although parameter definitions and measurement techniques are stan­
dardized for vacuum-type sensors, comparable documentation of the recently Iavailable solid-state imaging devices is not available. Successful application 
of the crD or CCD devices depends on an adequate characterization of properties 
such as spectral sensitivity, dynamic response, uniformity, and intensity. 
Work has been initiated to define the parameters relevant to a variety I 





G-IO. DNA Restriction Mapping Studies 
Personnel:	 V. w. Gerth, BCL I 
G. J. Blaine, BCL 
J. G. Dunham, BCL 
A. J. Gray,	 BCL IJ. S. Massey, BCL 
M. V. Olson, Ph.D., Genetics
 
SO. R. Prothero, BCL
 IL. J. Thomas, Jr., BCL 
Support:	 RR 00396 
Washington University I 
The objective of this activity is to construct a restriction map Iof yeast DNA sequences that is precisely catalogued with respect to the 
genomic origins of each clone. This map could be expected to be a valuable 
resource for a wide variety of experiments. I 
Analysis of the yeast genome could also be used as a rigorous proving 
ground for the coupling of automated methods of data acquisition and analysis 
to the simple experimental procedure of displaying restriction digests I 
on electrophonetic gels. This strategy, in turn, offers promise for bringing 
large-scale problems such as the restriction mapping of extremely complex 










Any presently forseeable method of physically mapping eukaryotic 
chromosomes will have to depend upon identifying overlapping DNA sequences 
in a pool of cloned recombinant DNA molecules. Currently-used methods, 
such as DNA-DNA hybridization, are ill-suited to large problems because 
the overlaps must be identified sequentially and because of the large 
I
 amount of time required to determine each overlap.
 
The alternative procedure proposed by this project uses the simpler
 
method of displaying restriction digests on electrophonetic gels to obtain
I independent data on a large number of clones. This is followed by a computer­
assisted topological analysis of the results.
 
I




of Eco RI fragments in approximately 3000 clon~s. This will require quan­

tifying the mobilities of approximately 5 x 10 fragments on 500 separate
 
gels. Precision of the gel reading is crucial, since pattern recognition
 
methods will be used for data reduction. Hand measurement methods will 
not provide the necessary precision, and are also too time-consuming. 
Reasonably-priced conventional gel scanners also have problems with precision,I since sample and reference gel lanes must be independently scanned and the resulting data aligned afterwards. In addition, such systems involve 
even more human labor than hand measurement. 
I 
I Therefore we propose to construct an automated image-acquisition 
system specifically designed to interpret photographs of gels on which 
restriction digests of DNA samples have been analyzed. This system would 
provide complete automation of the data acquisition, allow computer assisted 
human editing of the results, and output the fragment-size data in machine­
readable form for the topologic analysis by computer. 
I 
I Preliminary image acquisition experiments have been conducted and 
a system configuration has been proposed. Experiments conducted using 
a solid-state video camera (G-IO) indicated that a minimum resolution 
of 1024 elements per gel-lane would be required. Since the video camera's 
resolution is only 248 elements in one direction, a linear array (resolutions 
up to 1728 elements are currently available) and stage arrangement areI proposed. Attempts were made to read data directly from the gels, since the photographic process could conceivably introduce distortions which 
might affect the measurements. However, the low level of fluorescence 
I emitted by the dyed gel under ultraviolet light was insufficient to obtain 
I 
good data from the solid state imager. Backlighted photographic negatives 
were found to provide adequate light intensity and have the added advantage 
of being easy to handle and archive. 
The proposed system configuration is based on an LSI-II microcomputer 
for data acquisition, and fragment analysis. A graphics terminal wouldI facilitate interactive editing of results by the investigator. The resulting analyses of fragment sizes would be communicated to the computing center 









VI. INDUSTRIAL COLLABORATION 
IOne of the goals of the Biomedical Computer Laboratory is to foster 
the commercial development of useful medical computer systems. Industrial 
collaboration provides an additional outlet for laboratory developments 
and benefits the staff by keeping it abreast of the practical considerations I 
of reliability, maintainability, and cost. Progress being made in this 
important phase of the laboratory's activities is summarized here. IA. Arrhythmia Monitoring. Longstanding collaboration (PR 15, VI-A) 
with the Mennen-Medical Company (formerly Mennen-Greatbatch) continues in 
the areas of algorithm and experience sharing of the new QRS detector/ 
delineator (A-I). Concepts originally tested at BCL in a Holter-tape I 
processing environment have been applied to Mennen's monitoring system where 
they are now undergoing evaluation in the real-time environment. (BCL 
personnel: K. W. Clark, C. N. Mead, L. J. Thomas, Jr.) I 
B. Collaborative Drug Study. Following FDA approval of the experi­
mental design, a research project was begun in 1976 to evaluate the safety Iand efficacy of a beta-adrenergic antagonist, LB-46, on ventricular irritability 
(PR 15, VI-B). The study was underwritten by Sandoz-Wander, Inc., developer 
of LB-46. Patients were recruited at the Jewish Hospital of St. Louis. 
The study protocol was a double-blind crossover, against placebo, of 20 I 
ambulatory patients with a qualifying average-PVC rate of more than 20 PVCs/hr 
detected in a 24-hour baseline Holter recording. In addition to the relevant 
clinical observations and laboratory tests, a total of seven 24-hour Holter I 
tapes per patient were collected and analyzed on the Argus/H or Argus/2H 
arrhythmia analysis systems. The beat-by-beat results are now undergoing 
biostatistical analysis. (BCL personnel: K. W. Clark, K. A. Madden, IJ. P. Miller, G. C. Oliver, L. J. Thomas, Jr.) 
C. Exportation of Argus/2H Technology. Through a formal agreement 
between Washington University (WU) and Cardio-Bionic-Scanning-Incorporated I 
(CBS), BCL personnel have consulted for CBS to Digital Equipment Corporation 
(DEC) for a feasibility study to be offered by DEC to CBS for developing 
at DEC a high-speed Holter-tape processing system which would utilize much I
of the technology developed for the Argus/2H arrhythmia analysis system. 
The feasibility study was completed, and BCL reviewed it favorably but with 
minor reservations. The WU-CBS agreement could continue into an implementation 
phase at the option of CBS, which is now reviewing the financial feasibility I 
of the project. (BCL Personnel: K. W. Clark, R. E. Hitchens, C. N. Mead, 







VII. TRAINING ACTIVITIES 
During the year the Biomedical Computer Laboratory engaged in the 
following training activities: 
Introductory MUMPS Programming Course for Beginners, Fall 1979. 
A high-level programming language (~assachusetts General Hospital 
Qtility ~ulti-frogramming~stem - MUMPS), especially well suited for 
medical information systems and other textual and database applications, 
was presented by Joel Achtenberg, A.B. An Interactive MUMPS teaching 
program and access to a computer which supports Standard MUMPS were provided 
for laboratory exercises. 
Attending the course were: 
Alex Barnett, B.A. Computer Science 
Matthew Bodner, B.A. The Jewish Hospital 
Philip Burke, B.S. Psychiatry 
David Chi, M.S. Neurology 
Barbara Clark, B.S. Surgery, Wohl Hospital 
Lisa Clement Diabetes Education Center 
Seymour Fox, M.D. Radiation Oncology 
Donna Gross, M.S.W. Social Work, Washington University 
Ronald W. Hagen, M.S. Biomedical Computer Laboratory 
Wardell J. Hardy, A.A.S. Clinical Research Center 
Millard F. Johnson, M.L.S. Medical School Library 
Patricia Kane, M.L.S. Medical School Library 
Stephen A. Klem, A.B. WUMS I Medical Student 
Arthur M. Krieg, B.S. WUMS I Medical Student 
Kathleen A. Madden, A.B. Biomedical Computer Laboratory 
Jane McBride Radiation Oncology 
Yoshi S. Matsumoto Medical School Library 
Anneliese Pelech, R.N. The Jewish Hospital 
Michael A. Province, M.A. Biomedical Computer Laboratory 
Linda Rahmoller, A.A.S. The Jewish Hospital 
Polly E. Raith Biomedical Computer Laboratory 
Howard W. Renz Pre-med Student 
Steven Robinson, A.B. Medical School Library 
Loretta Stucki, M.S. Medical School Library 
Marcia Tenenbaum, B.S. Internal Medicine 
Patricia K. Thompson, B.S. Metabolism 
Eufaula Thornton Biomedical Computer Laboratory 
Ron Tissier, Ph.D. Radiation Oncology 
Deborah A. Valenzuela Glaucoma Center 




During the year the following seminars were sponsored by the 
I 
I 
Biomedical Computer Laboratory: 
"A Personal Philosophy of Data 
Systems" or "Why MUMPS?" or 
"That's a Helluva Way to Use a 
Computer" 
July 12, 1979 
"Series 3200 and Series 16 
Minicomputer Systems" 
August 23, 1979 
lIAcquisition and Processing of 
the Visual Evoked Response" 
October 31, 1979 
"Performance Bounds for Noiseless 
Source Coding" 
April 25, 1980 
"Automated Film Developer for 
Time-Lapse Cinemicrographs ll 
May 12, 1980 
I 
Mr. David A. Bridger 
Department of Pathology 
St. Louis University Medical School I 
St. Louis, Missouri 
I 
Mr. Arthur Prichard 
Computer Systems Division IPerkin-Elmer 
St. Louis, Missouri I 
Mr. James K. Hontrose 
Biomedical Computer Laboratory and 
Department of Electrical Engineering I 
Washington University 
St. Louis, Missouri I 
Dr. James G. Dunham 
Department of Electrical Engineering 
Washington University I 
St. Louis, Missouri 
IMr. Steve Von Rump 
Department of Electrical Engineering 
Washington University 










I IX. PUBLICATIONS AND ORAL PRESENTATIONS 
I Ahumada, G. G., Karlsberg, R. P., Jaffe, A. S., Ambos, H. D., Sobel, B. E., 
and Roberts, R., "Reduction of Early Ventricular Arrhythmia by Acebutolol 
I
 in Patients with Acute Myocardial Infarction," British Heart Journal, vol. 41,
 pp. 654-659, 1979. 
Ambos, H. D., Geltman, E. M., and Roberts, R., "The Relationship Between
I Infarct Size and the Time of Development of Q Waves," accepted for presentation




I American Heart Association Committee on Electrocardiography: Geselowitz, D. B.,
 
Arzbaecher, R. C., Barr, R. C., Briller, S. A., Damato, A. N., Flowers, N., 
I Millar, K., Oliver, G. C., Plonsey, R., and Smith, R. E., "Electrical Safety Standards for Electrocardiographic Apparatus," Circulation, vol. 61, no. 4., pp. 669-670, April 1980 (editorial). 
I Bergmann, S. R., Hack, S., Tewson, T., Welch, M. J., and Sobel, B. E., "The Dependence of Accumulation of l3NH3 by Myocardium on Metabolic Factors and Its 
Implications for Quantitative Assessment of Perfusion," Circulation, vol. 61, 
I
 pp. 34-43, 1980.
 
Bergmann, S. R., Yokoyama, M., Corr, P. B., and Sobel, B. E., "Lysophosphatidyl 
I Choline Induced Constriction of Isolated Coronary Arteries and Dysfunction of Isolated Hearts," Clinical Research, vol. 27, p. l54A, 1979 (abstract). 
I
 
Biello, D. R., Ambos, H. D., Sampathkumarin, K. S., and Hitchens, R. E.,
 
"A Cost-Effective, Portable, Digital Data Collection System," Journal of
 
Nuclear Medicine Technology, vol. 7, no. 3, pp. 154-156, September 1979. 
I Bowen, W. G., Branconi, J. M., Goldstein, R. A., Cain, M. E., Brodarick, S. M., Geltman, E. M., Jaffe, A. S., Ambos, H. D., and Roberts, R., "A Randomized 
Prospective Study of the Effects of Intravenous Nitroglycerin in Patients 
During Myocardial Infarction," Circulation, vol. 60, supplement II, p. 11-70,I 1979 (abstract). 
I 
Brandenburger, L. L., Oliver, G. C., Miller, J. P., Thomas, Jr., L. J., and 
Moore, P., "Development of a Computer-Assisted Follow-Up Method for Clinical 
Research," accepted for presentation at the Fourth Annual Symposium on Computer 
Applications in Medical Care, Washington, D. C., November 2-5, 1980. 
I Browder, M. W., Blaine, G. J., Montrose, J. K., Coben, L. A., and Thomas, Jr.,
 
L. J., "Visual Evoked Potential: Computer Assisted Acquisition and Processing,"
 
accepted for presentation at the Fourth Annual Symposium on Computer Applications
I in Medical Care, Washington, D. C., November 2-5, 1980.
 
Cain, M. E., Ruwitch, J. F., and Geltman, E. M., "Disparity Between Uniform 
I
 and Multiform Ventricular Tachycardia: Role of Initial Coupling Interval,"







Cheng, N. C., and Snyder, D. L., "A New Algorithm and Architecture for Fan 
Beam Tomography," Proceedings of the Society of Photo-Optical Instrumentation 
Engineers, vol. 180, p. 74, September 1979. I
 
Clark, G. L., Siegel, B. A., and Sobel, B. E., "External Evaluation of
 





Clark, R. E., and Swanson, W. M., "Durability of Prosthetic Heart Valves 
in Vitro and in Vivo," Prosthetic Heart Valves: Proceedings of the AAMI I
Symposium, pp. 443-452, 1979.
 
Corr, P. B., "Potential Arrhythmogenic Role of Biochemical Factors in Sudden 
Cardiac Death," in Ambulatory ECG Recording, Year Book Medical Publishers, I
 
in press. 
Corr, P. B., Snyder, D. W., Cain, M. E., and Sobel, B. E., "Slow Response I
 
Action Potentials Induced by Lysophosphoglycerides," Circulation, vol. 60,
 
supplement II, p. 11-85, 1979 (abstract).
 I
Corr, P. B., Snyder, D. W., and Sobel, B. E., "Potentiation of Arrhythmogenic
 
Effects of Lysophosphoglycerides by Acidosis," Clincal Research, vol. 28,
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x. MONOGRAPHS AND WORKING NOTES 
I 
I The Biomedical Computer Laboratory's Monograph Series was established 
to systematize the many reports, reprints, program descriptions and other 
documents written at BCL or supported in part by the Laboratory's facilities 
or staff. 
I A forum, much less formal than our monograph series, has been instituted to serve as a repository for materials such as: research notes, 
system and component documentation, technical survey notes and pre­
publication drafts. A Working Note File is maintained for access by anyoneI associated with the Washington University Computer Labs. Distribution for outside use can be made available with the consent of the contributor. 
I Monographs 
I 
Following is a list of the monographs published by BCL during the 
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